[{"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"hashtags":[{"start":23,"end":35,"tag":"RareDisease"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"438327225814118401"}],"text":"RT @eurordis: EURORDIS #RareDisease Day 2014 Policy Event: European Reference Networks provide care, reserch, best practices, training acro…","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438337068868313088","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-25T15:37:55.000Z","id":"438337068868313088","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":109,"end":124,"tag":"RareDiseaseDay"}],"urls":[{"start":86,"end":108,"url":"http://t.co/jT9MpwkY7D","expanded_url":"http://bit.ly/1cjFONF","display_url":"bit.ly/1cjFONF"}],"annotations":{}},"referenced_tweets":{},"text":"We've recommended 12 medicines for the treatment of rare diseases over the past year: http://t.co/jT9MpwkY7D #RareDiseaseDay","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":3,"quote_count":0},"conversation_id":"438327181207691264","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-25T14:58:38.000Z","id":"438327181207691264","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"hashtags":[{"start":20,"end":28,"tag":"Ranbaxy"},{"start":51,"end":56,"tag":"drug"}],"urls":[{"start":113,"end":135,"url":"http://t.co/OHtNCXiZl4","expanded_url":"http://ecoti.ms/fBeJvY","display_url":"ecoti.ms/fBeJvY"}],"annotations":[{"start":94,"end":111,"probability":0.5473,"type":"Organization","normalized_text":"The Economic Times"}]},"referenced_tweets":[{"type":"retweeted","id":"438323148891512832"}],"text":"RT @nakosbalamotis: #Ranbaxy Laboratories suspends #drug ingredients shipment from 2 plants - The Economic Times http://t.co/OHtNCXiZl4","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438326417907286016","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-25T14:55:36.000Z","id":"438326417907286016","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"hashtags":[{"start":23,"end":35,"tag":"RareDisease"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"438311407692812288"}],"text":"RT @eurordis: EURORDIS #RareDisease Day 2014 Policy Event: Involving patients in funding and all decisions key to addressing unmet medical …","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438311473497272320","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-25T13:56:13.000Z","id":"438311473497272320","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"JeanGeorgesAE","id":"1502220312"},{"start":104,"end":113,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"438291204690952192"}],"text":"RT @JeanGeorgesAE: Joint meeting of patients and consumers with healthcare professionals this afternoon @EMA_News: Pharmacovigilance &amp; tran…","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438291706774298624","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-25T12:37:40.000Z","id":"438291706774298624","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"},{"start":66,"end":75,"username":"eurordis","id":"26993786"}],"hashtags":[{"start":28,"end":40,"tag":"RareDisease"}],"urls":[{"start":76,"end":98,"url":"http://t.co/EoXipR1xvN","expanded_url":"http://ow.ly/tXn7v","display_url":"ow.ly/tXn7v"}],"annotations":[{"start":54,"end":61,"probability":0.9659,"type":"Place","normalized_text":"Brussels"}]},"referenced_tweets":[{"type":"retweeted","id":"438282799301550080"}],"text":"RT @rarediseaseday: Now on: #RareDisease Day event in Brussels by @eurordis http://t.co/EoXipR1xvN IMPROVING ACCESS to RARE DISEASE CARE: T…","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438287613594976256","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-25T12:21:24.000Z","id":"438287613594976256","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"hashtags":[{"start":34,"end":46,"tag":"RAREDISEASE"},{"start":99,"end":111,"tag":"RareDisease"},{"start":130,"end":139,"tag":"Brussels"}],"urls":[{"start":76,"end":98,"url":"http://t.co/F9H6kHr9cQ","expanded_url":"http://ow.ly/tYcHE","display_url":"ow.ly/tYcHE"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"438281019574472704"}],"text":"RT @eurordis: IMPROVING ACCESS to #RAREDISEASE CARE: THE VISION of PATIENTS\nhttp://t.co/F9H6kHr9cQ\n#RareDisease Day roundtable in #Brussels","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438287562344759296","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-25T12:21:12.000Z","id":"438287562344759296","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"hashtags":{},"urls":{},"annotations":[{"start":35,"end":44,"probability":0.5411,"type":"Person","normalized_text":"Ledipasvir"},{"start":50,"end":59,"probability":0.4008,"type":"Person","normalized_text":"Sofosbuvir"},{"start":114,"end":119,"probability":0.9784,"type":"Place","normalized_text":"Europe"}]},"referenced_tweets":[{"type":"retweeted","id":"438259242605494272"}],"text":"RT @Hep_Alliance: EMA advice means Ledipasvir and Sofosbuvir can now be used in compassionate use programs across Europe http://t.co/vWNyYw…","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438287076594024448","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-25T12:19:16.000Z","id":"438287076594024448","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"JeanGeorgesAE","id":"1502220312"},{"start":68,"end":77,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"438230106327511040"}],"text":"RT @JeanGeorgesAE: Attending Patients' and Consumers' Working Party @EMA_News today - EMA framework for interaction with patients to be dis…","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438247459815710720","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-25T09:41:51.000Z","id":"438247459815710720","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":10,"username":"louis_ide","id":"1548804618"},{"start":11,"end":22,"username":"bmj_latest","id":"16949344"}],"hashtags":{},"urls":[{"start":111,"end":133,"url":"http://t.co/wGi7gyK8z7","expanded_url":"http://bit.ly/19ulYBT","display_url":"bit.ly/19ulYBT"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"438014553889046528"}],"text":"@louis_ide @bmj_latest Yes we have seen your tweets. Information on our ongoing review of domperidone is here: http://t.co/wGi7gyK8z7","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"437938671841337344","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-25T09:40:54.000Z","id":"438247221520510976","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"1548804618","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":122,"end":144,"url":"http://t.co/EAcZzqlxnF","expanded_url":"http://bit.ly/1k4MrLE","display_url":"bit.ly/1k4MrLE"}],"annotations":{}},"referenced_tweets":{},"text":"Comment on our Q&amp;A on benzoic acid and benzoates for the revision of a guideline on excipients in medicine labelling: http://t.co/EAcZzqlxnF","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"438011832192598016","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-24T18:05:33.000Z","id":"438011832192598016","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":120,"end":142,"url":"http://t.co/MrkoCeOu6Q","expanded_url":"http://bit.ly/1cGSjpA","display_url":"bit.ly/1cGSjpA"}],"annotations":{}},"referenced_tweets":{},"text":"Comments invitied on a Q&amp;A on benzyl alcohol for the revision of the guideline on excipients in medicine labelling: http://t.co/MrkoCeOu6Q","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438011711262437376","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-24T18:05:04.000Z","id":"438011711262437376","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":112,"end":134,"url":"http://t.co/p1igTkqveC","expanded_url":"http://bit.ly/1do5Lfd","display_url":"bit.ly/1do5Lfd"}],"annotations":{}},"referenced_tweets":{},"text":"Comments invited on a Q&amp;A on ethanol for the revision of the guideline on excipients in medicine labelling: http://t.co/p1igTkqveC","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438011608942403584","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-24T18:04:40.000Z","id":"438011608942403584","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":90,"end":112,"url":"http://t.co/wxBKopxh3g","expanded_url":"http://bit.ly/1bcBnsu","display_url":"bit.ly/1bcBnsu"}],"annotations":{}},"referenced_tweets":{},"text":"One week left to comment on draft product-specific bioequivalence guidance for sunitinib: http://t.co/wxBKopxh3g","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"438011501840855040","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-24T18:04:14.000Z","id":"438011501840855040","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":96,"end":111,"username":"rarediseaseday","id":"19982434"}],"hashtags":{},"urls":[{"start":73,"end":95,"url":"http://t.co/yxKi3rqb05","expanded_url":"http://bit.ly/1k4fyvo","display_url":"bit.ly/1k4fyvo"}],"annotations":[{"start":37,"end":66,"probability":0.8945,"type":"Other","normalized_text":"International Rare Disease Day"}]},"referenced_tweets":[{"type":"retweeted","id":"437990957892374528"}],"text":"RT @EFPIA: 21 ways to participate in International Rare Disease Day 2014 http://t.co/yxKi3rqb05 @rarediseaseday","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438011158688436224","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-24T18:02:52.000Z","id":"438011158688436224","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":27,"end":37,"username":"EAHPtweet","id":"203357203"}],"hashtags":[{"start":38,"end":41,"tag":"EU"},{"start":42,"end":50,"tag":"Monitor"},{"start":76,"end":86,"tag":"medicines"},{"start":87,"end":97,"tag":"barcoding"},{"start":104,"end":111,"tag":"eahp14"}],"urls":[{"start":112,"end":134,"url":"http://t.co/3P1wUpY7DE","expanded_url":"http://bit.ly/1firm8j","display_url":"bit.ly/1firm8j"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"437994668282744833"}],"text":"RT @EAHPtweet: This week's @EAHPtweet #EU #Monitor covers FMD Dir, PQD Dir, #medicines #barcoding &amp; #eahp14 http://t.co/3P1wUpY7DE http://t…","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438011077067288576","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-24T18:02:33.000Z","id":"438011077067288576","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"hashtags":{},"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"438009529591427072"}],"text":"RT @FDA_MCMi: April 3-4: NIAID/FDA workshops - Dengue Human Infection Model &amp; Regulatory Issues Related to Dengue Vaccines http://t.co/qEZn…","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"438010775509434368","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-24T18:01:21.000Z","id":"438010775509434368","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"},{"start":120,"end":134,"username":"dsw_worldwide","id":"860097711714033665"}],"hashtags":[{"start":28,"end":37,"tag":"Patients"},{"start":53,"end":64,"tag":"Innovation"},{"start":68,"end":81,"tag":"GlobalHealth"}],"urls":[{"start":97,"end":119,"url":"http://t.co/XTwW8inYbP","expanded_url":"http://bit.ly/1c0Bicd","display_url":"bit.ly/1c0Bicd"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"437883360824668160"}],"text":"RT @EPHA_EU: [Save the date]#Patients’ Needs Driving #Innovation in #GlobalHealth - March 10,Brx:http://t.co/XTwW8inYbP @dsw_worldwide @EFP…","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"437961973129809920","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-24T14:47:26.000Z","id":"437961973129809920","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":53,"end":60,"tag":"cancer"}],"urls":[{"start":67,"end":89,"url":"http://t.co/OAPhhqUxuM","expanded_url":"http://bbc.in/1flxwsV","display_url":"bbc.in/1flxwsV"},{"start":90,"end":112,"url":"http://t.co/k3IV01HtjC","expanded_url":"https://twitter.com/EFPIA/status/437887937829535746/photo/1","display_url":"pic.twitter.com/k3IV01HtjC"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"437887937829535746"}],"text":"RT @EFPIA: DNA prostate test 'will predict deadliest #cancer risk' http://t.co/OAPhhqUxuM http://t.co/k3IV01HtjC","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"437961824479498240","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-24T14:46:50.000Z","id":"437961824479498240","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":["3_437887937837924352"]}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"}],"hashtags":[{"start":13,"end":22,"tag":"post2015"},{"start":32,"end":45,"tag":"GlobalHealth"},{"start":73,"end":75,"tag":"R"},{"start":94,"end":106,"tag":"development"}],"urls":[{"start":117,"end":139,"url":"http://t.co/m7L5BA0lzy","expanded_url":"http://bit.ly/1cHihtj","display_url":"bit.ly/1cHihtj"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"437940071161794560"}],"text":"RT @EPHA_EU: #post2015: Role of #GlobalHealth Research and Development ( #R&amp;D) in the new #development framework:http://t.co/m7L5BA0lzy  @P…","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"437959174321082368","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-24T14:36:18.000Z","id":"437959174321082368","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":16,"username":"JanetWilliams99","id":"250163834"},{"start":17,"end":27,"username":"Emma4facs","id":"277466861"}],"hashtags":{},"urls":[{"start":74,"end":96,"url":"http://t.co/rtRAGqmWa5","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"437712284362629120"}],"text":"@JanetWilliams99 @Emma4facs Please submit any data using our online form: http://t.co/rtRAGqmWa5. Different process for Art 107i referrals.","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"437712284362629120","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-24T11:43:07.000Z","id":"437915591450820608","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"250163834","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":90,"end":112,"url":"http://t.co/OTozfYOtrx","expanded_url":"http://bit.ly/1bcBnsu","display_url":"bit.ly/1bcBnsu"}],"annotations":{}},"referenced_tweets":{},"text":"One more week to comment on draft product-specific bioequivalence guidance for sunitinib: http://t.co/OTozfYOtrx","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"437904965844344832","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-24T11:00:54.000Z","id":"437904965844344832","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":105,"end":127,"url":"http://t.co/cJUuMC9tBn","expanded_url":"http://bit.ly/1do5Lfd","display_url":"bit.ly/1do5Lfd"}],"annotations":{}},"referenced_tweets":{},"text":"We've issued a Q&amp;A on ethanol for the revision of the guideline on excipients in medicine labelling: http://t.co/cJUuMC9tBn","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"437898733154746368","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-24T10:36:08.000Z","id":"437898733154746368","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":112,"end":134,"url":"http://t.co/qxdS5MJwl6","expanded_url":"http://bit.ly/1cGSjpA","display_url":"bit.ly/1cGSjpA"}],"annotations":{}},"referenced_tweets":{},"text":"We've issued a Q&amp;A on benzyl alcohol for the revision of the guideline on excipients in medicine labelling: http://t.co/qxdS5MJwl6","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"437898427373191168","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-24T10:34:55.000Z","id":"437898427373191168","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":122,"end":144,"url":"http://t.co/y3DwZBFODG","expanded_url":"http://bit.ly/1k4MrLE","display_url":"bit.ly/1k4MrLE"}],"annotations":{}},"referenced_tweets":{},"text":"We've issued a Q&amp;A on benzoic acid and benzoates for the revision of a guideline on excipients in medicine labelling: http://t.co/y3DwZBFODG","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"437898104365654016","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-24T10:33:38.000Z","id":"437898104365654016","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"hashtags":{},"urls":[{"start":97,"end":119,"url":"http://t.co/crFD5uRQPZ","expanded_url":"http://buff.ly/NhV5Z2","display_url":"buff.ly/NhV5Z2"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436921788707397632"}],"text":"RT @MHRAgovuk: Has a medicine or vaccine made your child sick? Report to the Yellow Card Scheme  http://t.co/crFD5uRQPZ http://t.co/LrKWORF…","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436931213253955585","author_id":"116716199","source":"Twitter for iPad","created_at":"2014-02-21T18:31:33.000Z","id":"436931213253955585","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"iTrainEU","id":"703909451439460356"}],"hashtags":[{"start":49,"end":56,"tag":"EUPHEM"},{"start":81,"end":86,"tag":"ECDC"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436921363442704384"}],"text":"RT @iTrainEU: Ever wanted to know in detail what #EUPHEM fellow do for a living?\n#ECDC publishes their reports. For example: http://t.co/H3…","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436931191292575745","author_id":"116716199","source":"Twitter for iPad","created_at":"2014-02-21T18:31:28.000Z","id":"436931191292575745","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"hashtags":{},"urls":[{"start":74,"end":96,"url":"http://t.co/nnSeCwiYgP","expanded_url":"http://www.infarmed.pt/portal/page/portal/INFARMED/MAIS_ALERTAS/DETALHE_ALERTA?itemid=9681873","display_url":"infarmed.pt/portal/page/po…"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"436920210600112128"}],"text":"RT @INFARMED_IP: Protelos and Osseor - New recommendation to restrict use http://t.co/nnSeCwiYgP","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"436920210600112128","author_id":"116716199","source":"Twitter for iPad","created_at":"2014-02-21T18:30:41.000Z","id":"436930995577962496","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"1392501529","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"hashtags":{},"urls":[{"start":73,"end":95,"url":"http://t.co/1zx3Lt4IOo","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON382706","display_url":"mhra.gov.uk/NewsCentre/Pre…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436908864530046976"}],"text":"RT @MHRAgovuk: New advice on osteoporosis medicine Protelos to be issued http://t.co/1zx3Lt4IOo","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436908967923834880","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-21T17:03:10.000Z","id":"436908967923834880","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":80,"end":87,"tag":"pharma"},{"start":88,"end":103,"tag":"pharmaceutical"}],"urls":[{"start":56,"end":78,"url":"http://t.co/ZA7X9QJ64N","expanded_url":"http://mnt.to/4kJ9","display_url":"mnt.to/4kJ9"}],"annotations":[{"start":24,"end":26,"probability":0.8517,"type":"Organization","normalized_text":"FDA"}]},"referenced_tweets":[{"type":"retweeted","id":"436908588435767296"}],"text":"RT @EFPIA: How does the FDA 'approve' medical products? http://t.co/ZA7X9QJ64N  #pharma #pharmaceutical","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436908860218281984","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-21T17:02:44.000Z","id":"436908860218281984","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":13,"end":25,"tag":"chikungunya"}],"urls":[{"start":115,"end":137,"url":"http://t.co/k0aebdX4Zj","expanded_url":"http://bit.ly/1fhouyA","display_url":"bit.ly/1fhouyA"}],"annotations":[{"start":42,"end":50,"probability":0.6253,"type":"Place","normalized_text":"Caribbean"},{"start":80,"end":92,"probability":0.9491,"type":"Place","normalized_text":"South America"}]},"referenced_tweets":[{"type":"retweeted","id":"436891398294740992"}],"text":"RT @ECDC_EU: #chikungunya outbreak in the Caribbean still ongoing, reaching now South America. ECDC latest update: http://t.co/k0aebdX4Zj","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436891555925069826","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-21T15:53:58.000Z","id":"436891555925069826","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"CDCgov","id":"146569971"}],"hashtags":{},"urls":[{"start":113,"end":135,"url":"http://t.co/eKNWAi9BGY","expanded_url":"http://go.usa.gov/Bsq3","display_url":"go.usa.gov/Bsq3"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436881605555392513"}],"text":"RT @CDCgov: Whooping cough is a very serious disease, especially for babies. Vaccines offer the best protection. http://t.co/eKNWAi9BGY","public_metrics":{"retweet_count":46,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436881758572007424","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-21T15:15:02.000Z","id":"436881758572007424","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"hashtags":[{"start":19,"end":23,"tag":"flu"}],"urls":[{"start":112,"end":134,"url":"http://t.co/AWEN3WzL02","expanded_url":"http://bit.ly/1fhk2Qv","display_url":"bit.ly/1fhk2Qv"}],"annotations":[{"start":46,"end":52,"probability":0.9329,"type":"Place","normalized_text":"Finland"},{"start":56,"end":61,"probability":0.9442,"type":"Place","normalized_text":"Greece"},{"start":85,"end":90,"probability":0.9755,"type":"Place","normalized_text":"Europe"}]},"referenced_tweets":[{"type":"retweeted","id":"436875687102656513"}],"text":"RT @ECDC_Flu: High #flu intensity reported by Finland &amp; Greece; mixed picture across Europe. Report week 7: http://t.co/AWEN3WzL02 http://t…","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436880134130647040","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-21T15:08:35.000Z","id":"436880134130647040","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":68,"end":75,"tag":"Pharma"},{"start":76,"end":83,"tag":"Health"},{"start":84,"end":93,"tag":"Podcasts"},{"start":94,"end":107,"tag":"Productivity"},{"start":108,"end":116,"tag":"EUFiles"},{"start":117,"end":126,"tag":"Strategy"},{"start":127,"end":136,"tag":"Genetics"}],"urls":[{"start":45,"end":67,"url":"http://t.co/LWu1qWDDE9","expanded_url":"http://bit.ly/1eduvGc","display_url":"bit.ly/1eduvGc"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436868183254118400"}],"text":"RT @EFPIA: It's FRIDAY! Read Our Newsletter! http://t.co/LWu1qWDDE9 #Pharma #Health #Podcasts #Productivity #EUFiles #Strategy #Genetics #S…","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436868518651637760","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-21T14:22:26.000Z","id":"436868518651637760","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"hashtags":[{"start":28,"end":40,"tag":"RareDisease"}],"urls":[{"start":115,"end":137,"url":"http://t.co/iZrb8szOZc","expanded_url":"http://www.rarediseaseday.org/article/what-is-rare-disease-day","display_url":"rarediseaseday.org/article/what-i…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436864251752620032"}],"text":"RT @rarediseaseday: What is #RareDisease Day? Find out what they day has meant and how it has evolved over 7 years\nhttp://t.co/iZrb8szOZc","public_metrics":{"retweet_count":41,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436865333685936128","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-21T14:09:46.000Z","id":"436865333685936128","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":{},"urls":[{"start":94,"end":116,"url":"http://t.co/7ts9ABHPst","expanded_url":"http://bit.ly/1fEOGOo","display_url":"bit.ly/1fEOGOo"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436858050587402240"}],"text":"RT @EFPIA: Scientists find resistance mechanism that could impact antibiotic drug development http://t.co/7ts9ABHPst","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436865174713430016","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-21T14:09:08.000Z","id":"436865174713430016","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"hashtags":{},"urls":[{"start":103,"end":125,"url":"http://t.co/Y6YTZZVB6i","expanded_url":"http://bit.ly/1jUM3iG","display_url":"bit.ly/1jUM3iG"}],"annotations":{}},"referenced_tweets":{},"text":"RT @AEMPSGOB: Finalisation of review of benefit-risk balance of strontium ranelate (Osseor, Protelos): http://t.co/Y6YTZZVB6i","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"436864877886709760","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-21T14:07:58.000Z","id":"436864877886709760","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"hashtags":[{"start":58,"end":70,"tag":"RareDisease"}],"urls":[{"start":85,"end":107,"url":"http://t.co/XWe4GPnglH","expanded_url":"http://www.rarediseaseday.org/page/news/rare-disease-day-2014-get-involved","display_url":"rarediseaseday.org/page/news/rare…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436855551847587840"}],"text":"RT @rarediseaseday: More ideas on ways to get involved in #RareDisease Day this year\nhttp://t.co/XWe4GPnglH","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436864168160153600","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-21T14:05:08.000Z","id":"436864168160153600","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":48,"end":70,"url":"http://t.co/lhgjSU3Dc7","expanded_url":"http://bit.ly/1edkwkm","display_url":"bit.ly/1edkwkm"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"436843242358079488"}],"text":"@Masrybs The information is now available here: http://t.co/lhgjSU3Dc7","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436801673097662464","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-21T14:01:42.000Z","id":"436863302426443776","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"738341252","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":18,"end":27,"tag":"Protelos"}],"urls":[{"start":85,"end":107,"url":"http://t.co/lhgjSU3Dc7","expanded_url":"http://bit.ly/1edkwkm","display_url":"bit.ly/1edkwkm"}],"annotations":{}},"referenced_tweets":{},"text":"We recommend that #Protelos / Osseor remain available but with further restrictions: http://t.co/lhgjSU3Dc7","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"436849994252181504","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-21T13:08:49.000Z","id":"436849994252181504","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":110,"end":132,"url":"http://t.co/CCCZ9aN72K","expanded_url":"http://bit.ly/1jjysPc","display_url":"bit.ly/1jjysPc"}],"annotations":[{"start":29,"end":32,"probability":0.47,"type":"Organization","normalized_text":"VICH"}]},"referenced_tweets":{},"text":"Send us your comments on the VICH guideline on file format requirements for electronic exchange of documents: http://t.co/CCCZ9aN72K","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436847057555689472","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-21T12:57:09.000Z","id":"436847057555689472","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":118,"end":140,"url":"http://t.co/h0InI7TgDN","expanded_url":"http://bit.ly/1aN4nXt","display_url":"bit.ly/1aN4nXt"}],"annotations":{}},"referenced_tweets":{},"text":"One more week to comment on reflection paper on data requirements for intravenous iron-based nano-colloidal products: http://t.co/h0InI7TgDN","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436846860834443264","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-21T12:56:22.000Z","id":"436846860834443264","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"hashtags":[{"start":20,"end":32,"tag":"RareDisease"}],"urls":[{"start":47,"end":69,"url":"http://t.co/zDuM6PFAY1","expanded_url":"http://ow.ly/i/4FsQD","display_url":"ow.ly/i/4FsQD"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436844131827347456"}],"text":"RT @rarediseaseday: #RareDisease Day in 1 week http://t.co/zDuM6PFAY1\nHow will you join together for better care this year?","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436846528461021184","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-21T12:55:03.000Z","id":"436846528461021184","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/R1ZfLKXlns","expanded_url":"http://bit.ly/1d9HnxG","display_url":"bit.ly/1d9HnxG"}],"annotations":[{"start":20,"end":33,"probability":0.4831,"type":"Person","normalized_text":"Dagens Medisin"}]},"referenced_tweets":{},"text":"RT @Legemiddelinfo: Dagens Medisin writes about the Norwegian medicines agency's guidance to industry / academia: http://t.co/R1ZfLKXlns","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436846477370208256","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-21T12:54:51.000Z","id":"436846477370208256","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":8,"username":"redacre","id":"380500399"}],"hashtags":{},"urls":[{"start":33,"end":55,"url":"http://t.co/e6xuVjIVOt","expanded_url":"http://bit.ly/1fhaJjf","display_url":"bit.ly/1fhaJjf"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"436833713213947904"}],"text":"@redacre They're available here: http://t.co/e6xuVjIVOt","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436833713213947904","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-21T12:50:01.000Z","id":"436845264620761088","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"380500399","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":72,"end":82,"tag":"hepatitis"}],"urls":[{"start":86,"end":108,"url":"http://t.co/oCuBhLywKN","expanded_url":"http://bit.ly/1edh6Ox","display_url":"bit.ly/1edh6Ox"}],"annotations":{}},"referenced_tweets":{},"text":"We advise on compassionate use of a new combination therapy for chronic #hepatitis C: http://t.co/oCuBhLywKN","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"436843996628144128","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-21T12:44:59.000Z","id":"436843996628144128","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":36,"end":49,"tag":"methysergide"}],"urls":[{"start":72,"end":94,"url":"http://t.co/qKyGx33uVc","expanded_url":"http://bit.ly/1hdLZFU","display_url":"bit.ly/1hdLZFU"}],"annotations":{}},"referenced_tweets":{},"text":"We recommend restricting the use of #methysergide-containing medicines: http://t.co/qKyGx33uVc","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"436843237119393792","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-21T12:41:58.000Z","id":"436843237119393792","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":93,"end":115,"url":"http://t.co/KjGDBQJKSZ","expanded_url":"http://bit.ly/1cxfzX6","display_url":"bit.ly/1cxfzX6"}],"annotations":{}},"referenced_tweets":{},"text":"We've just published a second positive opinion for a paediatric-use marketing authorisation: http://t.co/KjGDBQJKSZ","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"436842724483141632","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-21T12:39:56.000Z","id":"436842724483141632","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":25,"end":30,"tag":"CHMP"}],"urls":[{"start":52,"end":74,"url":"http://t.co/e6xuVjIVOt","expanded_url":"http://bit.ly/1fhaJjf","display_url":"bit.ly/1fhaJjf"}],"annotations":{}},"referenced_tweets":{},"text":"We've just published the #CHMP meeting highlights:  http://t.co/e6xuVjIVOt","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"436841929318612992","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-21T12:36:46.000Z","id":"436841929318612992","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":115,"end":137,"url":"http://t.co/CCCZ9aN72K","expanded_url":"http://bit.ly/1jjysPc","display_url":"bit.ly/1jjysPc"}],"annotations":{}},"referenced_tweets":{},"text":"We've released a VICH guideline on file format requirements for electronic exchange of documents for consultation: http://t.co/CCCZ9aN72K","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436817522533613568","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-21T10:59:47.000Z","id":"436817522533613568","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":{},"annotations":[{"start":42,"end":43,"probability":0.9253,"type":"Place","normalized_text":"UK"}]},"referenced_tweets":[{"type":"replied_to","id":"436801673097662464"}],"text":"@Masrybs We're publishing them at 12 noon UK time.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436801673097662464","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-21T09:57:53.000Z","id":"436801941939953664","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"738341252","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":25,"end":41,"username":"Eurosurveillanc","id":"455839750"}],"hashtags":[{"start":59,"end":65,"tag":"polio"}],"urls":[{"start":114,"end":136,"url":"http://t.co/NBoKpvwcOP","expanded_url":"http://bit.ly/1dTXMGj","display_url":"bit.ly/1dTXMGj"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436788165698154496"}],"text":"RT @ECDC_EU: This week's @Eurosurveillanc issue focuses on #polio and challenges to reach global eradication goal http://t.co/NBoKpvwcOP","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436788240876851200","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-21T09:03:26.000Z","id":"436788240876851200","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":118,"end":140,"url":"http://t.co/h0InI7TgDN","expanded_url":"http://bit.ly/1aN4nXt","display_url":"bit.ly/1aN4nXt"}],"annotations":{}},"referenced_tweets":{},"text":"One week left to comment on reflection paper on data requirements for intravenous iron-based nano-colloidal products: http://t.co/h0InI7TgDN","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436787895832440832","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-21T09:02:04.000Z","id":"436787895832440832","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":{},"urls":[{"start":122,"end":144,"url":"http://t.co/sV6y5W9QuP","expanded_url":"http://bit.ly/1brQbDM","display_url":"bit.ly/1brQbDM"}],"annotations":{}},"referenced_tweets":{},"text":"RT @LV_MPA: Innovation Office at the Medical Academy Seminar: Business models &amp; innovation strategies. See you there! http://t.co/sV6y5W9QuP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436786830986719232","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-21T08:57:50.000Z","id":"436786830986719232","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"USPharmacopeia","id":"47953929"},{"start":112,"end":126,"username":"FightTheFakes","id":"1860605736"}],"hashtags":[{"start":64,"end":73,"tag":"fakemeds"}],"urls":[{"start":85,"end":107,"url":"http://t.co/fqAGlxpQpm","expanded_url":"http://fightthefakes.org/join-the-fight","display_url":"fightthefakes.org/join-the-fight"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436545613342457856"}],"text":"RT @USPharmacopeia: Why should you join us in the fight against #fakemeds? Check out http://t.co/fqAGlxpQpm via @FightTheFakes","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436560525988995072","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-20T17:58:34.000Z","id":"436560525988995072","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"hashtags":[{"start":72,"end":76,"tag":"FDA"}],"urls":[{"start":115,"end":137,"url":"http://t.co/yNyCDsHsF0","expanded_url":"http://ht.ly/tNwS2","display_url":"ht.ly/tNwS2"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436549692751876097"}],"text":"RT @FDA_MCMi: For industry: How to report a shortage or supply issue to #FDA (includes drugs, biologics, devices): http://t.co/yNyCDsHsF0","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436560376709537792","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-20T17:57:59.000Z","id":"436560376709537792","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":78,"end":87,"tag":"pandemic"},{"start":88,"end":97,"tag":"vaccines"}],"urls":[{"start":117,"end":139,"url":"http://t.co/31EXTsNQH9","expanded_url":"http://bit.ly/1ff6xkj","display_url":"bit.ly/1ff6xkj"}],"annotations":{}},"referenced_tweets":{},"text":"We've published a document on lessons learned from the review of labelling of #pandemic #vaccines, for consultation: http://t.co/31EXTsNQH9","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"436559952057221120","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-20T17:56:18.000Z","id":"436559952057221120","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"ECNPtweets","id":"347180217"}],"hashtags":{},"urls":[{"start":112,"end":134,"url":"http://t.co/hkxzwjsKZR","expanded_url":"http://www.reuters.com/article/2014/02/18/health-depression-biomarker-idUSL6N0LM27720140218","display_url":"reuters.com/article/2014/0…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436442389591633920"}],"text":"RT @ECNPtweets: British scientists identified first biomarker that could help boys at risk of major depression. http://t.co/hkxzwjsKZR","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436473524103184384","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-20T12:12:52.000Z","id":"436473524103184384","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":36,"end":46,"tag":"influenza"},{"start":47,"end":53,"tag":"virus"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436443206054871041"}],"text":"RT @WHO: Recommended composition of #influenza #virus vaccines for use in the 2014-15 northern hemisphere influenza season http://t.co/trmJ…","public_metrics":{"retweet_count":73,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436473411754549248","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-20T12:12:25.000Z","id":"436473411754549248","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"hashtags":[{"start":50,"end":59,"tag":"IMPAKT14"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436449144237199360"}],"text":"RT @myESMO: Still a few places available for pre- #IMPAKT14 training course: transl. research in breast cancer. Register now! http://t.co/I…","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436473129968599040","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-20T12:11:18.000Z","id":"436473129968599040","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"hashtags":{},"urls":{},"annotations":[{"start":34,"end":54,"probability":0.4821,"type":"Organization","normalized_text":"Regulatory Rapporteur"}]},"referenced_tweets":[{"type":"retweeted","id":"436457727238619137"}],"text":"RT @TOPRANEWS: March's edition of Regulatory Rapporteur is out now - focus on the Paediatric Regulation. Read online: http://t.co/4mlDXSSQc…","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436472839534047232","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-20T12:10:08.000Z","id":"436472839534047232","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"hashtags":{},"urls":[{"start":112,"end":134,"url":"http://t.co/muDfoXXg9N","expanded_url":"http://bit.ly/1lyh51a","display_url":"bit.ly/1lyh51a"}],"annotations":[{"start":79,"end":84,"probability":0.9939,"type":"Place","normalized_text":"Surrey"},{"start":87,"end":88,"probability":0.7569,"type":"Place","normalized_text":"UK"}]},"referenced_tweets":[{"type":"retweeted","id":"436459594509189120"}],"text":"RT @TOPRANEWS: Five-day intensive regulatory affairs course starts 31 March in Surrey, UK. Book your place now: http://t.co/muDfoXXg9N #reg…","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436472759125041154","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-20T12:09:49.000Z","id":"436472759125041154","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":41,"end":50,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":57,"end":68,"tag":"IFAHEurope"}],"urls":[{"start":105,"end":127,"url":"http://t.co/V9CoqTdlBe","expanded_url":"http://bit.ly/1fr65LR","display_url":"bit.ly/1fr65LR"}],"annotations":[{"start":93,"end":98,"probability":0.9368,"type":"Place","normalized_text":"London"}]},"referenced_tweets":[{"type":"retweeted","id":"436436340872581120"}],"text":"RT @IFAHEurope: 1 week left to register! @EMA_News &amp; #IFAHEurope Info day, 13-14 March 2014, London: http://t.co/V9CoqTdlBe","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436441702279413760","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-20T10:06:25.000Z","id":"436441702279413760","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":91,"end":100,"tag":"pandemic"},{"start":101,"end":110,"tag":"vaccines"}],"urls":[{"start":112,"end":134,"url":"http://t.co/31EXTsNQH9","expanded_url":"http://bit.ly/1ff6xkj","display_url":"bit.ly/1ff6xkj"}],"annotations":{}},"referenced_tweets":{},"text":"We've published a consultation document on lessons learned from the review of labelling of #pandemic #vaccines: http://t.co/31EXTsNQH9","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436441290520416256","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-20T10:04:47.000Z","id":"436441290520416256","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":29,"end":34,"tag":"SMEs"},{"start":70,"end":80,"tag":"medicines"}],"urls":[{"start":111,"end":133,"url":"http://t.co/MlribWjdxt","expanded_url":"http://bit.ly/1kWgvcj","display_url":"bit.ly/1kWgvcj"}],"annotations":{}},"referenced_tweets":{},"text":"We're holding a workshop for #SMEs on 4 April focusing on quality for #medicines containing chemical entities: http://t.co/MlribWjdxt","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436440191436607488","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-20T10:00:24.000Z","id":"436440191436607488","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":39,"end":46,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":63,"end":81,"tag":"pharmacovigilance"}],"urls":[{"start":83,"end":105,"url":"http://t.co/CH4lyybNhT","expanded_url":"http://bit.ly/1jbUN18","display_url":"bit.ly/1jbUN18"}],"annotations":{}},"referenced_tweets":{},"text":"We're reinforcing our cooperation with @US_FDA in the field of #pharmacovigilance: http://t.co/CH4lyybNhT","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"436439588882878464","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-20T09:58:01.000Z","id":"436439588882878464","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":16,"end":23,"username":"US_FDA","id":"208120290"},{"start":28,"end":37,"username":"EMA_News","id":"116716199"},{"start":113,"end":122,"username":"FDA_MCMi","id":"1606025952"}],"hashtags":[{"start":66,"end":84,"tag":"pharmacovigilance"},{"start":90,"end":100,"tag":"medicines"},{"start":101,"end":108,"tag":"safety"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436193555741417472"}],"text":"RT @EU_Health: .@US_FDA and @EMA_News strengthen collaboration in #pharmacovigilance area #medicines #safety via @FDA_MCMi http://t.co/islZ…","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436193932859695105","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T17:41:52.000Z","id":"436193932859695105","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/kQiE8iDHVY","expanded_url":"http://bit.ly/1c2UxfN","display_url":"bit.ly/1c2UxfN"}],"annotations":{}},"referenced_tweets":{},"text":"RT @AEMPSGOB: Certificate of official documentary control of batch release for immunological veterinary medicines http://t.co/kQiE8iDHVY","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436193762474487809","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T17:41:11.000Z","id":"436193762474487809","possibly_sensitive":false,"lang":"ro","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"hashtags":[{"start":14,"end":18,"tag":"FDA"},{"start":23,"end":32,"tag":"European"},{"start":78,"end":96,"tag":"pharmacovigilance"}],"urls":[{"start":103,"end":125,"url":"http://t.co/qO5TRSzYp7","expanded_url":"http://ht.ly/tN2NF","display_url":"ht.ly/tN2NF"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436191572221517824"}],"text":"RT @FDA_MCMi: #FDA and #European Medicines Agency strengthen collaboration in #pharmacovigilance area. http://t.co/qO5TRSzYp7 (via @FDA_Dru…","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436191691440410624","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T17:32:57.000Z","id":"436191691440410624","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":65,"end":71,"username":"H_I_N","id":"15170795"}],"hashtags":[{"start":11,"end":24,"tag":"Infographics"}],"urls":[{"start":103,"end":125,"url":"http://t.co/OtsdEyTWrd","expanded_url":"http://www.pinterest.com/efpia/","display_url":"pinterest.com/efpia/"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436188557414522880"}],"text":"RT @EFPIA: #Infographics: The State of Healthcare Innovation via @H_I_N and on EFPIA's Pinterest board http://t.co/OtsdEyTWrd...","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436188643611660288","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T17:20:51.000Z","id":"436188643611660288","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":28,"end":37,"tag":"European"},{"start":83,"end":101,"tag":"pharmacovigilance"}],"urls":[{"start":108,"end":130,"url":"http://t.co/9nE8TcsEq7","expanded_url":"http://1.usa.gov/1h6EwIA","display_url":"1.usa.gov/1h6EwIA"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436185666980806656"}],"text":"RT @FDA_Drug_Info: #FDA and #European Medicines Agency strengthen collaboration in #pharmacovigilance area. http://t.co/9nE8TcsEq7","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436187735347712000","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T17:17:14.000Z","id":"436187735347712000","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"hashtags":{},"urls":[{"start":104,"end":126,"url":"http://t.co/Q1U0xGbm7w","expanded_url":"http://bit.ly/1dN1nu1","display_url":"bit.ly/1dN1nu1"}],"annotations":{}},"referenced_tweets":{},"text":"RT @INFARMED_IP: Prior assessment of medicinal products for human use for use in a hospital environment http://t.co/Q1U0xGbm7w","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436187621711413248","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T17:16:47.000Z","id":"436187621711413248","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"hashtags":{},"urls":[{"start":99,"end":121,"url":"http://t.co/KMzxOVdH56","expanded_url":"http://bit.ly/1c2StnO","display_url":"bit.ly/1c2StnO"}],"annotations":[{"start":66,"end":85,"probability":0.9426,"type":"Place","normalized_text":"Continental Portugal"}]},"referenced_tweets":{},"text":"RT @INFARMED_IP: Psychiatric drugs: development of consumption in Continental Portugal (2000-2012) http://t.co/KMzxOVdH56","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436187490333249536","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T17:16:16.000Z","id":"436187490333249536","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":107,"end":112,"tag":"hcsm"},{"start":113,"end":122,"tag":"healthIT"},{"start":123,"end":134,"tag":"HealthApps"}],"urls":[{"start":84,"end":106,"url":"http://t.co/qzQeFXMko2","expanded_url":"http://bit.ly/O9ZWMK","display_url":"bit.ly/O9ZWMK"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436173978680303616"}],"text":"RT @EFPIA: Understanding mobile health trends and opportunities for clinical trials http://t.co/qzQeFXMko2 #hcsm #healthIT #HealthApps","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436187240189136896","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T17:15:16.000Z","id":"436187240189136896","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":13,"end":18,"tag":"EFSA"},{"start":23,"end":28,"tag":"ECDC"}],"urls":[{"start":65,"end":87,"url":"http://t.co/bXsjJ5u249","expanded_url":"http://bit.ly/1fy5RRO","display_url":"bit.ly/1fy5RRO"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436169206690631680"}],"text":"RT @EFSA_EU: #EFSA and #ECDC together to fight zoonotic diseases http://t.co/bXsjJ5u249","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436186454650523648","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T17:12:09.000Z","id":"436186454650523648","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"HealthCanada","id":"928334374256472064"}],"hashtags":[{"start":54,"end":64,"tag":"antiviral"},{"start":112,"end":119,"tag":"health"},{"start":120,"end":127,"tag":"safety"}],"urls":[{"start":89,"end":111,"url":"http://t.co/cgXfl5PHsI","expanded_url":"http://bit.ly/1nNEnfr","display_url":"bit.ly/1nNEnfr"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436159702024470528"}],"text":"RT @HealthCanada: There is new safety information for #antiviral drug TELZIR. Read more: http://t.co/cgXfl5PHsI #health #safety","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436160160588115968","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T15:27:40.000Z","id":"436160160588115968","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"hashtags":[{"start":49,"end":56,"tag":"Animal"}],"urls":[{"start":106,"end":128,"url":"http://t.co/m8Eljs5ine","expanded_url":"http://1.usa.gov/1fyNfkv","display_url":"1.usa.gov/1fyNfkv"}],"annotations":[{"start":21,"end":23,"probability":0.6629,"type":"Organization","normalized_text":"FDA"}]},"referenced_tweets":[{"type":"retweeted","id":"436150921215504384"}],"text":"RT @FDAanimalhealth: FDA Seeking Public Input on #Animal Generic Drug User Fee Act Information Collection http://t.co/m8Eljs5ine","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436151099180212224","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T14:51:40.000Z","id":"436151099180212224","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":43,"end":50,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":54,"end":72,"tag":"pharmacovigilance"}],"urls":[{"start":74,"end":96,"url":"http://t.co/CH4lyybNhT","expanded_url":"http://bit.ly/1jbUN18","display_url":"bit.ly/1jbUN18"}],"annotations":{}},"referenced_tweets":{},"text":"We're strengthening our collaboration with @US_FDA in #pharmacovigilance: http://t.co/CH4lyybNhT","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"436150676838940672","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-19T14:49:59.000Z","id":"436150676838940672","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":49,"end":65,"tag":"microbiological"},{"start":77,"end":84,"tag":"herbal"}],"urls":[{"start":107,"end":129,"url":"http://t.co/KlVEb5E7ak","expanded_url":"http://bit.ly/1oRgc37","display_url":"bit.ly/1oRgc37"}],"annotations":{}},"referenced_tweets":{},"text":"Send us your comments on our reflection paper on #microbiological aspects of #herbal medicines by 15 June: http://t.co/KlVEb5E7ak","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"436149002854076416","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-19T14:43:20.000Z","id":"436149002854076416","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":18,"end":26,"tag":"vacancy"},{"start":33,"end":39,"tag":"legal"},{"start":122,"end":134,"tag":"recruitment"}],"urls":[{"start":98,"end":120,"url":"http://t.co/WQancDcY1f","expanded_url":"http://bit.ly/1fxYYQt","display_url":"bit.ly/1fxYYQt"}],"annotations":{}},"referenced_tweets":{},"text":"Apply now for our #vacancy for a #legal officer (short-term contract). Deadline is 19 March 2014: http://t.co/WQancDcY1f  #recruitment","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"436148678760202240","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-19T14:42:02.000Z","id":"436148678760202240","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":75,"end":80,"tag":"EFSA"},{"start":87,"end":92,"tag":"ECDC"},{"start":103,"end":112,"tag":"zoonoses"}],"urls":{},"annotations":[{"start":55,"end":56,"probability":0.6977,"type":"Place","normalized_text":"EU"}]},"referenced_tweets":[{"type":"retweeted","id":"436146676223324161"}],"text":"RT @EFSA_EU: Ups &amp; downs in zoonotic disease trends in EU: read latest #EFSA &amp; #ECDC report on #zoonoses and foodborne outbreaks http://t.c…","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436148192267501568","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T14:40:06.000Z","id":"436148192267501568","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":86,"end":101,"username":"VaccinesEurope","id":"1262320285"},{"start":102,"end":116,"username":"VaccinesToday","id":"205670342"}],"hashtags":[{"start":117,"end":126,"tag":"vaccines"}],"urls":[{"start":63,"end":85,"url":"http://t.co/iZDIP0G29Y","expanded_url":"http://bit.ly/MyCdox","display_url":"bit.ly/MyCdox"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436142607761027072"}],"text":"RT @EFPIA: Vaccines endure African temperatures without damage http://t.co/iZDIP0G29Y @VaccinesEurope @VaccinesToday #vaccines","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436147996515135488","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T14:39:20.000Z","id":"436147996515135488","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":65,"end":71,"username":"H_I_N","id":"15170795"}],"hashtags":[{"start":11,"end":24,"tag":"Infographics"}],"urls":[{"start":103,"end":125,"url":"http://t.co/Mg78pimw5O","expanded_url":"http://www.pinterest.com/efpia/","display_url":"pinterest.com/efpia/"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436130797431435264"}],"text":"RT @EFPIA: #Infographics: The State of Healthcare Innovation via @H_I_N and on EFPIA's Pinterest board http://t.co/Mg78pimw5O http://t.co/M…","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436147366744555521","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T14:36:50.000Z","id":"436147366744555521","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":81,"end":89,"username":"EFSA_EU","id":"84582815"},{"start":90,"end":98,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":22,"end":31,"tag":"zoonotic"}],"urls":[{"start":99,"end":121,"url":"http://t.co/m7vQ2CLZ0w","expanded_url":"http://bit.ly/1jbz0qf","display_url":"bit.ly/1jbz0qf"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436128346791870464"}],"text":"RT @EFSA_EU: What are #zoonotic diseases? Check out the latest infographics from @EFSA_EU @ECDC_EU http://t.co/m7vQ2CLZ0w","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436145784078491648","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T14:30:32.000Z","id":"436145784078491648","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"hashtags":[{"start":80,"end":90,"tag":"Parkinson"}],"urls":[{"start":94,"end":116,"url":"http://t.co/5a6jpSz0UG","expanded_url":"http://bit.ly/MER8cx","display_url":"bit.ly/MER8cx"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436126861362352128"}],"text":"RT @euparkinsons: 25 of the most frequently asked questions &amp; answers about #Parkinson's. http://t.co/5a6jpSz0UG","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436145741426589696","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T14:30:22.000Z","id":"436145741426589696","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"hashtags":[{"start":37,"end":47,"tag":"medicines"},{"start":94,"end":98,"tag":"a2m"}],"urls":[{"start":110,"end":132,"url":"http://t.co/SNZc6TYbYe","expanded_url":"http://bit.ly/1dLOG2H","display_url":"bit.ly/1dLOG2H"}],"annotations":[{"start":65,"end":74,"probability":0.6365,"type":"Place","normalized_text":"Parliament"},{"start":106,"end":107,"probability":0.9721,"type":"Place","normalized_text":"UK"}]},"referenced_tweets":[{"type":"retweeted","id":"436125291434360833"}],"text":"RT @HAIEurope: Delays in supplies of #medicines is brought up in Parliament as a hindrance to #a2m in the UK: http://t.co/SNZc6TYbYe","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436145616482476033","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T14:29:52.000Z","id":"436145616482476033","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":74,"end":86,"username":"PharmaTimes","id":"52354784"}],"hashtags":{},"urls":[{"start":87,"end":109,"url":"http://t.co/CPUebcpY5o","expanded_url":"http://bit.ly/1jGsOGp","display_url":"bit.ly/1jGsOGp"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436123759938785280"}],"text":"RT @EFPIA: Collaborative drugs management \"reduces errors by nearly 80%\"  @PharmaTimes http://t.co/CPUebcpY5o","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436145479492325377","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T14:29:20.000Z","id":"436145479492325377","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":111,"end":119,"username":"ECDC_EU","id":"204752573"},{"start":120,"end":128,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":29,"end":38,"tag":"zoonoses"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436121536575963136"}],"text":"RT @ECDC_EU: Know more about #zoonoses or diseases transmitted directly or indirectly bet.animals &amp; humans @ECDC_EU @EFSA_EU http://t.co/V1…","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436145160892997632","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T14:28:04.000Z","id":"436145160892997632","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":18,"end":26,"username":"ECDC_EU","id":"204752573"},{"start":33,"end":41,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":78,"end":87,"tag":"zoonoses"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436119001492914176"}],"text":"RT @ECDC_EU: From @ECDC_EU &amp; @EFSA_EU: Report on trends  &amp; sources of #zoonoses, zoonotic agents &amp; food-borne outbreaks in 2012 http://t.co…","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436145112696233984","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T14:27:52.000Z","id":"436145112696233984","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"hashtags":{},"urls":[{"start":74,"end":96,"url":"http://t.co/7EfEcoiAup","expanded_url":"http://bit.ly/1nNu6zM","display_url":"bit.ly/1nNu6zM"}],"annotations":[{"start":58,"end":72,"probability":0.5535,"type":"Organization","normalized_text":"Pramipexol Wynn"}]},"referenced_tweets":{},"text":"RT @INFARMED_IP: Regularisation of supply of the medicine Pramipexol Wynn http://t.co/7EfEcoiAup","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436144746218946560","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T14:26:25.000Z","id":"436144746218946560","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":38,"end":45,"tag":"Secure"},{"start":46,"end":53,"tag":"Supply"},{"start":97,"end":106,"tag":"imported"}],"urls":[{"start":114,"end":136,"url":"http://t.co/GXv8GXtvg6","expanded_url":"http://1.usa.gov/1bLa2OV","display_url":"1.usa.gov/1bLa2OV"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436113670691516416"}],"text":"RT @FDA_Drug_Info: #FDA initiates the #Secure #Supply Chain Pilot Program to enhance security of #imported drugs. http://t.co/GXv8GXtvg6","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436144202049925120","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T14:24:15.000Z","id":"436144202049925120","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":33,"end":42,"tag":"Northera"}],"urls":[{"start":88,"end":110,"url":"http://t.co/eTQaTlblQ5","expanded_url":"http://1.usa.gov/1gUNaLF","display_url":"1.usa.gov/1gUNaLF"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436113087616135170"}],"text":"RT @FDA_Drug_Info: #FDA approves #Northera to treat neurogenic orthostatic hypotension. http://t.co/eTQaTlblQ5","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436144064900395008","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T14:23:42.000Z","id":"436144064900395008","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"hashtags":{},"urls":[{"start":105,"end":127,"url":"http://t.co/dB3LmpFLix","expanded_url":"http://bit.ly/1hv6q5S","display_url":"bit.ly/1hv6q5S"}],"annotations":[{"start":35,"end":61,"probability":0.8155,"type":"Organization","normalized_text":"Heads of Medicines Agencies"},{"start":90,"end":103,"probability":0.5817,"type":"Place","normalized_text":"Athens, Greece"}]},"referenced_tweets":{},"text":"RT @URPLWMiPB: 75th meeting of the Heads of Medicines Agencies (HMA) 18-19 February 2014. Athens, Greece http://t.co/dB3LmpFLix","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"436143767415181312","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T14:22:31.000Z","id":"436143767415181312","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"urls":[{"start":90,"end":112,"url":"http://t.co/gJXw5vA2v5","expanded_url":"http://bit.ly/1hv65jw","display_url":"bit.ly/1hv65jw"}],"annotations":[{"start":61,"end":62,"probability":0.5651,"type":"Organization","normalized_text":"EU"}]},"referenced_tweets":{},"text":"RT @GCessak: Information on the 75th meeting of the heads of EU medicines agencies (HMA): http://t.co/gJXw5vA2v5","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"436143081889730560","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T14:19:48.000Z","id":"436143081889730560","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":29,"end":34,"tag":"SMEs"},{"start":59,"end":69,"tag":"medicines"}],"urls":[{"start":111,"end":133,"url":"http://t.co/MlribWjdxt","expanded_url":"http://bit.ly/1kWgvcj","display_url":"bit.ly/1kWgvcj"}],"annotations":{}},"referenced_tweets":{},"text":"We're holding a workshop for #SMEs focusing on quality for #medicines containing chemical entities on 4 April: http://t.co/MlribWjdxt","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"436107949841592320","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-19T12:00:12.000Z","id":"436107949841592320","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":37,"end":53,"tag":"microbiological"},{"start":65,"end":72,"tag":"herbal"}],"urls":[{"start":115,"end":137,"url":"http://t.co/u19G349LAE","expanded_url":"http://bit.ly/1oRgc37","display_url":"bit.ly/1oRgc37"}],"annotations":{}},"referenced_tweets":{},"text":"We've released a reflection paper on #microbiological aspects of #herbal medicines for consultation until 15 June: http://t.co/u19G349LAE","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436102724678340609","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-19T11:39:26.000Z","id":"436102724678340609","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"hashtags":[{"start":38,"end":47,"tag":"zoonoses"},{"start":49,"end":58,"tag":"zoonotic"}],"urls":[{"start":96,"end":118,"url":"http://t.co/v0IZpNYlZY","expanded_url":"http://bit.ly/O8Nwom","display_url":"bit.ly/O8Nwom"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436101236543074304"}],"text":"RT @EFSAJournal: EU summary report on #zoonoses, #zoonotic agents and food-borne outbreaks 2012 http://t.co/v0IZpNYlZY","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436101813088296960","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T11:35:49.000Z","id":"436101813088296960","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":13,"end":27,"tag":"Campylobacter"},{"start":48,"end":59,"tag":"Salmonella"},{"start":66,"end":75,"tag":"Listeria"},{"start":81,"end":86,"tag":"EFSA"},{"start":91,"end":96,"tag":"ECDC"}],"urls":[{"start":101,"end":123,"url":"http://t.co/bXsjJ5u249","expanded_url":"http://bit.ly/1fy5RRO","display_url":"bit.ly/1fy5RRO"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436101073514688512"}],"text":"RT @EFSA_EU: #Campylobacter decreases slightly, #Salmonella down, #Listeria up – #EFSA and #ECDC say http://t.co/bXsjJ5u249","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436101803080679424","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T11:35:46.000Z","id":"436101803080679424","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":27,"end":33,"tag":"legal"},{"start":115,"end":127,"tag":"recruitment"},{"start":128,"end":136,"tag":"vacancy"}],"urls":[{"start":92,"end":114,"url":"http://t.co/1hJgsWoAN0","expanded_url":"http://bit.ly/1fxYYQt","display_url":"bit.ly/1fxYYQt"}],"annotations":{}},"referenced_tweets":{},"text":"We're looking to recruit a #legal officer on a short-term contract. Apply by 19 March 2014: http://t.co/1hJgsWoAN0 #recruitment #vacancy","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436078413007556608","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-19T10:02:50.000Z","id":"436078413007556608","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":13,"end":21,"username":"ECDC_EU","id":"204752573"}],"hashtags":{},"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436066100888227840"}],"text":"RT @ECDC_EU: @ECDC_EU collaborates with  @PLOSCurrentsOut on call for papers on #vaccine hesitancy issue. Know more: http://t.co/lTX2K4L38r","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436074573499744256","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T09:47:34.000Z","id":"436074573499744256","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":82,"end":89,"tag":"future"},{"start":93,"end":102,"tag":"medicine"}],"urls":[{"start":115,"end":137,"url":"http://t.co/OSDsXo7Hs1","expanded_url":"http://bit.ly/1bKPaHA","display_url":"bit.ly/1bKPaHA"}],"annotations":{}},"referenced_tweets":{},"text":"RT @Aifa_ufficiale: Italian medicines agency editorial:  the $5bn protein and the #future of #medicine development http://t.co/OSDsXo7Hs1","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"436074232293109760","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T09:46:13.000Z","id":"436074232293109760","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"},{"start":16,"end":25,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":29,"end":36,"tag":"London"},{"start":54,"end":60,"tag":"legal"},{"start":92,"end":95,"tag":"eu"},{"start":96,"end":100,"tag":"job"},{"start":101,"end":109,"tag":"vacancy"}],"urls":[{"start":69,"end":91,"url":"http://t.co/eKCuaB6L1A","expanded_url":"http://new.eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:C:2014:047A:TOC","display_url":"new.eur-lex.europa.eu/legal-content/…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"436061858089283584"}],"text":"RT @EURLex: The @EMA_News in #London is looking for a #legal officer http://t.co/eKCuaB6L1A #eu #job #vacancy","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"436073225609826304","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-19T09:42:13.000Z","id":"436073225609826304","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":84,"end":94,"tag":"influenza"}],"urls":[{"start":95,"end":117,"url":"http://t.co/5Aqw5CKePC","expanded_url":"http://goo.gl/co4k1Y","display_url":"goo.gl/co4k1Y"},{"start":118,"end":140,"url":"http://t.co/8lKQ0BEnRb","expanded_url":"https://twitter.com/WHO/status/435811708204892160/photo/1","display_url":"pic.twitter.com/8lKQ0BEnRb"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"435811708204892160"}],"text":"RT @WHO: Be clean, be cautious, be caring: how to protect yourself against seasonal #influenza http://t.co/5Aqw5CKePC http://t.co/8lKQ0BEnRb","public_metrics":{"retweet_count":424,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435833426172993536","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-18T17:49:20.000Z","id":"435833426172993536","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":["3_435811708209086465"]}},{"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"hashtags":{},"urls":[{"start":102,"end":124,"url":"http://t.co/hQulmWR0nW","expanded_url":"http://bit.ly/1e3VSm0","display_url":"bit.ly/1e3VSm0"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"435831085944299520"}],"text":"RT @DrugInfoAssn: Training Course: Premarketing Clinical Safety and Pharmacovigilance ~ March 10-11 ~ http://t.co/hQulmWR0nW — in... http:/…","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435833186451750912","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-18T17:48:23.000Z","id":"435833186451750912","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"hashtags":[{"start":111,"end":121,"tag":"TEDxTalks"},{"start":122,"end":126,"tag":"TED"}],"urls":{},"annotations":[{"start":16,"end":22,"probability":0.6631,"type":"Place","normalized_text":"England"},{"start":63,"end":74,"probability":0.4747,"type":"Person","normalized_text":"Sally Davies"}]},"referenced_tweets":[{"type":"retweeted","id":"435720386274398208"}],"text":"RT @IAPOtweets: England's Chief Medical Office, Professor Dame Sally Davies talks about antibiotics resistance #TEDxTalks #TED http://t.co/…","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435808755557892096","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-18T16:11:18.000Z","id":"435808755557892096","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"hashtags":[{"start":32,"end":44,"tag":"RareDisease"}],"urls":[{"start":67,"end":89,"url":"http://t.co/HAd3D8tPyw","expanded_url":"http://ow.ly/tJIOn","display_url":"ow.ly/tJIOn"}],"annotations":[{"start":58,"end":65,"probability":0.9743,"type":"Place","normalized_text":"Brussels"}]},"referenced_tweets":[{"type":"retweeted","id":"435742256168189952"}],"text":"RT @eurordis: Press release for #RareDisease Day event in Brussels http://t.co/HAd3D8tPyw\nImproving Access to Rare Disease Care: The Vision…","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435807863915962368","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-18T16:07:46.000Z","id":"435807863915962368","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":[{"start":108,"end":116,"tag":"IMISMEs"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"435743541072261120"}],"text":"RT @IMI_JU: Antibiotics, cancer, depression, stem cells and IT tools among subjects of our elevator pitches #IMISMEs","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435807771209261056","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-18T16:07:24.000Z","id":"435807771209261056","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"},{"start":92,"end":103,"username":"FloodBreda","id":"1285591051"}],"hashtags":[{"start":22,"end":31,"tag":"patients"},{"start":66,"end":76,"tag":"medicines"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"435782512351387648"}],"text":"RT @EFA_Patients: How #patients are involved in the evaluation of #medicines? Our president @FloodBreda presents her experience of involvem…","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435790514773045249","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-18T14:58:49.000Z","id":"435790514773045249","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"USPharmacopeia","id":"47953929"}],"hashtags":{},"urls":{},"annotations":[{"start":69,"end":73,"probability":0.995,"type":"Place","normalized_text":"India"}]},"referenced_tweets":[{"type":"retweeted","id":"435457726601527296"}],"text":"RT @USPharmacopeia: In the news RT @nytimeshealth: Medicines Made in India Set Off Safety Worries http://t.co/HMP8Rp1o0e","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435458833847439360","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T17:00:51.000Z","id":"435458833847439360","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"hashtags":[{"start":29,"end":32,"tag":"EU"},{"start":69,"end":77,"tag":"vaccine"},{"start":90,"end":94,"tag":"flu"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"435451581656743936"}],"text":"RT @innovationunion: Ahchoo! #EU projects are working on a universal #vaccine against the #flu, a virus affecting millions: http://t.co/SzL…","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435458360780271616","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T16:58:58.000Z","id":"435458360780271616","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"hashtags":[{"start":15,"end":23,"tag":"Belgium"},{"start":85,"end":90,"tag":"data"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"435451272083165184"}],"text":"RT @HAIEurope: #Belgium announces its preparedness to open up its anonymised patient #data for the benefit of medical science http://t.co/x…","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435458221013499904","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T16:58:24.000Z","id":"435458221013499904","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"gr2014eu","id":"1397477076"},{"start":93,"end":109,"username":"AdonisGeorgiadi","id":"70340615"}],"hashtags":[{"start":25,"end":34,"tag":"gr2014eu"},{"start":85,"end":92,"tag":"Athens"}],"urls":{},"annotations":[{"start":36,"end":66,"probability":0.3586,"type":"Other","normalized_text":"Heads of Medicines Agencies Mtg"}]},"referenced_tweets":[{"type":"retweeted","id":"435439592565518336"}],"text":"RT @gr2014eu: Coming up: #gr2014eu “Heads of Medicines Agencies Mtg” on Feb 18-19 in #Athens @AdonisGeorgiadi @elytis1955 @EMA_News http://…","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435445140392783873","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T16:06:26.000Z","id":"435445140392783873","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":76,"end":82,"tag":"Cyani"},{"start":91,"end":98,"tag":"herbal"}],"urls":[{"start":110,"end":132,"url":"http://t.co/fpcq6cag63","expanded_url":"http://bit.ly/1fsGX67","display_url":"bit.ly/1fsGX67"}],"annotations":{}},"referenced_tweets":{},"text":"We've launched a call for scientific data for use in our assessment work on #Cyani flos in #herbal medicines: http://t.co/fpcq6cag63","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435423997958705152","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-17T14:42:25.000Z","id":"435423997958705152","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":76,"end":85,"tag":"Epilobii"},{"start":95,"end":102,"tag":"herbal"}],"urls":[{"start":114,"end":136,"url":"http://t.co/ELhdwEuhEl","expanded_url":"http://bit.ly/1dCqyzi","display_url":"bit.ly/1dCqyzi"}],"annotations":{}},"referenced_tweets":{},"text":"We've launched a call for scientific data for use in our assessment work on #Epilobii herba in #herbal medicines: http://t.co/ELhdwEuhEl","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435423747911061504","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-17T14:41:25.000Z","id":"435423747911061504","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":65,"end":73,"tag":"Glycine"},{"start":91,"end":98,"tag":"herbal"}],"urls":[{"start":110,"end":132,"url":"http://t.co/kXBkTOYTEq","expanded_url":"http://bit.ly/1bXzR8J","display_url":"bit.ly/1bXzR8J"}],"annotations":{}},"referenced_tweets":{},"text":"We've launched a call for data for use in our assessment work on #Glycine max, lecithin in #herbal medicines: http://t.co/kXBkTOYTEq","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435423427441090560","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-17T14:40:09.000Z","id":"435423427441090560","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"hashtags":[{"start":45,"end":60,"tag":"ClinicalTrials"}],"urls":[{"start":62,"end":84,"url":"http://t.co/Ma5RlWhBhj","expanded_url":"http://www.nakos-balamotis.com/2014/02/17/should-companies-conduct-clinical-trials/","display_url":"nakos-balamotis.com/2014/02/17/sho…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"435421794426580992"}],"text":"RT @nakosbalamotis: Should companies conduct #ClinicalTrials? http://t.co/Ma5RlWhBhj","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435422669853696000","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T14:37:08.000Z","id":"435422669853696000","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":76,"end":87,"tag":"Helichrysi"},{"start":96,"end":103,"tag":"herbal"}],"urls":[{"start":115,"end":137,"url":"http://t.co/kcPRxPMVHU","expanded_url":"http://bit.ly/1nGnYcE","display_url":"bit.ly/1nGnYcE"}],"annotations":{}},"referenced_tweets":{},"text":"We've launched a call for scientific data for use in our assessment work on #Helichrysi flos in #herbal medicines: http://t.co/kcPRxPMVHU","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435421848927342592","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-17T14:33:53.000Z","id":"435421848927342592","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":65,"end":73,"tag":"Origani"},{"start":93,"end":100,"tag":"herbal"}],"urls":[{"start":112,"end":134,"url":"http://t.co/oALh8zFSN3","expanded_url":"http://bit.ly/1jKtXQe","display_url":"bit.ly/1jKtXQe"}],"annotations":{}},"referenced_tweets":{},"text":"We've launched a call for data for use in our assessment work on #Origani majoranae herba in #herbal medicines: http://t.co/oALh8zFSN3","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"435421410702266368","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-17T14:32:08.000Z","id":"435421410702266368","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":63,"end":85,"url":"http://t.co/27fB6v5zAJ","expanded_url":"http://bit.ly/MrDTAe","display_url":"bit.ly/MrDTAe"}],"annotations":[{"start":32,"end":45,"probability":0.9551,"type":"Person","normalized_text":"Dina Tsiambaou"}]},"referenced_tweets":{},"text":"Our new Head of IT Development, Dina Tsiambaou, started today: http://t.co/27fB6v5zAJ","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"435421197535162371","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-17T14:31:17.000Z","id":"435421197535162371","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":56,"end":71,"tag":"bioequivalence"},{"start":85,"end":95,"tag":"sunitinib"}],"urls":[{"start":97,"end":119,"url":"http://t.co/wxBKopxh3g","expanded_url":"http://bit.ly/1bcBnsu","display_url":"bit.ly/1bcBnsu"}],"annotations":{}},"referenced_tweets":{},"text":"Two more weeks to comment on our draft product-specific #bioequivalence guidance for #sunitinib: http://t.co/wxBKopxh3g","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435420508754935809","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-17T14:28:33.000Z","id":"435420508754935809","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":76,"end":85,"tag":"Paeoniae"},{"start":95,"end":102,"tag":"herbal"}],"urls":[{"start":114,"end":136,"url":"http://t.co/jck2xIxnD2","expanded_url":"http://bit.ly/1mnHkYP","display_url":"bit.ly/1mnHkYP"}],"annotations":{}},"referenced_tweets":{},"text":"We've launched a call for scientific data for use in our assessment work on #Paeoniae radix in #herbal medicines: http://t.co/jck2xIxnD2","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"435419937260068864","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-17T14:26:17.000Z","id":"435419937260068864","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":73,"end":87,"username":"LorenaFoucher","id":"256999401"},{"start":88,"end":103,"username":"VaccinesEurope","id":"1262320285"}],"hashtags":[{"start":11,"end":24,"tag":"INFOGRAPHICS"},{"start":104,"end":108,"tag":"flu"},{"start":109,"end":118,"tag":"vaccines"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"435418146384519168"}],"text":"RT @EFPIA: #INFOGRAPHICS - The impact of Influenza vaccination in the EU @LorenaFoucher @VaccinesEurope #flu #vaccines http://t.co/H6h2kHRp…","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435419386032427008","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T14:24:05.000Z","id":"435419386032427008","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"hashtags":{},"urls":[{"start":108,"end":130,"url":"http://t.co/mvMkpbbYPW","expanded_url":"http://www.pjonline.com/news/european_medicines_agency_acknowledges_limitations_of_paediatric_licensing_rules#.UwIXTWTj8vM.twitter","display_url":"pjonline.com/news/european_…"}],"annotations":[{"start":15,"end":39,"probability":0.6231,"type":"Organization","normalized_text":"European Medicines Agency"},{"start":98,"end":106,"probability":0.4387,"type":"Organization","normalized_text":"PJ Online"}]},"referenced_tweets":[{"type":"retweeted","id":"435414886177189888"}],"text":"RT @EAHPtweet: European Medicines Agency acknowledges limitations of paediatric licensing rules | PJ Online http://t.co/mvMkpbbYPW","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435419089214124032","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T14:22:55.000Z","id":"435419089214124032","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"hashtags":{},"urls":{},"annotations":[{"start":88,"end":93,"probability":0.9266,"type":"Place","normalized_text":"Athens"}]},"referenced_tweets":[{"type":"retweeted","id":"435403810157387776"}],"text":"RT @URPLWMiPB: The 75th HMA Presidency Meeting (Heads of Medicines Agencies) is held in Athens on the 18th-19th February 2014 http://t.co/7…","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435418281978368000","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T14:19:42.000Z","id":"435418281978368000","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":{},"urls":[{"start":81,"end":103,"url":"http://t.co/JZXOlfG1I5","expanded_url":"http://bit.ly/1f5QmWb","display_url":"bit.ly/1f5QmWb"},{"start":104,"end":126,"url":"http://t.co/hmnkbm2PTi","expanded_url":"https://twitter.com/EFPIA/status/435401636513476608/photo/1","display_url":"pic.twitter.com/hmnkbm2PTi"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"435401636513476608"}],"text":"RT @EFPIA: Study on evolution of flu viruses may change textbooks, history books http://t.co/JZXOlfG1I5 http://t.co/hmnkbm2PTi","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435418257282301953","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T14:19:36.000Z","id":"435418257282301953","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":["3_435401636521865216"]}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"urls":{},"annotations":[{"start":86,"end":91,"probability":0.9266,"type":"Place","normalized_text":"Athens"}]},"referenced_tweets":[{"type":"retweeted","id":"435399963707998208"}],"text":"RT @GCessak: The 75th HMA Presidency Meeting (Heads of Medicines Agencies) is held in Athens on the 18th -19th February 2014 http://t.co/Ju…","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435418033746890752","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T14:18:43.000Z","id":"435418033746890752","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"hashtags":{},"urls":{},"annotations":[{"start":12,"end":14,"probability":0.9094,"type":"Organization","normalized_text":"FDA"}]},"referenced_tweets":[{"type":"retweeted","id":"435396488844562432"}],"text":"RT @myESMO: FDA approves Ibrutinib for Chronic Lymphocytic Leukaemia patients who've received at least 1 previous therapy http://t.co/o1be7…","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435417558477729793","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T14:16:50.000Z","id":"435417558477729793","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":53,"end":60,"tag":"cancer"}],"urls":[{"start":61,"end":83,"url":"http://t.co/DJSPOWLg2D","expanded_url":"http://bit.ly/1dCM7jm","display_url":"bit.ly/1dCM7jm"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"435396197432299521"}],"text":"RT @EFPIA: Grape seed promise in fight against bowel #cancer http://t.co/DJSPOWLg2D","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435417403829149697","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T14:16:13.000Z","id":"435417403829149697","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"hashtags":{},"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"435377668456853504"}],"text":"RT @MHRAmedicines: Class 2 Medicines Recall (action within 48 hours): COSOPT Preservative-Free, 20mg/ml +5mg/ml, eye drops, solut... http:/…","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435377718000373760","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T11:38:31.000Z","id":"435377718000373760","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":68,"end":74,"tag":"Cyani"},{"start":83,"end":90,"tag":"herbal"}],"urls":[{"start":102,"end":124,"url":"http://t.co/ZsRBVXMxjK","expanded_url":"http://bit.ly/1fsGX67","display_url":"bit.ly/1fsGX67"}],"annotations":{}},"referenced_tweets":{},"text":"We're calling for scientific data for use in our assessment work on #Cyani flos in #herbal medicines: http://t.co/ZsRBVXMxjK","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435366362689830912","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-17T10:53:24.000Z","id":"435366362689830912","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":68,"end":77,"tag":"Epilobii"},{"start":87,"end":94,"tag":"herbal"}],"urls":[{"start":106,"end":128,"url":"http://t.co/a1rn1d8ksd","expanded_url":"http://bit.ly/1dCqyzi","display_url":"bit.ly/1dCqyzi"}],"annotations":{}},"referenced_tweets":{},"text":"We're calling for scientific data for use in our assessment work on #Epilobii herba in #herbal medicines: http://t.co/a1rn1d8ksd","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435365814913740800","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-17T10:51:13.000Z","id":"435365814913740800","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":68,"end":76,"tag":"Glycine"},{"start":94,"end":101,"tag":"herbal"}],"urls":[{"start":113,"end":135,"url":"http://t.co/K0Up8VMZ9S","expanded_url":"http://bit.ly/1bXzR8J","display_url":"bit.ly/1bXzR8J"}],"annotations":{}},"referenced_tweets":{},"text":"We're calling for scientific data for use in our assessment work on #Glycine max, lecithin in #herbal medicines: http://t.co/K0Up8VMZ9S","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435365326105374721","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-17T10:49:17.000Z","id":"435365326105374721","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":68,"end":79,"tag":"Helichrysi"},{"start":88,"end":95,"tag":"herbal"}],"urls":[{"start":107,"end":129,"url":"http://t.co/AX2nSXm5K0","expanded_url":"http://bit.ly/1nGnYcE","display_url":"bit.ly/1nGnYcE"}],"annotations":{}},"referenced_tweets":{},"text":"We're calling for scientific data for use in our assessment work on #Helichrysi flos in #herbal medicines: http://t.co/AX2nSXm5K0","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435364488154734592","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-17T10:45:57.000Z","id":"435364488154734592","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":68,"end":76,"tag":"Origani"},{"start":96,"end":103,"tag":"herbal"}],"urls":[{"start":115,"end":137,"url":"http://t.co/bXBOaRA1Fx","expanded_url":"http://bit.ly/1jKtXQe","display_url":"bit.ly/1jKtXQe"}],"annotations":{}},"referenced_tweets":{},"text":"We're calling for scientific data for use in our assessment work on #Origani majoranae herba in #herbal medicines: http://t.co/bXBOaRA1Fx","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435364190539493376","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-17T10:44:46.000Z","id":"435364190539493376","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":68,"end":77,"tag":"Paeoniae"},{"start":87,"end":94,"tag":"herbal"}],"urls":[{"start":106,"end":128,"url":"http://t.co/BklU43kR3v","expanded_url":"http://bit.ly/1mnHkYP","display_url":"bit.ly/1mnHkYP"}],"annotations":{}},"referenced_tweets":{},"text":"We're calling for scientific data for use in our assessment work on #Paeoniae radix in #herbal medicines: http://t.co/BklU43kR3v","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435363611071238144","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-17T10:42:28.000Z","id":"435363611071238144","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":118,"end":140,"url":"http://t.co/HEhhxsFMxL","expanded_url":"http://bit.ly/1ez7ihC","display_url":"bit.ly/1ez7ihC"}],"annotations":{}},"referenced_tweets":{},"text":"On Friday we launched a call for data for use in assessment of Saccharomyces cerevisiae/boulardii in herbal medicine: http://t.co/HEhhxsFMxL","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435361131205361664","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-17T10:32:36.000Z","id":"435361131205361664","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":79,"end":86,"tag":"Ricini"},{"start":96,"end":103,"tag":"herbal"}],"urls":[{"start":115,"end":137,"url":"http://t.co/GFMAvVeOxj","expanded_url":"http://bit.ly/M0p72w","display_url":"bit.ly/M0p72w"}],"annotations":{}},"referenced_tweets":{},"text":"On Friday we launched a call for scientific data for use in assessment work on #Ricini oleum in #herbal medicines: http://t.co/GFMAvVeOxj","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435360735686688768","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-17T10:31:02.000Z","id":"435360735686688768","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":{},"urls":[{"start":68,"end":90,"url":"http://t.co/C1PP40jWig","expanded_url":"http://bbc.in/1gTuGdf","display_url":"bbc.in/1gTuGdf"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"435360054997291009"}],"text":"RT @EFPIA: Cancer: 'Tumour monorail' can lead cancers to their doom http://t.co/C1PP40jWig","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435360450449264640","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T10:29:54.000Z","id":"435360450449264640","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"},{"start":59,"end":69,"username":"bbchealth","id":"621543"}],"hashtags":{},"urls":[{"start":71,"end":93,"url":"http://t.co/75BtQfiBOy","expanded_url":"http://bbc.in/1oFMXjI","display_url":"bbc.in/1oFMXjI"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"435356364718616576"}],"text":"RT @ESEndocrinology: 'Cancer monorail' can kill tumours RT @bbchealth: http://t.co/75BtQfiBOy","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435360364122099712","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T10:29:34.000Z","id":"435360364122099712","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":118,"end":140,"url":"http://t.co/w2nmfPmVCH","expanded_url":"http://bit.ly/MjDPlP","display_url":"bit.ly/MjDPlP"}],"annotations":{}},"referenced_tweets":{},"text":"On Friday we launched a call for data for use in assessment work on Cisti cretici folium/resinum in herbal medicines: http://t.co/w2nmfPmVCH","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435359988492423168","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-17T10:28:04.000Z","id":"435359988492423168","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":68,"end":77,"tag":"Pistacia"}],"urls":[{"start":118,"end":140,"url":"http://t.co/6PqheWsbd9","expanded_url":"http://bit.ly/M0oLc5","display_url":"bit.ly/M0oLc5"}],"annotations":{}},"referenced_tweets":{},"text":"On Friday we launched a call for data for use in assessment work on #Pistacia lentiscus, resinum in herbal medicines: http://t.co/6PqheWsbd9","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435359175380447232","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-17T10:24:50.000Z","id":"435359175380447232","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":35,"end":42,"tag":"herbal"},{"start":83,"end":90,"tag":"Ginkgo"}],"urls":[{"start":98,"end":120,"url":"http://t.co/NiXN61Enjx","expanded_url":"http://bit.ly/1eWeyKC","display_url":"bit.ly/1eWeyKC"}],"annotations":{}},"referenced_tweets":{},"text":"Send us your comments on our draft #herbal monograph for Ginkgo biloba L., folium (#Ginkgo leaf): http://t.co/NiXN61Enjx","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"435358902591315968","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-17T10:23:45.000Z","id":"435358902591315968","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":62,"end":73,"tag":"Calendulae"},{"start":96,"end":103,"tag":"herbal"}],"urls":[{"start":115,"end":137,"url":"http://t.co/E5Ws34EV7m","expanded_url":"http://bit.ly/1jhhZKy","display_url":"bit.ly/1jhhZKy"}],"annotations":{}},"referenced_tweets":{},"text":"We've published a call for data for use in assessment work on #Calendulae herba in the field of #herbal medicines: http://t.co/E5Ws34EV7m","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435358722294947841","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-17T10:23:02.000Z","id":"435358722294947841","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":38,"end":42,"tag":"CAT"}],"urls":[{"start":84,"end":106,"url":"http://t.co/6UEb1opg3H","expanded_url":"http://bit.ly/1dsWOoq","display_url":"bit.ly/1dsWOoq"}],"annotations":[{"start":56,"end":72,"probability":0.9893,"type":"Person","normalized_text":"Paula Salmikangas"}]},"referenced_tweets":{},"text":"Our committee for advanced therapies, #CAT, has elected Paula Salmikangas as chair: http://t.co/6UEb1opg3H","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"435357892527390720","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-17T10:19:44.000Z","id":"435357892527390720","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":35,"end":46,"tag":"veterinary"},{"start":76,"end":81,"tag":"CVMP"}],"urls":[{"start":94,"end":116,"url":"http://t.co/swv53liFsm","expanded_url":"http://bit.ly/1gzVTTj","display_url":"bit.ly/1gzVTTj"}],"annotations":{}},"referenced_tweets":{},"text":"We published the highlights of our #veterinary medicines committee meeting, #CVMP, on Friday: http://t.co/swv53liFsm","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435357207417217024","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-17T10:17:01.000Z","id":"435357207417217024","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":113,"end":129,"username":"Eurosurveillanc","id":"455839750"}],"hashtags":[{"start":73,"end":77,"tag":"flu"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"435355594342801408"}],"text":"RT @ECDC_Flu: Low to moderate vaccine effectiveness estimated in 2012/13 #flu season, I-Move case control study, @Eurosurveillanc: http://t…","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435355688689491968","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T10:10:59.000Z","id":"435355688689491968","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":71,"end":93,"url":"http://t.co/ogM97k5MZ1","expanded_url":"http://bit.ly/MrDTAe","display_url":"bit.ly/MrDTAe"}],"annotations":[{"start":24,"end":45,"probability":0.5686,"type":"Other","normalized_text":"Head of IT Development"},{"start":48,"end":61,"probability":0.9554,"type":"Person","normalized_text":"Dina Tsiambaou"}]},"referenced_tweets":{},"text":"We're welcoming our new Head of IT Development, Dina Tsiambaou, today: http://t.co/ogM97k5MZ1","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435354813199822848","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-17T10:07:30.000Z","id":"435354813199822848","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"}],"hashtags":[{"start":14,"end":21,"tag":"CARESS"},{"start":75,"end":88,"tag":"CHEMOTHERAPY"}],"urls":[{"start":89,"end":112,"url":"https://t.co/HIzXVbG8Wl","expanded_url":"https://cordis.europa.eu/wire/index.cfm?fuseaction=article.Detail&rcn=42469&rev=0","display_url":"cordis.europa.eu/wire/index.cfm…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"435350958021693441"}],"text":"RT @myCORDIS: #CARESS - A NEW DIAGNOSTIC TOOL TO EVALUATE COMPATIBILITY OF #CHEMOTHERAPY https://t.co/HIzXVbG8Wl","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435351760811859968","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T09:55:22.000Z","id":"435351760811859968","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"},{"start":120,"end":135,"username":"cochranecollab","id":"20429156"}],"hashtags":[{"start":39,"end":46,"tag":"Pharma"},{"start":75,"end":90,"tag":"ClinicalTrials"}],"urls":[{"start":97,"end":119,"url":"http://t.co/S97Bo4QGG2","expanded_url":"http://www.business-standard.com/article/companies/pharma-companies-shouldn-t-conduct-clinical-trials-peter-c-g%C3%B8tzsche-114021501019_1.html","display_url":"business-standard.com/article/compan…"}],"annotations":[{"start":20,"end":35,"probability":0.9355,"type":"Person","normalized_text":"Peter C Gøtzsche"}]},"referenced_tweets":[{"type":"retweeted","id":"435349790004477952"}],"text":"RT @nakosbalamotis: Peter C Gøtzsche: \"#Pharma companies shouldn't conduct #ClinicalTrials:http\" http://t.co/S97Bo4QGG2 @cochranecollab","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435351640145932289","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T09:54:54.000Z","id":"435351640145932289","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":56,"end":71,"tag":"bioequivalence"},{"start":85,"end":95,"tag":"sunitinib"}],"urls":[{"start":98,"end":120,"url":"http://t.co/OTozfYOtrx","expanded_url":"http://bit.ly/1bcBnsu","display_url":"bit.ly/1bcBnsu"}],"annotations":{}},"referenced_tweets":{},"text":"Two weeks left to comment on our draft product-specific #bioequivalence guidance for #sunitinib:  http://t.co/OTozfYOtrx","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435350001183899648","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-17T09:48:23.000Z","id":"435350001183899648","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":64,"end":71,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":{},"urls":[{"start":72,"end":94,"url":"http://t.co/dpgkiyBjOW","expanded_url":"http://bit.ly/1oG1SdI","display_url":"bit.ly/1oG1SdI"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"435343680522579968"}],"text":"RT @EFPIA: IMI ENABLE programme tackles Gram-negative pathogens @IMI_JU http://t.co/dpgkiyBjOW","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435349122754043904","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T09:44:53.000Z","id":"435349122754043904","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":37,"end":44,"tag":"pharma"},{"start":45,"end":52,"tag":"health"},{"start":53,"end":61,"tag":"placebo"}],"urls":[{"start":62,"end":84,"url":"http://t.co/TMYDq3qwIW","expanded_url":"http://bbc.in/1cfXWLr","display_url":"bbc.in/1cfXWLr"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"435339428878225408"}],"text":"RT @EFPIA: The medicine in our minds #pharma #health #placebo http://t.co/TMYDq3qwIW","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435348748596572160","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T09:43:24.000Z","id":"435348748596572160","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":129,"end":136,"tag":"pharma"}],"urls":[{"start":105,"end":127,"url":"http://t.co/Ktrc1s0DQa","expanded_url":"http://bit.ly/N27vnH","display_url":"bit.ly/N27vnH"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"435331619050631168"}],"text":"RT @EFPIA: R&amp;D Productivity – what matters in making it a success? Answer: Dropping the lemons early http://t.co/Ktrc1s0DQa  #pharma #resea…","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"435348307591053312","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-17T09:41:39.000Z","id":"435348307591053312","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":93,"end":98,"tag":"CVMP"}],"urls":[{"start":100,"end":122,"url":"http://t.co/lspYzkEaL3","expanded_url":"http://bit.ly/1gzVTTj","display_url":"bit.ly/1gzVTTj"}],"annotations":{}},"referenced_tweets":{},"text":"We've published the highlights of this week's meeting of our veterinary medicines committee, #CVMP: http://t.co/lspYzkEaL3","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"434374185385992192","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-14T17:10:50.000Z","id":"434374185385992192","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":122,"end":130,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":43,"end":53,"tag":"influenza"},{"start":100,"end":104,"tag":"flu"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"434357333896859650"}],"text":"RT @ECDC_Flu: Only 1 country reported high #influenza intensity last week – see more in this week's #flu infographic from @ECDC_EU http://t…","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"434373173686329344","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-14T17:06:49.000Z","id":"434373173686329344","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":31,"end":36,"tag":"CHMP"}],"urls":[{"start":97,"end":119,"url":"http://t.co/0sp891vVKQ","expanded_url":"http://bit.ly/LO8I1U","display_url":"bit.ly/LO8I1U"}],"annotations":{}},"referenced_tweets":{},"text":"Our human medicines committee, #CHMP, meets next week. Highlights will be published next Friday: http://t.co/0sp891vVKQ","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"434372477188190208","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-14T17:04:03.000Z","id":"434372477188190208","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":89,"end":104,"tag":"bioequivalence"}],"urls":[{"start":106,"end":128,"url":"http://t.co/ojXivn0vSz","expanded_url":"http://bit.ly/1ifPXQq","display_url":"bit.ly/1ifPXQq"}],"annotations":{}},"referenced_tweets":{},"text":"Last chance to comment on our 16 product-specific guidance documents on demonstration of #bioequivalence: http://t.co/ojXivn0vSz","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"434372255934472192","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-14T17:03:10.000Z","id":"434372255934472192","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":110,"end":132,"url":"http://t.co/xUCYattFac","expanded_url":"http://bit.ly/1crVrCP","display_url":"bit.ly/1crVrCP"}],"annotations":{}},"referenced_tweets":{},"text":"One day left to comment on our draft public statement on herbal medicines containing pyrrolizidine alkaloids: http://t.co/xUCYattFac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"434372163504599040","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-14T17:02:48.000Z","id":"434372163504599040","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/7qO4CzfJFg","expanded_url":"http://bit.ly/1aN4nXt","display_url":"bit.ly/1aN4nXt"}],"annotations":{}},"referenced_tweets":{},"text":"Two weeks to comment on reflection paper on data requirements for intravenous iron-based nano-colloidal products: http://t.co/7qO4CzfJFg","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"434372046319910913","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-14T17:02:20.000Z","id":"434372046319910913","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":108,"end":130,"url":"http://t.co/mqOqg6LqXk","expanded_url":"http://bit.ly/1bRl4wp","display_url":"bit.ly/1bRl4wp"}],"annotations":{}},"referenced_tweets":{},"text":"The eSubmission Gateway can be used for referrals, veterinary and paediatric submissions from 1 April 2014: http://t.co/mqOqg6LqXk","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"434371848873066496","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-14T17:01:33.000Z","id":"434371848873066496","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":115,"end":137,"url":"http://t.co/0xg21a1YvW","expanded_url":"http://bit.ly/1ez7ihC","display_url":"bit.ly/1ez7ihC"}],"annotations":{}},"referenced_tweets":{},"text":"We're calling for scientific data for use in assessment of Saccharomyces cerevisiae/boulardii in herbal medicine:  http://t.co/0xg21a1YvW","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"434371447524708353","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-14T16:59:57.000Z","id":"434371447524708353","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":98,"end":120,"url":"http://t.co/IXQ0AzCkAl","expanded_url":"http://bit.ly/M0p72w","display_url":"bit.ly/M0p72w"}],"annotations":{}},"referenced_tweets":{},"text":"We're calling for scientific data for use in assessment work on Ricini oleum in herbal medicines: http://t.co/IXQ0AzCkAl","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"434371078203645952","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-14T16:58:29.000Z","id":"434371078203645952","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/K0kAzIVTML","expanded_url":"http://bit.ly/MjDPlP","display_url":"bit.ly/MjDPlP"}],"annotations":{}},"referenced_tweets":{},"text":"We're calling for scientific data for use in assessment work on Cisti cretici folium/resinum in herbal medicines: http://t.co/K0kAzIVTML","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"434370916248985601","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-14T16:57:51.000Z","id":"434370916248985601","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":113,"end":135,"url":"http://t.co/0asbhRxmNF","expanded_url":"http://bit.ly/M0oLc5","display_url":"bit.ly/M0oLc5"}],"annotations":{}},"referenced_tweets":{},"text":"We're calling for scientific data for use in assessment work on Pistacia lentiscus, resinum in herbal medicines: http://t.co/0asbhRxmNF","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"434370723231313920","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-14T16:57:05.000Z","id":"434370723231313920","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":73,"end":80,"tag":"Ginkgo"}],"urls":[{"start":88,"end":110,"url":"http://t.co/TLtJbhLhA9","expanded_url":"http://bit.ly/1eWeyKC","display_url":"bit.ly/1eWeyKC"}],"annotations":{}},"referenced_tweets":{},"text":"We've published the draft herbal monograph for Ginkgo biloba L., folium (#Ginkgo leaf): http://t.co/TLtJbhLhA9","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"434370278844801024","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-14T16:55:19.000Z","id":"434370278844801024","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":113,"end":135,"url":"http://t.co/r96KDQ01AG","expanded_url":"http://bit.ly/1jhhZKy","display_url":"bit.ly/1jhhZKy"}],"annotations":{}},"referenced_tweets":{},"text":"We've published a call for data for use in assessment work on Calendulae herba in the field of herbal medicines: http://t.co/r96KDQ01AG","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"434370012347117568","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-14T16:54:15.000Z","id":"434370012347117568","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":82,"end":86,"tag":"CAT"}],"urls":[{"start":112,"end":134,"url":"http://t.co/ys9rs7FcZI","expanded_url":"http://bit.ly/1dsWOoq","display_url":"bit.ly/1dsWOoq"}],"annotations":{}},"referenced_tweets":{},"text":"We've published a round-up of activities of our committee for advanced therapies, #CAT. New chair just elected: http://t.co/ys9rs7FcZI","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"434369106062901248","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-14T16:50:39.000Z","id":"434369106062901248","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":{},"urls":[{"start":94,"end":116,"url":"http://t.co/GURR0KMrn5","expanded_url":"http://bit.ly/LZzdAG","display_url":"bit.ly/LZzdAG"}],"annotations":[{"start":46,"end":92,"probability":0.469,"type":"Organization","normalized_text":"European Institute of Innovation and Technology"}]},"referenced_tweets":[{"type":"retweeted","id":"434281637975584769"}],"text":"RT @EFPIA: New opportunities to work with the European Institute of Innovation and Technology http://t.co/GURR0KMrn5","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"434318357584945152","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-14T13:29:00.000Z","id":"434318357584945152","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":22,"end":37,"tag":"cardiovascular"},{"start":72,"end":75,"tag":"EU"},{"start":76,"end":83,"tag":"Health"}],"urls":[{"start":112,"end":134,"url":"http://t.co/mcQbk6ElIf","expanded_url":"http://bit.ly/1gDm6PG","display_url":"bit.ly/1gDm6PG"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"434283418893819904"}],"text":"RT @EU_Health: 80% of #cardiovascular diseases (CVD) can be prevented - #EU #Health Program funded EuroHeart II http://t.co/mcQbk6ElIf #lov…","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"434318265847128064","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-14T13:28:38.000Z","id":"434318265847128064","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":118,"end":140,"url":"http://t.co/vu3X9B4TiH","expanded_url":"http://bit.ly/1bRl4wp","display_url":"bit.ly/1bRl4wp"}],"annotations":{}},"referenced_tweets":{},"text":"We're extending use of the eSubmission Gateway to referrals, veterinary and paediatric submissions from 1 April 2014: http://t.co/vu3X9B4TiH","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"434290267391533056","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-14T11:37:23.000Z","id":"434290267391533056","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/h0InI7TgDN","expanded_url":"http://bit.ly/1aN4nXt","display_url":"bit.ly/1aN4nXt"}],"annotations":{}},"referenced_tweets":{},"text":"Two weeks to comment on reflection paper on data requirements for intravenous iron-based nano-colloidal products: http://t.co/h0InI7TgDN","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"434265141841264640","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-14T09:57:32.000Z","id":"434265141841264640","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":105,"end":127,"url":"http://t.co/vlikiAtv9y","expanded_url":"http://bit.ly/1crVrCP","display_url":"bit.ly/1crVrCP"}],"annotations":{}},"referenced_tweets":{},"text":"Last chance to comment on draft public statement on herbal medicines containing pyrrolizidine alkaloids: http://t.co/vlikiAtv9y","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"434264704291450880","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-14T09:55:48.000Z","id":"434264704291450880","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":85,"end":100,"tag":"bioequivalence"}],"urls":[{"start":102,"end":124,"url":"http://t.co/LFE1dwRYqR","expanded_url":"http://bit.ly/1ifPXQq","display_url":"bit.ly/1ifPXQq"}],"annotations":{}},"referenced_tweets":{},"text":"Last chance to comment on 16 product-specific guidance documents on demonstration of #bioequivalence: http://t.co/LFE1dwRYqR","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"434263936511520768","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-14T09:52:45.000Z","id":"434263936511520768","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":35,"end":40,"tag":"CHMP"}],"urls":[{"start":92,"end":114,"url":"http://t.co/11nNPPeBxP","expanded_url":"http://bit.ly/LO8I1U","display_url":"bit.ly/LO8I1U"}],"annotations":{}},"referenced_tweets":{},"text":"Our committee for human medicines, #CHMP, is meeting next week. Highlights out next Friday: http://t.co/11nNPPeBxP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"434263265540333568","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-14T09:50:05.000Z","id":"434263265540333568","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"hashtags":{},"urls":[{"start":90,"end":112,"url":"http://t.co/r2uismjFj0","expanded_url":"http://bit.ly/1hgfQSr","display_url":"bit.ly/1hgfQSr"}],"annotations":{}},"referenced_tweets":{},"text":"RT @AEMPSGOB: January 2014 monthly newsletter from the Spanish medicines agency published http://t.co/r2uismjFj0","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"434020794386366464","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-13T17:46:35.000Z","id":"434020794386366464","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":[{"start":21,"end":29,"tag":"vaccine"}],"urls":[{"start":111,"end":133,"url":"http://t.co/dl57gj9IGj","expanded_url":"http://bit.ly/1gbxt2T","display_url":"bit.ly/1gbxt2T"}],"annotations":[{"start":96,"end":98,"probability":0.8,"type":"Place","normalized_text":"Bxl"}]},"referenced_tweets":[{"type":"retweeted","id":"434007500476518401"}],"text":"RT @IMI_JU: Meet top #vaccine experts and have your say on the future of EU vaccine research in Bxl on 12-13/3 http://t.co/dl57gj9IGj","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"434011490602192896","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-13T17:09:37.000Z","id":"434011490602192896","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"hashtags":{},"urls":[{"start":118,"end":140,"url":"http://t.co/1I4bIyb47u","expanded_url":"http://ow.ly/tASF8","display_url":"ow.ly/tASF8"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"434000102110560256"}],"text":"RT @myESMO: Where do innovative medicines in the EU originate from? Profile of org. involved in dev. of new medicines http://t.co/1I4bIyb47u","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"434001888376528896","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-13T16:31:28.000Z","id":"434001888376528896","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"hashtags":{},"urls":[{"start":84,"end":106,"url":"http://t.co/S4MwKxRnDF","expanded_url":"http://newsletter.echa.europa.eu/","display_url":"newsletter.echa.europa.eu"}],"annotations":[{"start":34,"end":48,"probability":0.766,"type":"Organization","normalized_text":"ECHA Newsletter"}]},"referenced_tweets":[{"type":"retweeted","id":"433985696156884992"}],"text":"RT @EU_ECHA: The new issue of the ECHA Newsletter is out - Building for the future: http://t.co/S4MwKxRnDF","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433987313048510464","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-13T15:33:33.000Z","id":"433987313048510464","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"hashtags":{},"urls":[{"start":100,"end":122,"url":"http://t.co/xJJpcoB5B6","expanded_url":"http://www.emcdda.europa.eu/publications/work-programmes/2014","display_url":"emcdda.europa.eu/publications/w…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"433969738918932480"}],"text":"RT @EMCDDA: Just published: find out what we have planned for this year in our 2014 work programme: http://t.co/xJJpcoB5B6","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433978848821379072","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-13T14:59:55.000Z","id":"433978848821379072","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"hashtags":[{"start":32,"end":35,"tag":"EU"},{"start":38,"end":50,"tag":"Horizon2020"},{"start":96,"end":109,"tag":"HorizonMagEU"}],"urls":[{"start":73,"end":95,"url":"http://t.co/2r8QJki1WY","expanded_url":"http://bit.ly/EUhorizon2020","display_url":"bit.ly/EUhorizon2020"},{"start":110,"end":132,"url":"http://t.co/u5pbis9kP8","expanded_url":"https://twitter.com/innovationunion/status/433956254851932160/photo/1","display_url":"pic.twitter.com/u5pbis9kP8"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"433956254851932160"}],"text":"RT @innovationunion: How is the #EU’s #Horizon2020 budget being spent? \n http://t.co/2r8QJki1WY #HorizonMagEU http://t.co/u5pbis9kP8","public_metrics":{"retweet_count":49,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433961153698742272","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-13T13:49:36.000Z","id":"433961153698742272","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":["3_433956254675763200"]}},{"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":{},"urls":[{"start":108,"end":130,"url":"http://t.co/tCfQJCpmrY","expanded_url":"http://bit.ly/1euNN9V","display_url":"bit.ly/1euNN9V"}],"annotations":{}},"referenced_tweets":{},"text":"RT @Aifa_ufficiale: Independent training of health professionals: the Italian medicines agency's activities http://t.co/tCfQJCpmrY","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433926625231908864","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-13T11:32:24.000Z","id":"433926625231908864","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"hashtags":[{"start":62,"end":66,"tag":"HIV"},{"start":80,"end":89,"tag":"hepatits"}],"urls":[{"start":99,"end":121,"url":"http://t.co/HuulACuBgf","expanded_url":"http://goo.gl/1Eb4ls","display_url":"goo.gl/1Eb4ls"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"433902840474787842"}],"text":"RT @Hep_Alliance: Learning lessons from the global resonse to #HIV can help the #hepatits campaign http://t.co/HuulACuBgf","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433904112485531648","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-13T10:02:56.000Z","id":"433904112485531648","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"},{"start":78,"end":88,"username":"NICEComms","id":"85555796"}],"hashtags":[{"start":112,"end":116,"tag":"hta"},{"start":117,"end":128,"tag":"regaffairs"}],"urls":[{"start":89,"end":111,"url":"http://t.co/upWkyfLLfY","expanded_url":"http://bit.ly/1b17Thu","display_url":"bit.ly/1b17Thu"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"433642640718848000"}],"text":"RT @TOPRANEWS: Health Technology Assessment - Joint workshop run by TOPRA and @NICEcomms http://t.co/upWkyfLLfY #hta #regaffairs","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433659955808595968","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-12T17:52:45.000Z","id":"433659955808595968","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"},{"start":69,"end":83,"username":"EU_Commission","id":"157981564"},{"start":94,"end":109,"username":"JanDeMaeseneer","id":"1568116975"}],"hashtags":[{"start":59,"end":68,"tag":"Brussels"}],"urls":{},"annotations":[{"start":20,"end":42,"probability":0.5427,"type":"Other","normalized_text":"Chronic Diseases Summit"}]},"referenced_tweets":[{"type":"retweeted","id":"433643732706267137"}],"text":"RT @PrimaryCare4um: Chronic Diseases Summit 3-4 April 2014 #Brussels @EU_Commission incl EFPC @JanDeMaeseneer chairing workshop 3 http://t.…","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433659856692969473","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-12T17:52:21.000Z","id":"433659856692969473","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":{},"urls":[{"start":74,"end":96,"url":"http://t.co/jhGQs4UFqH","expanded_url":"http://ow.ly/tyqrQ","display_url":"ow.ly/tyqrQ"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"433651738361737216"}],"text":"RT @EFPIA: Scientists create computer chips that can 'listen' to bacteria http://t.co/jhGQs4UFqH","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433659720650731520","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-12T17:51:49.000Z","id":"433659720650731520","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":17,"end":27,"username":"EU_Health","id":"606325697"}],"hashtags":{},"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"433647273516736512"}],"text":"RT @eubookshop: .@EU_Health   Your right to medical care in another EU country and to have the costs of treatment covered http://t.co/hB7aI…","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433647799885131776","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-12T17:04:26.000Z","id":"433647799885131776","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"hashtags":[{"start":124,"end":135,"tag":"regaffairs"}],"urls":[{"start":101,"end":123,"url":"http://t.co/F2Gkbt4e19","expanded_url":"http://bit.ly/1erkPId","display_url":"bit.ly/1erkPId"}],"annotations":[{"start":94,"end":99,"probability":0.9896,"type":"Place","normalized_text":"London"}]},"referenced_tweets":[{"type":"retweeted","id":"433640196492378112"}],"text":"RT @TOPRANEWS: TOPRA's popular Basics of Medical Devices Regulatory Affairs runs on 27 Feb in London http://t.co/F2Gkbt4e19 #regaffairs #me…","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433640357507919872","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-12T16:34:52.000Z","id":"433640357507919872","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"hashtags":[{"start":107,"end":113,"tag":"H2020"},{"start":114,"end":118,"tag":"ICT"},{"start":119,"end":127,"tag":"funding"}],"urls":[{"start":82,"end":104,"url":"http://t.co/Q0xS7D5FIA","expanded_url":"http://bit.ly/1m15zMc","display_url":"bit.ly/1m15zMc"}],"annotations":[{"start":20,"end":21,"probability":0.5481,"type":"Organization","normalized_text":"EU"}]},"referenced_tweets":[{"type":"retweeted","id":"433544659051102208"}],"text":"RT @EU_eHealth: Get EU funding for your ICT research or innovation project. Watch http://t.co/Q0xS7D5FIA - #H2020 #ICT #funding http://t.co…","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433568174106505216","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-12T11:48:02.000Z","id":"433568174106505216","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"IntDiabetesFed","id":"38393473"}],"hashtags":[{"start":54,"end":62,"tag":"WDC2013"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"433552144239583232"}],"text":"RT @IntDiabetesFed: Everything you need to know about #WDC2013 is in this newsletter: results, webcasts and much more! http://t.co/6XTSI5LC…","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433567999115931648","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-12T11:47:20.000Z","id":"433567999115931648","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":115,"end":137,"url":"http://t.co/xX04tY4FCz","expanded_url":"http://bit.ly/1g2YXYp","display_url":"bit.ly/1g2YXYp"}],"annotations":{}},"referenced_tweets":{},"text":"We're introducing product numbers to track medicines through pre-authorisation procedures - find out how to apply: http://t.co/xX04tY4FCz","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433531581735501824","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-12T09:22:38.000Z","id":"433531581735501824","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":94,"end":116,"url":"http://t.co/Uu89ugJ5Kh","expanded_url":"http://bit.ly/1g2YXYp","display_url":"bit.ly/1g2YXYp"}],"annotations":{}},"referenced_tweets":{},"text":"We've introduced new product numbers to track medicines through pre-authorisation procedures: http://t.co/Uu89ugJ5Kh","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"433280382684114944","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-11T16:44:27.000Z","id":"433280382684114944","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":61,"end":73,"username":"RareConnect","id":"320293216"}],"hashtags":[{"start":11,"end":24,"tag":"INFOGRAPHICS"}],"urls":[{"start":74,"end":96,"url":"http://t.co/aG6GWFWvSp","expanded_url":"https://twitter.com/EFPIA/status/433234399186780160/photo/1","display_url":"pic.twitter.com/aG6GWFWvSp"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"433269960941785088"}],"text":"RT @EFPIA: #INFOGRAPHICS : Rare Diseases - Behçet's Syndrome @RareConnect http://t.co/aG6GWFWvSp","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433270186217865216","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-11T16:03:56.000Z","id":"433270186217865216","possibly_sensitive":false,"lang":"fr","attachments":{"media_keys":["3_433234399190974465"]}},{"entities":{"mentions":[{"start":3,"end":15,"username":"FDAMedWatch","id":"205847300"}],"hashtags":{},"urls":{},"annotations":[{"start":96,"end":98,"probability":0.486,"type":"Organization","normalized_text":"FDA"}]},"referenced_tweets":[{"type":"retweeted","id":"433263282640912384"}],"text":"RT @FDAMedWatch: Saxagliptin (marketed as Onglyza &amp; Kombiglyze XR): Drug Safety Communication - FDA to Review Heart Failure Risk http://t.c…","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433267432669847552","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-11T15:53:00.000Z","id":"433267432669847552","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"EuroParlPress","id":"199196447"}],"hashtags":[{"start":34,"end":41,"tag":"Animal"},{"start":55,"end":61,"tag":"pests"},{"start":104,"end":115,"tag":"foodsafety"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"433258852767657984"}],"text":"RT @EuroParlPress: Press release: #Animal diseases and #pests: MEPs call for stronger measures to boost #foodsafety in the EU: http://t.co/…","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433266516365438976","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-11T15:49:21.000Z","id":"433266516365438976","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"hashtags":[{"start":57,"end":66,"tag":"diabetes"},{"start":97,"end":105,"tag":"Onglyza"},{"start":110,"end":121,"tag":"Kombiglyze"}],"urls":{},"annotations":[{"start":19,"end":21,"probability":0.8015,"type":"Organization","normalized_text":"FDA"}]},"referenced_tweets":[{"type":"retweeted","id":"433250012639010819"}],"text":"RT @FDA_Drug_Info: FDA to review heart failure risk with #diabetes drug saxagliptin (marketed as #Onglyza and #Kombiglyze XR). http://t.co/…","public_metrics":{"retweet_count":38,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433259284055752704","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-11T15:20:37.000Z","id":"433259284055752704","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":61,"end":73,"username":"RareConnect","id":"320293216"}],"hashtags":[{"start":11,"end":24,"tag":"INFOGRAPHICS"}],"urls":[{"start":74,"end":96,"url":"http://t.co/aG6GWFWvSp","expanded_url":"https://twitter.com/EFPIA/status/433234399186780160/photo/1","display_url":"pic.twitter.com/aG6GWFWvSp"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"433234399186780160"}],"text":"RT @EFPIA: #INFOGRAPHICS : Rare Diseases - Behçet's Syndrome @RareConnect http://t.co/aG6GWFWvSp","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433257526411681792","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-11T15:13:38.000Z","id":"433257526411681792","possibly_sensitive":false,"lang":"fr","attachments":{"media_keys":["3_433234399190974465"]}},{"entities":{"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"},{"start":67,"end":71,"username":"ORF","id":"1192686992"},{"start":90,"end":99,"username":"agesnews","id":"223456379"}],"hashtags":{},"urls":[{"start":118,"end":140,"url":"http://t.co/Lo6yG7fIA1","expanded_url":"http://bit.ly/1oeMxQV","display_url":"bit.ly/1oeMxQV"}],"annotations":{}},"referenced_tweets":{},"text":"RT @agesnews: Intolerance - lactose is present in many medicines - @ORF specifically with @agesnews expert Baumgärtel http://t.co/Lo6yG7fIA1","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"433221668140765185","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-11T12:51:09.000Z","id":"433221668140765185","possibly_sensitive":false,"lang":"de","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"hashtags":{},"urls":[{"start":102,"end":124,"url":"http://t.co/c1HXMOY2Qk","expanded_url":"http://ow.ly/tvdza","display_url":"ow.ly/tvdza"}],"annotations":[{"start":15,"end":24,"probability":0.9712,"type":"Person","normalized_text":"Mark Birse"},{"start":54,"end":70,"probability":0.4605,"type":"Other","normalized_text":"Orange Guide 2014"}]},"referenced_tweets":[{"type":"retweeted","id":"433207189579505664"}],"text":"RT @MHRAgovuk: Mark Birse discusses what’s new in the Orange Guide 2014, rules and guidance for GMDP: http://t.co/c1HXMOY2Qk","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433209809341394944","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-11T12:04:01.000Z","id":"433209809341394944","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"hashtags":[{"start":58,"end":62,"tag":"DNA"},{"start":109,"end":119,"tag":"hepatitis"},{"start":128,"end":132,"tag":"HCV"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"433201616951738368"}],"text":"RT @Hep_Alliance: Scientists discover tiny differences to #DNA sequence can affect your ability to fight the #hepatitis C virus #HCV http:/…","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433209648733487104","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-11T12:03:23.000Z","id":"433209648733487104","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":45,"end":50,"tag":"H7N9"},{"start":54,"end":60,"tag":"China"}],"urls":[{"start":61,"end":83,"url":"http://t.co/COwYqDUg0m","expanded_url":"http://goo.gl/LCZekp","display_url":"goo.gl/LCZekp","unwound_url":"https://www.who.int/csr/don/2014_02_11/en/index.html"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"433191815030665216"}],"text":"RT @WHO: Latest WHO Disease Outbreak News on #H7N9 in #China http://t.co/COwYqDUg0m (9 &amp; 10 February 2014)","public_metrics":{"retweet_count":53,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433197242372341760","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-11T11:14:05.000Z","id":"433197242372341760","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":75,"end":85,"tag":"variation"}],"urls":[{"start":113,"end":135,"url":"http://t.co/9sfJpynFnw","expanded_url":"http://bit.ly/NtGx9o","display_url":"bit.ly/NtGx9o"}],"annotations":{}},"referenced_tweets":{},"text":"Yesterday we issued a clarification of how to interpret the new regulatory #variation classification categories: http://t.co/9sfJpynFnw","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433172243175071744","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-11T09:34:45.000Z","id":"433172243175071744","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":117,"end":139,"url":"http://t.co/sOtQ16RxEw","expanded_url":"http://bit.ly/1h3I5Uh","display_url":"bit.ly/1h3I5Uh"}],"annotations":{}},"referenced_tweets":{},"text":"Yesterday we published a concept paper on the need for a single note for guidance on chemistry of active substances: http://t.co/sOtQ16RxEw","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433171720107589632","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-11T09:32:40.000Z","id":"433171720107589632","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":38,"end":54,"username":"SALUSProject_EU","id":"589818820"}],"hashtags":[{"start":95,"end":99,"tag":"ADE"}],"urls":[{"start":114,"end":137,"url":"https://t.co/QnCw2I4U1Y","expanded_url":"https://ec.europa.eu/digital-agenda/news-redirect/14381","display_url":"ec.europa.eu/digital-agenda…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"433163184770256896"}],"text":"RT @EU_eHealth: New tool developed by @SALUSProject_EU makes reporting of adverse drug events (#ADE) much easier: https://t.co/QnCw2I4U1Y #…","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433169130020438016","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-11T09:22:23.000Z","id":"433169130020438016","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":72,"end":78,"tag":"cells"},{"start":102,"end":111,"tag":"research"}],"urls":[{"start":79,"end":101,"url":"http://t.co/2s8YClTZP4","expanded_url":"http://bit.ly/1dDXymf","display_url":"bit.ly/1dDXymf"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"433158023792447488"}],"text":"RT @EFPIA: Nanomotors are controlled, for the first time, inside living #cells http://t.co/2s8YClTZP4 #research","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"433168248092504064","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-11T09:18:52.000Z","id":"433168248092504064","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":59,"end":68,"tag":"diabetes"}],"urls":[{"start":70,"end":92,"url":"http://t.co/xIs6aOhQeM","expanded_url":"http://bit.ly/1gfyIO0","display_url":"bit.ly/1gfyIO0"}],"annotations":{}},"referenced_tweets":{},"text":"We've published the EPAR for Xigduo, a medicine for type 2 #diabetes: http://t.co/xIs6aOhQeM","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"432935448311128065","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-10T17:53:49.000Z","id":"432935448311128065","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"hashtags":[{"start":64,"end":72,"tag":"chronic"},{"start":73,"end":82,"tag":"diseases"},{"start":117,"end":125,"tag":"eHealth"},{"start":126,"end":130,"tag":"AHA"}],"urls":[{"start":93,"end":116,"url":"https://t.co/6Z2fCWHCSW","expanded_url":"https://ec.europa.eu/digital-agenda/news-redirect/14401","display_url":"ec.europa.eu/digital-agenda…"}],"annotations":[{"start":26,"end":33,"probability":0.7227,"type":"Place","normalized_text":"Brussels"},{"start":86,"end":91,"probability":0.9837,"type":"Place","normalized_text":"Europe"}]},"referenced_tweets":[{"type":"retweeted","id":"432896761858772992"}],"text":"RT @EU_eHealth: 3-4 April Brussels: EU summit on how to address #chronic #diseases in Europe https://t.co/6Z2fCWHCSW #eHealth #AHA via @EU_…","public_metrics":{"retweet_count":28,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"432935189720096768","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-10T17:52:47.000Z","id":"432935189720096768","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"hashtags":[{"start":44,"end":53,"tag":"melanoma"}],"urls":[{"start":63,"end":85,"url":"http://t.co/sGYDtGyfRW","expanded_url":"http://www.healthnewsreview.org/review/new-drugs-improve-options-for-melanoma-patients/","display_url":"healthnewsreview.org/review/new-dru…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"432905958126149632"}],"text":"RT @cancereu: New drugs improve options for #melanoma patients http://t.co/sGYDtGyfRW","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"432934959352139776","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-10T17:51:52.000Z","id":"432934959352139776","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":105,"end":127,"url":"http://t.co/dVGRka16Id","expanded_url":"http://bit.ly/NtGx9o","display_url":"bit.ly/NtGx9o"}],"annotations":{}},"referenced_tweets":{},"text":"We've issued a clarification of how to interpret the new regulatory variation classification categories: http://t.co/dVGRka16Id","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"432904542188228610","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-10T15:51:00.000Z","id":"432904542188228610","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/HlqbLE2ZXP","expanded_url":"http://bit.ly/1h3I5Uh","display_url":"bit.ly/1h3I5Uh"}],"annotations":{}},"referenced_tweets":{},"text":"We've published a concept paper on the need for a single note for guidance on the chemistry of active substances: http://t.co/HlqbLE2ZXP","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"432868675142815744","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-10T13:28:29.000Z","id":"432868675142815744","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"},{"start":107,"end":122,"username":"uniofedinburgh","id":"2900418178"},{"start":124,"end":135,"username":"uppsalauni","id":"26198882"}],"hashtags":[{"start":24,"end":33,"tag":"research"},{"start":73,"end":83,"tag":"diabetics"}],"urls":[{"start":84,"end":106,"url":"http://t.co/FrRigZAC6X","expanded_url":"http://cordis.europa.eu/news/rcn/36441_en.html","display_url":"cordis.europa.eu/news/rcn/36441…"}],"annotations":[{"start":42,"end":47,"probability":0.9858,"type":"Place","normalized_text":"Europe"}]},"referenced_tweets":[{"type":"retweeted","id":"432864352052330496"}],"text":"RT @myCORDIS: Stem-cell #research to help Europe's growing population of #diabetics http://t.co/FrRigZAC6X @UniofEdinburgh \n@uppsalauni","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"432867518127292416","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-10T13:23:53.000Z","id":"432867518127292416","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"hashtags":{},"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"432867275234762752"}],"text":"RT @HAIEurope: Antimicrobial resistance is a growing problem, but how so? A nice step-by-step animation of drug-resistant bacteria: http://…","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"432867311188721664","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-10T13:23:03.000Z","id":"432867311188721664","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":29,"end":34,"tag":"PRAC"}],"urls":[{"start":55,"end":77,"url":"http://t.co/OpNdXGFjSb","expanded_url":"http://bit.ly/Mxa6FR","display_url":"bit.ly/Mxa6FR"}],"annotations":{}},"referenced_tweets":{},"text":"Last Friday we published the #PRAC meeting highlights: http://t.co/OpNdXGFjSb","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"432844299185573888","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-10T11:51:37.000Z","id":"432844299185573888","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":72,"end":81,"tag":"diabetes"}],"urls":[{"start":83,"end":105,"url":"http://t.co/yCye8EZE4D","expanded_url":"http://bit.ly/1gfyIO0","display_url":"bit.ly/1gfyIO0"}],"annotations":[{"start":42,"end":47,"probability":0.3484,"type":"Person","normalized_text":"Xigduo"}]},"referenced_tweets":{},"text":"We've published the assessment report for Xigduo, a medicine for type 2 #diabetes: http://t.co/yCye8EZE4D","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"432833637864976384","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-10T11:09:15.000Z","id":"432833637864976384","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/oNt2nwwcGn","expanded_url":"http://bit.ly/1gTcJzI","display_url":"bit.ly/1gTcJzI"}],"annotations":{}},"referenced_tweets":{},"text":"From 1 March, using the eSubmission Gateway or web client will be mandatory for all centralised eCTD submissions: http://t.co/oNt2nwwcGn","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"432822396878200833","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-10T10:24:35.000Z","id":"432822396878200833","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":74,"end":84,"tag":"influenza"},{"start":85,"end":94,"tag":"vaccines"}],"urls":[{"start":96,"end":118,"url":"http://t.co/tvuvPqfbSI","expanded_url":"http://bit.ly/1carAOA","display_url":"bit.ly/1carAOA"}],"annotations":{}},"referenced_tweets":{},"text":"We've updated our guidance regarding the annual strain change of seasonal #influenza #vaccines: http://t.co/tvuvPqfbSI","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"432822147380047872","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-10T10:23:36.000Z","id":"432822147380047872","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":74,"end":78,"tag":"3Rs"}],"urls":[{"start":115,"end":137,"url":"http://t.co/ZtMjs3z22b","expanded_url":"http://bit.ly/1caQb5O","display_url":"bit.ly/1caQb5O"}],"annotations":{}},"referenced_tweets":{},"text":"Comments invited on review of our guidelines on best practice in applying #3Rs in regulatory testing of medicines: http://t.co/ZtMjs3z22b","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"432821701005430784","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-10T10:21:49.000Z","id":"432821701005430784","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":46,"end":58,"tag":"chikungunya"},{"start":72,"end":82,"tag":"Caribbean"}],"urls":[{"start":90,"end":112,"url":"http://t.co/0Tq38LozHR","expanded_url":"http://bit.ly/MxOysD","display_url":"bit.ly/MxOysD"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431839089609175040"}],"text":"RT @ECDC_EU: Update on autochthonous cases of #chikungunya fever in the #Caribbean region http://t.co/0Tq38LozHR","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431839126430953472","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T17:17:25.000Z","id":"431839126430953472","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"hashtags":[{"start":37,"end":49,"tag":"RareDisease"}],"urls":[{"start":113,"end":135,"url":"http://t.co/nLpQy0mX0N","expanded_url":"http://ow.ly/to1oj","display_url":"ow.ly/to1oj"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431838776743428096"}],"text":"RT @eurordis: European Conference on #RareDisease (ECRD) 2014: Earlybird Registration closes on the 15 February! http://t.co/nLpQy0mX0N","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431838894259449856","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T17:16:30.000Z","id":"431838894259449856","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":67,"end":75,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":44,"end":54,"tag":"influenza"}],"urls":[{"start":76,"end":98,"url":"http://t.co/6CnOmt4SiH","expanded_url":"http://bit.ly/MxNOno","display_url":"bit.ly/MxNOno"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431838491463655424"}],"text":"RT @ECDC_EU: Epidemiological update A(H7N9) #influenza, 7 Feb from @ECDC_EU http://t.co/6CnOmt4SiH","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431838612674871296","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T17:15:23.000Z","id":"431838612674871296","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"hashtags":[{"start":43,"end":54,"tag":"biosimilar"},{"start":55,"end":66,"tag":"regulatory"}],"urls":[{"start":88,"end":110,"url":"http://t.co/EbNkaKI4h7","expanded_url":"http://www.gabionline.net/Biosimilars/Research/The-case-for-improving-biosimilar-regulatory-frameworks-worldwide","display_url":"gabionline.net/Biosimilars/Re…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431828723277369344"}],"text":"RT @nakosbalamotis: The case for improving #biosimilar #regulatory frameworks worldwide http://t.co/EbNkaKI4h7","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431829090119995393","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T16:37:32.000Z","id":"431829090119995393","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"hashtags":{},"urls":[{"start":90,"end":112,"url":"http://t.co/GxVPID1enj","expanded_url":"http://ow.ly/toi3N","display_url":"ow.ly/toi3N"}],"annotations":[{"start":61,"end":62,"probability":0.7469,"type":"Place","normalized_text":"UK"}]},"referenced_tweets":[{"type":"retweeted","id":"431826860532830208"}],"text":"RT @MHRApress: CPRD data used in important research study on UK insulin use by diabetics: http://t.co/GxVPID1enj","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431827047422623744","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T16:29:25.000Z","id":"431827047422623744","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"hashtags":{},"urls":[{"start":90,"end":112,"url":"http://t.co/fwlWgd3fTc","expanded_url":"http://ow.ly/tohuM","display_url":"ow.ly/tohuM"}],"annotations":[{"start":61,"end":62,"probability":0.7469,"type":"Place","normalized_text":"UK"}]},"referenced_tweets":[{"type":"retweeted","id":"431826859723358209"}],"text":"RT @MHRAgovuk: CPRD data used in important research study on UK insulin use by diabetics: http://t.co/fwlWgd3fTc","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431827032948101120","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T16:29:22.000Z","id":"431827032948101120","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":110,"end":114,"tag":"3Rs"}],"urls":[{"start":116,"end":138,"url":"http://t.co/jM1xEGu7fI","expanded_url":"http://bit.ly/1caQb5O","display_url":"bit.ly/1caQb5O"}],"annotations":{}},"referenced_tweets":{},"text":"Public consultation now open on review and update of our guidelines to implement best practice with regard to #3Rs: http://t.co/jM1xEGu7fI","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"431825118810365952","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-07T16:21:45.000Z","id":"431825118810365952","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"hashtags":[{"start":100,"end":110,"tag":"influenza"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431821848188178432"}],"text":"RT @WHO_Europe_VPI: EuroFlu weekly update: Most European countries continue to report low-intensity #influenza activity http://t.co/PgvFI1p…","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431821918103429120","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T16:09:02.000Z","id":"431821918103429120","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":{},"urls":[{"start":76,"end":98,"url":"http://t.co/424kpDUv8f","expanded_url":"http://bit.ly/LWV2Bj","display_url":"bit.ly/LWV2Bj"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431821672031588352"}],"text":"RT @EFPIA: Whole-genome testing helps identify treatments for breast cancer http://t.co/424kpDUv8f","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431821776042360832","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T16:08:28.000Z","id":"431821776042360832","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431819043210035200"}],"text":"RT @GCessak: eSubmission Gateway or web client mandatory for all eCTD submissions through the centralised procedure from 1.03.2014 http://t…","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431819123086360576","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T15:57:56.000Z","id":"431819123086360576","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"urls":[{"start":113,"end":135,"url":"http://t.co/RXQBHu7Yav","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/02/news_detail_002019.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431818774376112129"}],"text":"RT @GCessak: European Medicines Agency updates guidance for annual strain change of seasonal influenza vaccines: http://t.co/RXQBHu7Yav","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431819109668761600","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T15:57:53.000Z","id":"431819109668761600","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"hashtags":[{"start":58,"end":62,"tag":"flu"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431818696227434496"}],"text":"RT @ECDC_Flu: Regional or widespread geographic spread of #flu activity increased in week 5. See latest report for full details: http://t.c…","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431819097001984000","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T15:57:50.000Z","id":"431819097001984000","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"hashtags":[{"start":18,"end":22,"tag":"flu"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431817164987699201"}],"text":"RT @ECDC_Flu: Low #flu intensity in 22 European countries last week. Only 1 saw high intensity. See more in our new infographic http://t.co…","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431818542724706304","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T15:55:38.000Z","id":"431818542724706304","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"},{"start":93,"end":100,"username":"Forbes","id":"91478624"}],"hashtags":{},"urls":[{"start":66,"end":88,"url":"http://t.co/TC97xjvWB5","expanded_url":"http://onforb.es/1o0rVMh","display_url":"onforb.es/1o0rVMh"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431815724764385280"}],"text":"RT @nakosbalamotis: A Way To Increase Drug R&amp;D Success Rates  http://t.co/TC97xjvWB5 via @forbes","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431818475720695809","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T15:55:22.000Z","id":"431818475720695809","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"},{"start":71,"end":80,"username":"eurordis","id":"26993786"}],"hashtags":[{"start":31,"end":43,"tag":"RareDisease"}],"urls":[{"start":81,"end":103,"url":"http://t.co/wQ3nGhHw55","expanded_url":"http://ow.ly/tnGQz","display_url":"ow.ly/tnGQz"}],"annotations":[{"start":57,"end":64,"probability":0.9661,"type":"Place","normalized_text":"Brussels"}]},"referenced_tweets":[{"type":"retweeted","id":"431814695650340864"}],"text":"RT @rarediseaseday: Agenda for #RareDisease Day event in Brussels with @eurordis http://t.co/wQ3nGhHw55\nYou're invited, free registration n…","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431818260183801857","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T15:54:30.000Z","id":"431818260183801857","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":88,"end":95,"tag":"health"},{"start":96,"end":103,"tag":"pharma"},{"start":104,"end":114,"tag":"medicines"}],"urls":[{"start":64,"end":86,"url":"http://t.co/ONuvYWoYiY","expanded_url":"http://bit.ly/1d1DlLl","display_url":"bit.ly/1d1DlLl"},{"start":115,"end":137,"url":"http://t.co/pMl8AxTZAn","expanded_url":"https://twitter.com/EFPIA/status/431720524851331072/photo/1","display_url":"pic.twitter.com/pMl8AxTZAn"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431811968882597888"}],"text":"RT @EFPIA: EFPIA's New Webpage dedicated to Health &amp; Growth http://t.co/ONuvYWoYiY  #health #pharma #medicines http://t.co/pMl8AxTZAn","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431818194916225024","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T15:54:15.000Z","id":"431818194916225024","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":["3_431720524855525378"]}},{"entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"hashtags":[{"start":19,"end":23,"tag":"FDA"}],"urls":[{"start":86,"end":108,"url":"http://t.co/CphnekXR2W","expanded_url":"http://1.usa.gov/LEprne","display_url":"1.usa.gov/LEprne"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431808625364197376"}],"text":"RT @FDA_Drug_Info: #FDA First Annual Report on Drug Shortages for Calendar Year 2013. http://t.co/CphnekXR2W","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431818026229698560","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T15:53:34.000Z","id":"431818026229698560","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"USPharmacopeia","id":"47953929"}],"hashtags":{},"urls":{},"annotations":[{"start":59,"end":97,"probability":0.2319,"type":"Organization","normalized_text":"FREE Veterinary Drugs Stakeholder Forum"}]},"referenced_tweets":[{"type":"retweeted","id":"431808589985218561"}],"text":"RT @USPharmacopeia: There's still time to register for our FREE Veterinary Drugs Stakeholder Forum (including a remote Webex option!)  http…","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431818013315436544","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T15:53:31.000Z","id":"431818013315436544","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"hashtags":{},"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431803896244088832"}],"text":"RT @nakosbalamotis: eSubmission Gateway or web client mandatory for all eCTD submissions through the centralised procedure from 1/3/14 http…","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431804325405683712","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T14:59:08.000Z","id":"431804325405683712","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":43,"end":48,"tag":"H7N9"},{"start":58,"end":64,"tag":"China"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431801823482355714"}],"text":"RT @WHO: Seven of the latest lab-confirmed #H7N9 cases in #China (8 Feb 2014) are reported to have had exposure to poultry or a live poultr…","public_metrics":{"retweet_count":46,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431804292643962881","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T14:59:00.000Z","id":"431804292643962881","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":29,"end":35,"tag":"China"},{"start":86,"end":91,"tag":"H7N9"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431799012069744640"}],"text":"RT @WHO: On 7 February 2014, #China notified WHO of 8 additional laboratory-confirmed #H7N9 cases","public_metrics":{"retweet_count":42,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431799056961384449","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T14:38:12.000Z","id":"431799056961384449","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":64,"end":74,"tag":"influenza"},{"start":75,"end":84,"tag":"vaccines"}],"urls":[{"start":86,"end":108,"url":"http://t.co/AtEVI30OOk","expanded_url":"http://bit.ly/1carAOA","display_url":"bit.ly/1carAOA"}],"annotations":{}},"referenced_tweets":{},"text":"We've updated our guidance for annual strain change of seasonal #influenza #vaccines: http://t.co/AtEVI30OOk","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431797191712440320","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-07T14:30:47.000Z","id":"431797191712440320","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":113,"end":135,"url":"http://t.co/IWotp1UskL","expanded_url":"http://bit.ly/1gTcJzI","display_url":"bit.ly/1gTcJzI"}],"annotations":{}},"referenced_tweets":{},"text":"From 1 March,  the eSubmission Gateway or web client will become mandatory for all centralised eCTD submissions: http://t.co/IWotp1UskL","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431796868369375233","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-07T14:29:30.000Z","id":"431796868369375233","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":24,"end":31,"tag":"Cancer"}],"urls":[{"start":67,"end":89,"url":"http://t.co/zDTGCxRBjZ","expanded_url":"http://nyti.ms/1fDpOI9","display_url":"nyti.ms/1fDpOI9"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431792827077365760"}],"text":"RT @EFPIA: A Catalog of #Cancer Genes That’s Done, or Just a Start http://t.co/zDTGCxRBjZ","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431796164300898304","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T14:26:42.000Z","id":"431796164300898304","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":13,"username":"PierrikFaure","id":"377336516"}],"hashtags":{},"urls":[{"start":52,"end":74,"url":"http://t.co/81mvfkEvbJ","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"431770241165565953"}],"text":"@PierrikFaure Please forward your question to us at http://t.co/81mvfkEvbJ so that we can respond to you in full.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431766052519677952","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T12:45:08.000Z","id":"431770602719174657","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"377336516","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":58,"end":65,"tag":"herbal"},{"start":87,"end":101,"tag":"pyrrolizidine"},{"start":102,"end":112,"tag":"alkaloids"}],"urls":[{"start":114,"end":136,"url":"http://t.co/xUCYattFac","expanded_url":"http://bit.ly/1crVrCP","display_url":"bit.ly/1crVrCP"}],"annotations":{}},"referenced_tweets":{},"text":"One week left to comment on our draft public statement on #herbal medicines containing #pyrrolizidine #alkaloids: http://t.co/xUCYattFac","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431766143754178560","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-07T12:27:25.000Z","id":"431766143754178560","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":100,"end":115,"tag":"bioequivalence"}],"urls":[{"start":117,"end":139,"url":"http://t.co/BZ9TH8Tn8U","expanded_url":"http://bit.ly/1a63PMi","display_url":"bit.ly/1a63PMi"}],"annotations":{}},"referenced_tweets":{},"text":"There's just one week left to comment on our 16 product-specific guidelines on the demonstration of #bioequivalence: http://t.co/BZ9TH8Tn8U","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"431766052519677952","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-07T12:27:03.000Z","id":"431766052519677952","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":28,"end":39,"tag":"veterinary"},{"start":51,"end":56,"tag":"CVMP"}],"urls":[{"start":98,"end":120,"url":"http://t.co/Cw5TvV1ird","expanded_url":"http://bit.ly/1fNbWNK","display_url":"bit.ly/1fNbWNK"}],"annotations":{}},"referenced_tweets":{},"text":"The February meeting of our #veterinary committee, #CVMP, is next week. Highlights out on Friday: http://t.co/Cw5TvV1ird","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431765892699930624","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-07T12:26:25.000Z","id":"431765892699930624","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"urls":[{"start":60,"end":82,"url":"http://t.co/HRBJy9SElG","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Newsletter/2014/02/WC500160566.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431761000870584321"}],"text":"RT @GCessak: EMA: Human medicines highlights - January 2014 http://t.co/HRBJy9SElG","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431763867015061504","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T12:18:22.000Z","id":"431763867015061504","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"hashtags":{},"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431752026549387265"}],"text":"RT @myESMO: Correct URL: Landmark study across cancer types reveals universe of cancer mutations much bigger than thought http://t.co/Tcz1C…","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431763717005795328","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T12:17:46.000Z","id":"431763717005795328","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":25,"end":30,"tag":"PRAC"}],"urls":[{"start":52,"end":74,"url":"http://t.co/FmUJubL2Ns","expanded_url":"http://bit.ly/Mxa6FR","display_url":"bit.ly/Mxa6FR"}],"annotations":{}},"referenced_tweets":{},"text":"We've just published the #PRAC meeting highlights:  http://t.co/FmUJubL2Ns","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"431761648748347392","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-07T12:09:33.000Z","id":"431761648748347392","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"hashtags":{},"urls":[{"start":80,"end":102,"url":"http://t.co/Lo5fYaThgE","expanded_url":"http://www.eurekalert.org/pub_releases/2014-02/acs-ecd020514.php#.UvS8VK8WT1Y.twitter","display_url":"eurekalert.org/pub_releases/2…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431743785106558976"}],"text":"RT @nakosbalamotis: Electronically controlled drugs could minimize side effects http://t.co/Lo5fYaThgE","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431744077093421056","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T10:59:44.000Z","id":"431744077093421056","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"hashtags":[{"start":24,"end":29,"tag":"drug"}],"urls":[{"start":91,"end":113,"url":"http://t.co/PkgFZAnRL7","expanded_url":"http://blogs.scientificamerican.com/the-curious-wavefunction/2014/02/05/why-drug-discovery-is-hard-part-4-taking-the-fight-to-the-enemy/","display_url":"blogs.scientificamerican.com/the-curious-wa…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431738963452100609"}],"text":"RT @nakosbalamotis: Why #drug discovery is hard – Part 4: Taking the fight to the “enemy”. http://t.co/PkgFZAnRL7","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431739231476932608","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T10:40:28.000Z","id":"431739231476932608","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":43,"end":48,"tag":"H7N9"},{"start":58,"end":64,"tag":"China"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431733389184737280"}],"text":"RT @WHO: Eight of the latest lab-confirmed #H7N9 cases in #China (5 Feb 2014) are reported to have had exposure to poultry or a live poultr…","public_metrics":{"retweet_count":43,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431733508714037248","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T10:17:44.000Z","id":"431733508714037248","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":70,"end":77,"tag":"Health"},{"start":78,"end":85,"tag":"Growth"},{"start":86,"end":96,"tag":"EFPIALIVE"},{"start":97,"end":101,"tag":"IMI"},{"start":102,"end":110,"tag":"Twitter"},{"start":111,"end":126,"tag":"WorldCancerDay"}],"urls":[{"start":47,"end":69,"url":"http://t.co/N4w8DsYGVJ","expanded_url":"http://bit.ly/1aCmQWT","display_url":"bit.ly/1aCmQWT"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431728857775763456"}],"text":"RT @EFPIA: It's Friday! Our Newsletter is OUT! http://t.co/N4w8DsYGVJ #Health #Growth #EFPIALIVE #IMI #Twitter #WorldCancerDay http://t.co/…","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431729813154709504","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T10:03:03.000Z","id":"431729813154709504","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":29,"end":35,"tag":"China"},{"start":87,"end":92,"tag":"H7N9"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431728424512937984"}],"text":"RT @WHO: On 5 February 2014, #China notified WHO of 10 additional laboratory-confirmed #H7N9 cases","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431729754488975360","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T10:02:49.000Z","id":"431729754488975360","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"urls":[{"start":48,"end":70,"url":"http://t.co/Yiynun3W75","expanded_url":"http://bit.ly/1kjO5ZB","display_url":"bit.ly/1kjO5ZB"}],"annotations":{}},"referenced_tweets":{},"text":"RT @GCessak: Vitamin C divides the oncologists: http://t.co/Yiynun3W75","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"431729705080086529","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T10:02:37.000Z","id":"431729705080086529","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"ECNPtweets","id":"347180217"}],"hashtags":{},"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431726844237197313"}],"text":"RT @ECNPtweets: EMA draft guideline for public consultation: how pharmacogenomics can support pharmacovigilance activities. \nhttp://t.co/P6…","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431729558581432320","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T10:02:02.000Z","id":"431729558581432320","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":56,"end":63,"tag":"herbal"},{"start":85,"end":99,"tag":"pyrrolizidine"},{"start":100,"end":110,"tag":"alkaloids"}],"urls":[{"start":112,"end":134,"url":"http://t.co/xUCYattFac","expanded_url":"http://bit.ly/1crVrCP","display_url":"bit.ly/1crVrCP"}],"annotations":{}},"referenced_tweets":{},"text":"One more week to comment on a draft public statement on #herbal medicines containing #pyrrolizidine #alkaloids: http://t.co/xUCYattFac","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"431728352202727424","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-07T09:57:14.000Z","id":"431728352202727424","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":13,"end":23,"username":"EAHPtweet","id":"203357203"},{"start":92,"end":101,"username":"ECDC_Flu","id":"1371668696"},{"start":102,"end":110,"username":"ECDC_TB","id":"1282878908"},{"start":115,"end":128,"username":"ECDC_HIVAIDS","id":"2182569746"}],"hashtags":[{"start":42,"end":45,"tag":"ff"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431722794041483264"}],"text":"RT @ECDC_EU: @EAHPtweet Thank you for the #ff! Check out our disease-specific accounts too: @ECDC_Flu @ECDC_TB and @ECDC_HIVAIDS","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431722897363980288","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T09:35:34.000Z","id":"431722897363980288","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"IDFEuropeBXL","id":"848831221"},{"start":129,"end":138,"username":"guardian","id":"87818409"}],"hashtags":[{"start":92,"end":101,"tag":"diabetes"}],"urls":[{"start":102,"end":124,"url":"http://t.co/BxhB76Y7ih","expanded_url":"http://gu.com/p/3mgne/tw","display_url":"gu.com/p/3mgne/tw"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431721945067827200"}],"text":"RT @IDFEuropeBxl: Exciting development: Scientists move closer to stem cell cure for type 1 #diabetes http://t.co/BxhB76Y7ih via @guardian","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431722146973630464","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T09:32:35.000Z","id":"431722146973630464","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":83,"end":98,"tag":"bioequivalence"}],"urls":[{"start":100,"end":122,"url":"http://t.co/BZ9TH8Tn8U","expanded_url":"http://bit.ly/1a63PMi","display_url":"bit.ly/1a63PMi"}],"annotations":{}},"referenced_tweets":{},"text":"One more week to comment on 16 product-specific guidelines on the demonstration of #bioequivalence: http://t.co/BZ9TH8Tn8U","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431720520183070720","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-07T09:26:07.000Z","id":"431720520183070720","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":4,"end":15,"tag":"veterinary"},{"start":27,"end":32,"tag":"CVMP"}],"urls":[{"start":97,"end":119,"url":"http://t.co/SXtzC4ObVa","expanded_url":"http://bit.ly/1fNbWNK","display_url":"bit.ly/1fNbWNK"}],"annotations":{}},"referenced_tweets":{},"text":"Our #veterinary committee, #CVMP, meets next week. We're publishing the main outcomes on Friday: http://t.co/SXtzC4ObVa","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"431720041953128448","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-07T09:24:13.000Z","id":"431720041953128448","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":112,"end":128,"username":"Eurosurveillanc","id":"455839750"}],"hashtags":[{"start":14,"end":18,"tag":"flu"},{"start":101,"end":106,"tag":"H1n1"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431709677852704768"}],"text":"RT @ECDC_Flu: #flu vaccine effectiveness estimates in Canada indicate substantial protection against #H1n1, via @Eurosurveillanc: http://t.…","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431718477179932672","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-07T09:18:00.000Z","id":"431718477179932672","possibly_sensitive":false,"lang":"ca","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/yWPVgXSpYM","expanded_url":"http://bit.ly/1fxRCOd","display_url":"bit.ly/1fxRCOd"}],"annotations":{}},"referenced_tweets":{},"text":"We've published the EPAR for Zoledronic Acid Accord, a medicine to prevent bone complications in cancer patients: http://t.co/yWPVgXSpYM","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431471490362388480","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-06T16:56:34.000Z","id":"431471490362388480","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":11,"end":24,"tag":"INFOGRAPHICS"}],"urls":[{"start":85,"end":107,"url":"http://t.co/tVNmurX83R","expanded_url":"https://twitter.com/EFPIA/status/431439763246039042/photo/1","display_url":"pic.twitter.com/tVNmurX83R"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431439763246039042"}],"text":"RT @EFPIA: #INFOGRAPHICS: Rare disease clinical trials: facts, figures and processes http://t.co/tVNmurX83R","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431471148648632320","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-06T16:55:12.000Z","id":"431471148648632320","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":["3_431439763254427648"]}},{"entities":{"mentions":{},"hashtags":[{"start":29,"end":37,"tag":"Sovaldi"},{"start":39,"end":50,"tag":"sofosbuvir"},{"start":77,"end":88,"tag":"hepatitisC"}],"urls":[{"start":100,"end":122,"url":"http://t.co/PRCemaYFgo","expanded_url":"http://bit.ly/1lAybf1","display_url":"bit.ly/1lAybf1"}],"annotations":{}},"referenced_tweets":{},"text":"We've published the EPAR for #Sovaldi (#sofosbuvir), a new medicine to treat #hepatitisC in adults: http://t.co/PRCemaYFgo","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"431376241577324544","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-06T10:38:05.000Z","id":"431376241577324544","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":29,"end":37,"tag":"Tivicay"},{"start":39,"end":52,"tag":"dolutegravir"},{"start":79,"end":83,"tag":"HIV"}],"urls":[{"start":85,"end":107,"url":"http://t.co/VSAm5Q2uk7","expanded_url":"http://bit.ly/1gMpEU1","display_url":"bit.ly/1gMpEU1"}],"annotations":{}},"referenced_tweets":{},"text":"We've published the EPAR for #Tivicay (#dolutegravir), a new medicine to treat #HIV: http://t.co/VSAm5Q2uk7","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431376115077115904","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-06T10:37:35.000Z","id":"431376115077115904","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"},{"start":14,"end":22,"username":"borgton","id":"1605512862"}],"hashtags":[{"start":81,"end":100,"tag":"PatientEmpowerment"},{"start":123,"end":138,"tag":"tacklingcancer"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431118585180614656"}],"text":"RT @cancereu: @borgton announced the Commission has begun a mapping  exercise on #PatientEmpowerment initiatives across EU #tacklingcancer …","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431119241975443457","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-05T17:36:51.000Z","id":"431119241975443457","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"hashtags":[{"start":21,"end":32,"tag":"Veterinary"},{"start":42,"end":50,"tag":"Student"},{"start":96,"end":107,"tag":"Internship"}],"urls":[{"start":116,"end":138,"url":"http://t.co/JK5IwRZYp8","expanded_url":"http://1.usa.gov/1dqhlpb","display_url":"1.usa.gov/1dqhlpb"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431112954893697024"}],"text":"RT @FDAanimalhealth: #Veterinary Medicine #Student Program -2014 Windows to Regulatory Research #Internship Program http://t.co/JK5IwRZYp8","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431115806421028864","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-05T17:23:12.000Z","id":"431115806421028864","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":45,"end":50,"tag":"H7N9"},{"start":54,"end":60,"tag":"China"}],"urls":[{"start":61,"end":83,"url":"http://t.co/BqiLbThSow","expanded_url":"http://goo.gl/1NbOhH","display_url":"goo.gl/1NbOhH"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431111545415032832"}],"text":"RT @WHO: Latest WHO Disease Outbreak News on #H7N9 in #China http://t.co/BqiLbThSow (4 February 2014)","public_metrics":{"retweet_count":49,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431115736007049216","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-05T17:22:55.000Z","id":"431115736007049216","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":41,"end":46,"tag":"H7N9"},{"start":56,"end":62,"tag":"China"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431108693292490753"}],"text":"RT @WHO: All of the latest lab-confirmed #H7N9 cases in #China (4 Feb 2014) are reported to have had exposure to poultry or a live poultry …","public_metrics":{"retweet_count":52,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431109509843804161","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-05T16:58:11.000Z","id":"431109509843804161","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":29,"end":35,"tag":"China"},{"start":86,"end":91,"tag":"H7N9"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431107119396687872"}],"text":"RT @WHO: On 4 February 2014, #China notified WHO of 8 additional laboratory-confirmed #H7N9 cases, incl. two deaths","public_metrics":{"retweet_count":39,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431107509093691393","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-05T16:50:14.000Z","id":"431107509093691393","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":{},"annotations":[{"start":41,"end":46,"probability":0.4584,"type":"Place","normalized_text":"Europe"}]},"referenced_tweets":[{"type":"replied_to","id":"431091742293884929"}],"text":"@VanessaVanHalen ...Lenalidomide Celgene Europe (976 days, negative opinion); Xagrid (832 days, positive opinion).","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430926683273986048","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-05T15:48:33.000Z","id":"431091988033982464","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":{},"annotations":[{"start":43,"end":65,"probability":0.2582,"type":"Organization","normalized_text":"Natalizumab Elan Pharma"}]},"referenced_tweets":[{"type":"replied_to","id":"430926683273986048"}],"text":"@VanessaVanHalen The longest CHMP reviews: Natalizumab Elan Pharma (1,123 days, negative opinion); Zeftera (1,073 days, negative opinion)...","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"430926683273986048","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-05T15:47:35.000Z","id":"431091742293884929","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"2305187534","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":47,"end":55,"tag":"Tivicay"},{"start":57,"end":70,"tag":"dolutegravir"},{"start":97,"end":101,"tag":"HIV"}],"urls":[{"start":103,"end":125,"url":"http://t.co/l4DvvNZs7t","expanded_url":"http://bit.ly/1gMpEU1","display_url":"bit.ly/1gMpEU1"}],"annotations":{}},"referenced_tweets":{},"text":"We've just published the assessment report for #Tivicay (#dolutegravir), a new medicine to treat #HIV: http://t.co/l4DvvNZs7t","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431085410908123136","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-05T15:22:25.000Z","id":"431085410908123136","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"hashtags":[{"start":21,"end":24,"tag":"EU"},{"start":115,"end":122,"tag":"cancer"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431079600761106433"}],"text":"RT @innovationunion: #EU project has examined the DNA of 250 000 individuals to identify genetic mutations causing #cancer http://t.co/Zfb9…","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431084009414983680","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-05T15:16:51.000Z","id":"431084009414983680","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"hashtags":[{"start":19,"end":27,"tag":"Podcast"},{"start":30,"end":34,"tag":"FDA"},{"start":103,"end":116,"tag":"testosterone"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431077209403817984"}],"text":"RT @FDA_Drug_Info: #Podcast:  #FDA evaluating risk of stroke, heart attack and death with FDA-approved #testosterone products. http://t.co/…","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431083940364169216","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-05T15:16:35.000Z","id":"431083940364169216","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":47,"end":55,"tag":"Sovaldi"},{"start":57,"end":68,"tag":"sofosbuvir"},{"start":95,"end":106,"tag":"hepatitisC"}],"urls":[{"start":118,"end":140,"url":"http://t.co/Cvah7NjOSn","expanded_url":"http://bit.ly/1lAybf1","display_url":"bit.ly/1lAybf1"}],"annotations":{}},"referenced_tweets":{},"text":"We've just published the assessment report for #Sovaldi (#sofosbuvir), a new medicine to treat #hepatitisC in adults: http://t.co/Cvah7NjOSn","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431079589688143872","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-05T14:59:17.000Z","id":"431079589688143872","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"hashtags":[{"start":20,"end":32,"tag":"Researchers"},{"start":69,"end":75,"tag":"liver"},{"start":99,"end":110,"tag":"painkiller"},{"start":111,"end":120,"tag":"overdose"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431075782534774785"}],"text":"RT @nakosbalamotis: #Researchers identify key step for prevention of #liver failure resulting from #painkiller #overdose http://t.co/aZvI54…","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431077512203218945","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-05T14:51:02.000Z","id":"431077512203218945","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"hashtags":[{"start":60,"end":68,"tag":"vaccine"}],"urls":{},"annotations":[{"start":103,"end":131,"probability":0.419,"type":"Organization","normalized_text":"University of Colorado Denver"}]},"referenced_tweets":[{"type":"retweeted","id":"431070455886139392"}],"text":"RT @nakosbalamotis: Thousands of unvaccinated adults die of #vaccine-preventable diseases | Newsroom | University of Colorado Denver http:/…","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431077164357005312","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-05T14:49:39.000Z","id":"431077164357005312","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":74,"end":81,"tag":"cancer"}],"urls":[{"start":82,"end":104,"url":"http://t.co/EPZSAyVjRD","expanded_url":"http://bit.ly/1fHhqcI","display_url":"bit.ly/1fHhqcI"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431066762767917056"}],"text":"RT @EFPIA: Existing medicines show promise for treating stomach and bowel #cancer http://t.co/EPZSAyVjRD","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431076923364876288","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-05T14:48:42.000Z","id":"431076923364876288","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":41,"end":46,"tag":"H7N9"},{"start":50,"end":56,"tag":"China"}],"urls":[{"start":57,"end":79,"url":"http://t.co/WfmMwe5Zsi","expanded_url":"http://goo.gl/f9mMe4","display_url":"goo.gl/f9mMe4"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431046321688944641"}],"text":"RT @WHO: Latest Disease Outbreak News on #H7N9 in #China http://t.co/WfmMwe5Zsi (3 February 2014)","public_metrics":{"retweet_count":50,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431075723575832577","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-05T14:43:56.000Z","id":"431075723575832577","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"hashtags":[{"start":92,"end":102,"tag":"hepatitis"},{"start":120,"end":124,"tag":"HIV"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"431027932984000512"}],"text":"RT @Hep_Alliance: We're working to ensure every government and every stakeholder know viral #hepatitis kills as many as #HIV/AIDS http://t.…","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431075030550990848","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-05T14:41:10.000Z","id":"431075030550990848","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"hashtags":{},"urls":[{"start":122,"end":144,"url":"http://t.co/I5Pq9O4vuy","expanded_url":"http://bit.ly/1n9GM3H","display_url":"bit.ly/1n9GM3H"}],"annotations":{}},"referenced_tweets":{},"text":"RT @agesnews: Jobs at the Austrian medicines agency: looking for medical doctor - training for hygiene &amp; microbiology http://t.co/I5Pq9O4vuy","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"431011721608966144","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-05T10:29:36.000Z","id":"431011721608966144","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"hashtags":[{"start":36,"end":50,"tag":"antimicrobial"},{"start":119,"end":124,"tag":"EAAD"}],"urls":[{"start":96,"end":118,"url":"http://t.co/PoyPMKELtO","expanded_url":"http://bit.ly/1lyFGTL","display_url":"bit.ly/1lyFGTL"}],"annotations":[{"start":66,"end":71,"probability":0.9968,"type":"Place","normalized_text":"Europe"}]},"referenced_tweets":[{"type":"retweeted","id":"430738572052676608"}],"text":"RT @EAAD_EU: What are the trends of #antimicrobial consumption in Europe? See new ECDC report:  http://t.co/PoyPMKELtO #EAAD http://t.co/zY…","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430739279447613440","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-04T16:27:01.000Z","id":"430739279447613440","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":61,"end":70,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":73,"end":84,"tag":"IFAHEurope"}],"urls":[{"start":110,"end":132,"url":"http://t.co/7emkqBvr3g","expanded_url":"http://bit.ly/1fr65LR","display_url":"bit.ly/1fr65LR"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"430691442269224961"}],"text":"RT @IFAHEurope: Registration forms and updated programme for @EMA_News / #IFAHEurope Info day available here: http://t.co/7emkqBvr3g","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430713911688839168","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-04T14:46:13.000Z","id":"430713911688839168","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":117,"end":124,"tag":"orphan"}],"urls":[{"start":93,"end":115,"url":"http://t.co/NlxscaNCnR","expanded_url":"http://bit.ly/1foANVR","display_url":"bit.ly/1foANVR"}],"annotations":{}},"referenced_tweets":{},"text":"We've published a roundup of the activities of our committee on medicines for rare diseases: http://t.co/NlxscaNCnR  #orphan","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":3,"quote_count":0},"conversation_id":"430666062338600960","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-04T11:36:05.000Z","id":"430666062338600960","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":71,"end":86,"tag":"clinicaltrials"}],"urls":[{"start":112,"end":134,"url":"http://t.co/MbKpXGcNXA","expanded_url":"http://bit.ly/1lwSNEU","display_url":"bit.ly/1lwSNEU"}],"annotations":{}},"referenced_tweets":{},"text":"We've issued a guideline on investigation of subgroups in confirmatory #clinicaltrials for public consultation: http://t.co/MbKpXGcNXA","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"430665365530501121","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-04T11:33:19.000Z","id":"430665365530501121","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":1,"end":13,"username":"INFARMED_IP","id":"1392501529"}],"hashtags":{},"urls":[{"start":84,"end":106,"url":"http://t.co/lazd4seh2M","expanded_url":"http://www.infarmed.pt/portal/page/portal/INFARMED/MAIS_ALERTAS/DETALHE_ALERTA?itemid=9661314","display_url":"infarmed.pt/portal/page/po…"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"430395236133511168"}],"text":"“@INFARMED_IP: Hydergine (dihydroergotoxin) - suspension of marketing authorisation http://t.co/lazd4seh2M”","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"430395236133511168","author_id":"116716199","source":"Twitter for iPhone","created_at":"2014-02-03T19:55:57.000Z","id":"430429471888658433","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"1392501529","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"hashtags":[{"start":20,"end":27,"tag":"Pharma"},{"start":83,"end":94,"tag":"Regulatory"}],"urls":[{"start":109,"end":131,"url":"http://t.co/jEpdC9pL8G","expanded_url":"http://www.cuttingedgeinfo.com/2014/improve-product-development-increase-communication-regulatory-affairs-cross-functional-teams/","display_url":"cuttingedgeinfo.com/2014/improve-p…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"430385770210144256"}],"text":"RT @nakosbalamotis: #Pharma Companies Increase Cross-Functional Communication with #Regulatory Affairs Teams http://t.co/jEpdC9pL8G","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430385922551865344","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T17:02:54.000Z","id":"430385922551865344","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"USPharmacopeia","id":"47953929"},{"start":33,"end":37,"username":"WHO","id":"14499829"}],"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/DAc5TbncSQ","expanded_url":"http://www.reuters.com/article/2014/02/03/us-cancer-idUSBREA120X920140203","display_url":"reuters.com/article/2014/0…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"430385186514419713"}],"text":"RT @USPharmacopeia: In the news: @WHO World Cancer Report 2014: Drugs alone can’t beat cancer; prevention crucial http://t.co/DAc5TbncSQ","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430385611481305088","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T17:01:40.000Z","id":"430385611481305088","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"hashtags":{},"urls":[{"start":109,"end":131,"url":"http://t.co/4xMll8wUTa","expanded_url":"http://bit.ly/1eNgvng","display_url":"bit.ly/1eNgvng"}],"annotations":{}},"referenced_tweets":{},"text":"RT @AEMPSGOB: Update: supply situation for medicines with adrenaline solution for injection in prefilled pen http://t.co/4xMll8wUTa","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430385471186038784","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T17:01:07.000Z","id":"430385471186038784","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"},{"start":97,"end":105,"username":"Reuters","id":"1652541"}],"hashtags":[{"start":28,"end":32,"tag":"HPV"},{"start":33,"end":41,"tag":"vaccine"},{"start":64,"end":68,"tag":"sex"}],"urls":[{"start":70,"end":92,"url":"http://t.co/v7ThNuP053","expanded_url":"http://reut.rs/1dm0BPU","display_url":"reut.rs/1dm0BPU"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"430383350432272384"}],"text":"RT @nakosbalamotis: Study: \"#HPV #vaccine doesn't promote risky #sex\" http://t.co/v7ThNuP053 via @reuters","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430383652347052033","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T16:53:53.000Z","id":"430383652347052033","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"hashtags":[{"start":30,"end":38,"tag":"measles"},{"start":43,"end":49,"tag":"mumps"},{"start":68,"end":71,"tag":"EU"},{"start":109,"end":118,"tag":"vaccines"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"430359366416736256"}],"text":"RT @innovationunion: Cases of #measles and #mumps increasing in the #EU due to unfounded scare stories about #vaccines: http://t.co/douQQRP…","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430359497081880577","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T15:17:54.000Z","id":"430359497081880577","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":77,"end":92,"tag":"clinicaltrials"}],"urls":[{"start":118,"end":140,"url":"http://t.co/Rpaw3vQ3Wr","expanded_url":"http://bit.ly/1lwSNEU","display_url":"bit.ly/1lwSNEU"}],"annotations":{}},"referenced_tweets":{},"text":"We've released a guideline on the investigation of subgroups in confirmatory #clinicaltrials for public consultation: http://t.co/Rpaw3vQ3Wr","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"430358756988563457","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-03T15:14:58.000Z","id":"430358756988563457","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":23,"end":33,"tag":"medicines"},{"start":94,"end":107,"tag":"rarediseases"},{"start":132,"end":139,"tag":"orphan"}],"urls":[{"start":109,"end":131,"url":"http://t.co/0dNkvkxcPc","expanded_url":"http://bit.ly/1foANVR","display_url":"bit.ly/1foANVR"}],"annotations":{}},"referenced_tweets":{},"text":"11 out of the 81 human #medicines we recommended for marketing authorisation in 2013 were for #rarediseases: http://t.co/0dNkvkxcPc #orphan","public_metrics":{"retweet_count":9,"reply_count":1,"like_count":5,"quote_count":0},"conversation_id":"430357244220567552","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-03T15:08:57.000Z","id":"430357244220567552","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"hashtags":[{"start":38,"end":50,"tag":"Animal_Drug"}],"urls":[{"start":60,"end":82,"url":"http://t.co/oYSfmzNRE2","expanded_url":"http://1.usa.gov/LHjRRG","display_url":"1.usa.gov/LHjRRG"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"430354975189778432"}],"text":"RT @FDAanimalhealth: Updated Approved #Animal_Drug Products http://t.co/oYSfmzNRE2","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430356499609968640","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T15:05:59.000Z","id":"430356499609968640","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":26,"end":35,"username":"ICH_news","id":"305434870"}],"hashtags":[{"start":53,"end":65,"tag":"photosafety"},{"start":80,"end":96,"tag":"pharmaceuticals"}],"urls":[{"start":98,"end":120,"url":"http://t.co/OhXdozgnwQ","expanded_url":"http://bit.ly/1bjkoQ5","display_url":"bit.ly/1bjkoQ5"}],"annotations":{}},"referenced_tweets":{},"text":"On Friday we published an @ICH_news guideline on the #photosafety evaluation of #pharmaceuticals: http://t.co/OhXdozgnwQ","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"430353702235303938","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-03T14:54:52.000Z","id":"430353702235303938","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":67,"end":77,"tag":"medicines"},{"start":115,"end":125,"tag":"Article57"}],"urls":[{"start":92,"end":114,"url":"http://t.co/dazirYIuU8","expanded_url":"http://bit.ly/1gFQu0b","display_url":"bit.ly/1gFQu0b"}],"annotations":{}},"referenced_tweets":{},"text":"On Friday we published plans for the maintenance of information on #medicines by companies: http://t.co/dazirYIuU8 #Article57","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430353624795844608","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-03T14:54:34.000Z","id":"430353624795844608","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":52,"end":67,"username":"VaccinesEurope","id":"1262320285"}],"hashtags":[{"start":11,"end":24,"tag":"INFOGRAPHICS"},{"start":68,"end":76,"tag":"vaccine"},{"start":77,"end":84,"tag":"health"},{"start":85,"end":92,"tag":"pharma"}],"urls":[{"start":93,"end":115,"url":"http://t.co/lxhP1bwwdo","expanded_url":"https://twitter.com/EFPIA/status/430337662344388608/photo/1","display_url":"pic.twitter.com/lxhP1bwwdo"}],"annotations":[{"start":27,"end":50,"probability":0.5688,"type":"Other","normalized_text":"The Journey of a Vaccine"}]},"referenced_tweets":[{"type":"retweeted","id":"430337662344388608"}],"text":"RT @EFPIA: #INFOGRAPHICS - The Journey of a Vaccine @VaccinesEurope #vaccine #health #pharma http://t.co/lxhP1bwwdo","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430352970321252352","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T14:51:58.000Z","id":"430352970321252352","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":["3_430337662352777216"]}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":35,"end":42,"tag":"cancer"},{"start":101,"end":116,"tag":"CancerReport14"}],"urls":[{"start":78,"end":100,"url":"http://t.co/aNZNQRRyvG","expanded_url":"http://goo.gl/zC4CUc","display_url":"goo.gl/zC4CUc"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"430335278599770112"}],"text":"RT @WHO: The most common causes of #cancer death were lung, liver and stomach http://t.co/aNZNQRRyvG #CancerReport14","public_metrics":{"retweet_count":104,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430352845175799808","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T14:51:28.000Z","id":"430352845175799808","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"}],"hashtags":[{"start":35,"end":45,"tag":"Alzheimer"}],"urls":[{"start":113,"end":135,"url":"http://t.co/y4O8KzRuny","expanded_url":"http://www.alz.co.uk/associations","display_url":"alz.co.uk/associations"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"430329636195532801"}],"text":"RT @AlzDisInt: What is the role of #Alzheimer associations? Support, inform, advocate, educate. Find yours here. http://t.co/y4O8KzRuny","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430352711734013952","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T14:50:56.000Z","id":"430352711734013952","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":115,"end":130,"tag":"CancerReport14"}],"urls":[{"start":92,"end":114,"url":"http://t.co/aNZNQRRyvG","expanded_url":"http://goo.gl/zC4CUc","display_url":"goo.gl/zC4CUc"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"430327720837267456"}],"text":"RT @WHO: Globally, in 2012 the most common cancers diagnosed were lung, breast, large bowel http://t.co/aNZNQRRyvG #CancerReport14","public_metrics":{"retweet_count":103,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430352621028016130","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T14:50:35.000Z","id":"430352621028016130","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":42,"end":49,"tag":"cancer"},{"start":124,"end":139,"tag":"CancerReport14"}],"urls":[{"start":101,"end":123,"url":"http://t.co/aNZNQRRyvG","expanded_url":"http://goo.gl/zC4CUc","display_url":"goo.gl/zC4CUc"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"430325935196237824"}],"text":"RT @WHO: In 2012, the worldwide burden of #cancer rose to an estimated 14 million new cases per year http://t.co/aNZNQRRyvG #CancerReport14","public_metrics":{"retweet_count":95,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430352311261855744","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T14:49:21.000Z","id":"430352311261855744","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":67,"end":74,"tag":"cancer"},{"start":98,"end":113,"tag":"CancerReport14"}],"urls":[{"start":114,"end":136,"url":"http://t.co/aNZNQRRyvG","expanded_url":"http://goo.gl/zC4CUc","display_url":"goo.gl/zC4CUc"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"430322941604024320"}],"text":"RT @WHO: The Intl Agency for Research on Cancer, WHO's specialized #cancer agency, launches World #CancerReport14 http://t.co/aNZNQRRyvG","public_metrics":{"retweet_count":74,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430352186103844864","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T14:48:51.000Z","id":"430352186103844864","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":87,"end":99,"tag":"chikungunya"}],"urls":[{"start":118,"end":140,"url":"http://t.co/t3bB2UIXOO","expanded_url":"http://bit.ly/1fAV8t8","display_url":"bit.ly/1fAV8t8"}],"annotations":[{"start":74,"end":79,"probability":0.994,"type":"Place","normalized_text":"Europe"},{"start":103,"end":111,"probability":0.5655,"type":"Place","normalized_text":"Caribbean"}]},"referenced_tweets":[{"type":"retweeted","id":"430322704898879488"}],"text":"RT @ECDC_EU: Week 5/2014 disease threat report incl seasonal influenza in Europe &amp; #chikungunya in the Caribbean: http://t.co/t3bB2UIXOO","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430349355665854464","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T14:37:36.000Z","id":"430349355665854464","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":90,"end":97,"tag":"health"},{"start":98,"end":105,"tag":"cancer"}],"urls":[{"start":67,"end":89,"url":"http://t.co/fUP5v65Cvu","expanded_url":"http://bit.ly/LqSbzL#pharma","display_url":"bit.ly/LqSbzL#pharma"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"430304866695512066"}],"text":"RT @EFPIA: Body kills 'spontaneous' blood cancers on a daily basis http://t.co/fUP5v65Cvu #health #cancer","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430305904702291968","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T11:44:57.000Z","id":"430305904702291968","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":8,"username":"Eu2P","id":"420241833"}],"hashtags":[{"start":59,"end":77,"tag":"Pharmacovigilance"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"430299766900023296"}],"text":"RT @Eu2P: 4 reasons you should go for our online Master in #Pharmacovigilance. Apply now for the next 2014-2015 intake. https://t.co/UsS4Du…","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430300236666634241","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T11:22:25.000Z","id":"430300236666634241","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"urls":{},"annotations":[{"start":13,"end":15,"probability":0.5754,"type":"Organization","normalized_text":"EMA"}]},"referenced_tweets":[{"type":"retweeted","id":"430278913831354368"}],"text":"RT @GCessak: EMA announces next steps for the maintenance of information on authorised medicines by MAH | Regulatory information: http://t.…","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430278982270222338","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T09:57:58.000Z","id":"430278982270222338","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":19,"end":28,"username":"ICH_news","id":"305434870"}],"hashtags":[{"start":46,"end":58,"tag":"photosafety"},{"start":73,"end":89,"tag":"pharmaceuticals"}],"urls":[{"start":91,"end":113,"url":"http://t.co/SyXNhxGyDF","expanded_url":"http://bit.ly/1bjkoQ5","display_url":"bit.ly/1bjkoQ5"}],"annotations":{}},"referenced_tweets":{},"text":"We've published an @ICH_news guideline on the #photosafety evaluation of #pharmaceuticals: http://t.co/SyXNhxGyDF","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430278237416325120","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-03T09:55:00.000Z","id":"430278237416325120","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":69,"end":79,"tag":"medicines"}],"urls":[{"start":116,"end":138,"url":"http://t.co/v0q4vM8u5k","expanded_url":"http://bit.ly/1gFQu0b","display_url":"bit.ly/1gFQu0b"}],"annotations":{}},"referenced_tweets":{},"text":"We've announced the next steps for the maintenance of information on #medicines by marketing-authorisation holders: http://t.co/v0q4vM8u5k","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430277519225683968","author_id":"116716199","source":"bitly bitlink","created_at":"2014-02-03T09:52:09.000Z","id":"430277519225683968","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"},{"start":13,"end":21,"username":"EU_ECHA","id":"331604970"}],"hashtags":[{"start":103,"end":108,"tag":"jobs"},{"start":109,"end":112,"tag":"EU"}],"urls":[{"start":80,"end":102,"url":"http://t.co/fZlbqZKiS0","expanded_url":"http://bit.ly/15xbvBD","display_url":"bit.ly/15xbvBD","status":200,"unwound_url":"https://echa.europa.eu/web/guest/about-us/jobs/open-positions"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"430276743094493184"}],"text":"RT @EU_ECHA: @EU_ECHA is recruiting Scientific Officers, apply by 3 March noon. http://t.co/fZlbqZKiS0 #jobs #EU","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430277145039224832","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T09:50:40.000Z","id":"430277145039224832","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":11,"end":24,"tag":"INFOGRAPHICS"}],"urls":[{"start":106,"end":128,"url":"http://t.co/yE4IXhuP4y","expanded_url":"http://bit.ly/1imh4sx","display_url":"bit.ly/1imh4sx"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"430274783662440448"}],"text":"RT @EFPIA: #INFOGRAPHICS Pharma industry’s 360-degree efforts to fight Neglected Tropical Diseases (NTDs) http://t.co/yE4IXhuP4y http://t.c…","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430277024922763264","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T09:50:11.000Z","id":"430277024922763264","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":117,"end":123,"username":"IFPMA","id":"949399644"}],"hashtags":[{"start":26,"end":33,"tag":"Pharma"},{"start":111,"end":116,"tag":"NCDs"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"430273794578464768"}],"text":"RT @EFPIA: 2013 report on #Pharma R&amp;D Projects to Develop New Cures for Patients with Neglected Conditions #NCDs @IFPMA http://t.co/ERpS3uH…","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430276941909098496","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T09:49:51.000Z","id":"430276941909098496","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":92,"end":114,"url":"http://t.co/81mvfkEvbJ","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"430273350838263808"}],"text":"@VanessaVanHalen If you'd like a more detailed response, please send your question to us at http://t.co/81mvfkEvbJ.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"429388398470889472","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T09:36:45.000Z","id":"430273642631802880","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":{},"annotations":[{"start":72,"end":79,"probability":0.5067,"type":"Organization","normalized_text":"Scenesse"}]},"referenced_tweets":[{"type":"replied_to","id":"429388398470889472"}],"text":"@VanessaVanHalen Our committee, CHMP, is evaluating the application for Scenesse. We will release full details at the end of the evaluation.","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"429388398470889472","author_id":"116716199","source":"TweetDeck","created_at":"2014-02-03T09:35:35.000Z","id":"430273350838263808","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"2305187534","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":110,"end":132,"url":"http://t.co/xUCYattFac","expanded_url":"http://bit.ly/1crVrCP","display_url":"bit.ly/1crVrCP"}],"annotations":{}},"referenced_tweets":{},"text":"Two weeks left to comment on a draft public statement on herbal medicines containing pyrrolizidine alkaloids: http://t.co/xUCYattFac","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"430268063972212736","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-03T09:14:35.000Z","id":"430268063972212736","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":77,"end":92,"tag":"bioequivalence"}],"urls":[{"start":94,"end":116,"url":"http://t.co/BZ9TH8Tn8U","expanded_url":"http://bit.ly/1a63PMi","display_url":"bit.ly/1a63PMi"}],"annotations":{}},"referenced_tweets":{},"text":"Two weeks left to comment on 16 product-specific guidelines on demonstrating #bioequivalence: http://t.co/BZ9TH8Tn8U","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430267867716517888","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-03T09:13:48.000Z","id":"430267867716517888","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":116,"end":127,"tag":"innovation"}],"urls":[{"start":92,"end":114,"url":"http://t.co/7jSb2sfTWY","expanded_url":"http://bit.ly/1gwFKBf","display_url":"bit.ly/1gwFKBf"}],"annotations":[{"start":81,"end":89,"probability":0.3522,"type":"Organization","normalized_text":"EMA staff"}]},"referenced_tweets":{},"text":"Read about the originators of innovative medicines in the EU in a new article by EMA staff: http://t.co/7jSb2sfTWY  #innovation","public_metrics":{"retweet_count":12,"reply_count":1,"like_count":3,"quote_count":0},"conversation_id":"430267392581570560","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-03T09:11:55.000Z","id":"430267392581570560","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"}],"urls":[{"start":90,"end":112,"url":"http://t.co/AextTqw2IZ","expanded_url":"http://bit.ly/1n2pe9C","display_url":"bit.ly/1n2pe9C"}],"annotations":{}},"referenced_tweets":{},"text":"Our #pharmacovigilance committee (PRAC) is meeting this week. Highlights out this Friday: http://t.co/AextTqw2IZ","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"430266870961164288","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-02-03T09:09:50.000Z","id":"430266870961164288","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"}],"hashtags":[{"start":12,"end":17,"tag":"List"},{"start":88,"end":98,"tag":"medicinal"}],"urls":[{"start":109,"end":131,"url":"http://t.co/iuhZBGKwvy","expanded_url":"http://eur-lex.europa.eu/JOHtml.do?uri=OJ:C:2014:029:SOM:EN:HTML","display_url":"eur-lex.europa.eu/JOHtml.do?uri=…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"429180230004011008"}],"text":"RT @EURLex: #List of European Union decisions on marketing authorisations in respect of #medicinal  products http://t.co/iuhZBGKwvy","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"429213083752759296","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-31T11:22:28.000Z","id":"429213083752759296","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":11,"end":24,"tag":"INFOGRAPHICS"},{"start":82,"end":88,"tag":"efpia"},{"start":89,"end":96,"tag":"pharma"},{"start":97,"end":106,"tag":"research"},{"start":107,"end":118,"tag":"innovation"}],"urls":[{"start":59,"end":81,"url":"http://t.co/NaQN7ZQYL6","expanded_url":"http://bit.ly/1a5Sw6C","display_url":"bit.ly/1a5Sw6C"},{"start":119,"end":141,"url":"http://t.co/9O4kS1sEcz","expanded_url":"https://twitter.com/EFPIA/status/429188513699885056/photo/1","display_url":"pic.twitter.com/9O4kS1sEcz"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"429188513699885056"}],"text":"RT @EFPIA: #INFOGRAPHICS Research &amp; Development - 2012 http://t.co/NaQN7ZQYL6 #efpia #pharma #research #innovation http://t.co/9O4kS1sEcz","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"429212792839995392","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-31T11:21:18.000Z","id":"429212792839995392","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":["3_429188513708273664"]}},{"entities":{"mentions":{},"hashtags":[{"start":84,"end":99,"tag":"bioequivalence"}],"urls":[{"start":101,"end":123,"url":"http://t.co/nxrfcZvAxm","expanded_url":"http://bit.ly/1a63PMi","display_url":"bit.ly/1a63PMi"}],"annotations":{}},"referenced_tweets":{},"text":"Two more weeks to comment on 16 product-specific guidelines on the demonstration of #bioequivalence: http://t.co/nxrfcZvAxm","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"429211051973177344","author_id":"116716199","source":"bitly bitlink","created_at":"2014-01-31T11:14:23.000Z","id":"429211051973177344","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":110,"end":132,"url":"http://t.co/vlikiAtv9y","expanded_url":"http://bit.ly/1crVrCP","display_url":"bit.ly/1crVrCP"}],"annotations":{}},"referenced_tweets":{},"text":"Two more weeks to comment on a draft public statement on herbal medicines containing pyrrolizidine alkaloids: http://t.co/vlikiAtv9y","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"429209559367159808","author_id":"116716199","source":"bitly bitlink","created_at":"2014-01-31T11:08:27.000Z","id":"429209559367159808","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":117,"end":128,"tag":"innovation"}],"urls":[{"start":94,"end":116,"url":"http://t.co/UDc3dBtciq","expanded_url":"http://bit.ly/1gwFKBf","display_url":"bit.ly/1gwFKBf"}],"annotations":[{"start":83,"end":91,"probability":0.3496,"type":"Organization","normalized_text":"EMA staff"}]},"referenced_tweets":{},"text":"Who are the originators of innovative medicines in the EU? Read the new article by EMA staff: http://t.co/UDc3dBtciq #innovation","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"429208542730792960","author_id":"116716199","source":"bitly bitlink","created_at":"2014-01-31T11:04:25.000Z","id":"429208542730792960","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":10,"username":"sTuDiO54x","id":"22255878"}],"hashtags":{},"urls":[{"start":117,"end":139,"url":"http://t.co/OHmO1q7yPu","expanded_url":"http://bit.ly/ZoTtg0","display_url":"bit.ly/ZoTtg0"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"429190564509388800"}],"text":"@sTuDiO54x For more information in your country please contact the national authority - contact details on our site: http://t.co/OHmO1q7yPu","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428925100986212354","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-31T09:56:18.000Z","id":"429191400694222848","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":10,"username":"sTuDiO54x","id":"22255878"}],"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/3tn1iLL9sg","expanded_url":"http://bit.ly/17yT6q0","display_url":"bit.ly/17yT6q0"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"429022076343554048"}],"text":"@sTuDiO54x We're assessing a marketing-authorisation application and have issued an opinion on compassionate use: http://t.co/3tn1iLL9sg","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"428925100986212354","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-31T09:52:59.000Z","id":"429190564509388800","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"22255878","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"}],"urls":[{"start":90,"end":112,"url":"http://t.co/XLLWuVhZnY","expanded_url":"http://bit.ly/1n2pe9C","display_url":"bit.ly/1n2pe9C"}],"annotations":{}},"referenced_tweets":{},"text":"Our #pharmacovigilance committee (PRAC) is meeting next week. Highlights out next Friday: http://t.co/XLLWuVhZnY","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"429182546161967104","author_id":"116716199","source":"bitly bitlink","created_at":"2014-01-31T09:21:07.000Z","id":"429182546161967104","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":40,"end":57,"tag":"pharmacogenomics"}],"urls":[{"start":105,"end":127,"url":"http://t.co/X9qWUgM346","expanded_url":"http://bit.ly/1gtHM59","display_url":"bit.ly/1gtHM59"}],"annotations":{}},"referenced_tweets":{},"text":"We've published draft guidance on using #pharmacogenomics to improve the safety monitoring of medicines: http://t.co/X9qWUgM346","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"429181585645006849","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-31T09:17:18.000Z","id":"429181585645006849","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":35,"end":40,"tag":"H7N9"},{"start":126,"end":139,"tag":"LunarNewYear"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428949401542086657"}],"text":"RT @WHO: Further sporadic cases of #H7N9 are expected, especially w/ increases in poultry trade, transport assoc. w/ upcoming #LunarNewYear","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428949587970523136","author_id":"116716199","source":"Twitter for iPhone","created_at":"2014-01-30T17:55:25.000Z","id":"428949587970523136","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"hashtags":[{"start":126,"end":137,"tag":"H2020Views"},{"start":138,"end":144,"tag":"h2020"}],"urls":[{"start":103,"end":125,"url":"http://t.co/guCuxRpLfY","expanded_url":"http://bit.ly/H2020Views","display_url":"bit.ly/H2020Views"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428945752388550656"}],"text":"RT @EU_H2020: Watch (up to!) 769 very short video opinions on Research &amp; Innovation and our future http://t.co/guCuxRpLfY #H2020Views #h2020","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428947572930379776","author_id":"116716199","source":"Twitter for iPhone","created_at":"2014-01-30T17:47:25.000Z","id":"428947572930379776","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":74,"end":79,"tag":"H7N9"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428942246445322240"}],"text":"RT @WHO: At this time there is no indication that international spread of #H7N9 has occurred through humans or animals","public_metrics":{"retweet_count":44,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428947341773914112","author_id":"116716199","source":"Twitter for iPhone","created_at":"2014-01-30T17:46:30.000Z","id":"428947341773914112","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"CDCgov","id":"146569971"}],"hashtags":[{"start":17,"end":32,"tag":"drugresistance"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428941073709137920"}],"text":"RT @CDCgov: Stop #drugresistance: prevent infections, use abx responsibly, track resistance patterns, develop new drugs &amp; tests http://t.co…","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428947322815660032","author_id":"116716199","source":"Twitter for iPhone","created_at":"2014-01-30T17:46:25.000Z","id":"428947322815660032","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":23,"end":28,"tag":"H7N9"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428938030175764480"}],"text":"RT @WHO: The source of #H7N9 infection is still under investigation. So far, there is no evidence of sustained human-to-human transmission","public_metrics":{"retweet_count":56,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428940270508711936","author_id":"116716199","source":"Twitter for iPhone","created_at":"2014-01-30T17:18:24.000Z","id":"428940270508711936","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":25,"end":30,"tag":"H7N9"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428932713865678848"}],"text":"RT @WHO: Eighteen of the #H7N9 cases are reported to have had exposure to poultry or a live poultry market/environment","public_metrics":{"retweet_count":48,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428940244504047616","author_id":"116716199","source":"Twitter for iPhone","created_at":"2014-01-30T17:18:18.000Z","id":"428940244504047616","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"hashtags":[{"start":20,"end":28,"tag":"Generic"},{"start":44,"end":48,"tag":"FDA"},{"start":73,"end":82,"tag":"Labeling"}],"urls":[{"start":88,"end":110,"url":"http://t.co/FLpzW74cym","expanded_url":"http://www.raps.org/focus-online/news/news-article-view/article/4560/generic-industry-slams-fdas-proposed-generic-drug-labeling-rule.aspx#.Uup_7b0Vz4U.twitter","display_url":"raps.org/focus-online/n…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428930184813621248"}],"text":"RT @nakosbalamotis: #Generic Industry Slams #FDA's Proposed Generic Drug #Labeling Rule http://t.co/FLpzW74cym","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428940095308460032","author_id":"116716199","source":"Twitter for iPhone","created_at":"2014-01-30T17:17:42.000Z","id":"428940095308460032","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":105,"end":121,"username":"Eurosurveillanc","id":"455839750"}],"hashtags":[{"start":14,"end":18,"tag":"flu"}],"urls":{},"annotations":[{"start":29,"end":34,"probability":0.9978,"type":"Place","normalized_text":"Europe"}]},"referenced_tweets":[{"type":"retweeted","id":"428929140994375680"}],"text":"RT @ECDC_Flu: #flu season in Europe has started with A(H1)pdm09 virus as the most prevalent subtype, via @Eurosurveillanc: http://t.co/aogY…","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428939848263950336","author_id":"116716199","source":"Twitter for iPhone","created_at":"2014-01-30T17:16:43.000Z","id":"428939848263950336","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"hashtags":{},"urls":[{"start":85,"end":107,"url":"http://t.co/lw98tM2oyf","expanded_url":"http://bit.ly/LsNWV2","display_url":"bit.ly/LsNWV2"}],"annotations":{}},"referenced_tweets":{},"text":"RT @INFARMED_IP: Notification and validation of the treatment of chronic hepatitis C http://t.co/lw98tM2oyf","public_metrics":{"retweet_count":2,"reply_count":2,"like_count":0,"quote_count":0},"conversation_id":"428925100986212354","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-30T16:18:07.000Z","id":"428925100986212354","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":{},"urls":[{"start":52,"end":74,"url":"http://t.co/93suyHC9NR","expanded_url":"http://bit.ly/1jNOBi5","display_url":"bit.ly/1jNOBi5"}],"annotations":{}},"referenced_tweets":{},"text":"RT @LV_MPA: Monthly report from CHMP (January 2014) http://t.co/93suyHC9NR","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"428912428668436480","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-30T15:27:46.000Z","id":"428912428668436480","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":38,"end":55,"tag":"pharmacogenomics"}],"urls":[{"start":103,"end":125,"url":"http://t.co/kCeMEramUW","expanded_url":"http://bit.ly/1gtHM59","display_url":"bit.ly/1gtHM59"}],"annotations":{}},"referenced_tweets":{},"text":"We've released guidance on the use of #pharmacogenomics to improve the safety monitoring of medicines: http://t.co/kCeMEramUW","public_metrics":{"retweet_count":23,"reply_count":1,"like_count":7,"quote_count":0},"conversation_id":"428900615251845120","author_id":"116716199","source":"bitly bitlink","created_at":"2014-01-30T14:40:49.000Z","id":"428900615251845120","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":8,"username":"uicc","id":"53023973"}],"hashtags":[{"start":18,"end":33,"tag":"WorldCancerDay"}],"urls":[{"start":90,"end":112,"url":"http://t.co/HIntOWZrci","expanded_url":"http://ow.ly/spBdT","display_url":"ow.ly/spBdT"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428875842643841024"}],"text":"RT @uicc: Use the #WorldCancerDay Poster &amp; Postcards to mark the Day! Available here: http://t.co/HIntOWZrci","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428878851578793984","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-30T13:14:21.000Z","id":"428878851578793984","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":41,"end":51,"username":"EAHPtweet","id":"203357203"},{"start":72,"end":86,"username":"EU_Commission","id":"157981564"},{"start":123,"end":127,"username":"WHO","id":"14499829"}],"hashtags":[{"start":103,"end":111,"tag":"patient"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428868246637277184"}],"text":"RT @EAHPtweet: Hot off the press! Latest @EAHPtweet EU Monitor includes @EU_Commission consultation on #patient safety and @WHO news http:/…","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428873374040096768","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-30T12:52:35.000Z","id":"428873374040096768","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"eumsplatform","id":"600110872"}],"hashtags":[{"start":48,"end":66,"tag":"MultipleSclerosis"}],"urls":[{"start":67,"end":89,"url":"http://t.co/PIcUjokcJP","expanded_url":"http://www.emsp.org/news/web-alert/232-emsp-web-alert-january-2014","display_url":"emsp.org/news/web-alert…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428864965043179521"}],"text":"RT @eumsplatform: Our January Web Alert is out! #MultipleSclerosis http://t.co/PIcUjokcJP","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428865235148374016","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-30T12:20:14.000Z","id":"428865235148374016","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":93,"end":102,"username":"EUnetHTA","id":"56493220"}],"hashtags":[{"start":103,"end":107,"tag":"HTA"},{"start":108,"end":119,"tag":"healthcare"},{"start":120,"end":127,"tag":"pharma"},{"start":128,"end":140,"tag":"assessments"}],"urls":[{"start":70,"end":92,"url":"http://t.co/JcAFGBsMws","expanded_url":"http://bit.ly/1d5P1YN","display_url":"bit.ly/1d5P1YN"}],"annotations":[{"start":21,"end":40,"probability":0.403,"type":"Person","normalized_text":"EUnetHTA Exploratory"}]},"referenced_tweets":[{"type":"retweeted","id":"428863689957986304"}],"text":"RT @EFPIA: EFPIA and EUnetHTA Exploratory Meeting : Minutes published http://t.co/JcAFGBsMws @EUnetHTA #HTA #healthcare #pharma #assessments","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428863846582063104","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-30T12:14:43.000Z","id":"428863846582063104","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":88,"end":99,"tag":"withdrawal"}],"urls":[{"start":109,"end":131,"url":"http://t.co/ee3XNmieSU","expanded_url":"http://bit.ly/1dANpe9","display_url":"bit.ly/1dANpe9"}],"annotations":{}},"referenced_tweets":{},"text":"Last chance to comment on revision of guidance on the approach towards harmonisation of #withdrawal periods: http://t.co/ee3XNmieSU","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428860477330845696","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-30T12:01:20.000Z","id":"428860477330845696","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":104,"end":108,"tag":"ALS"}],"urls":[{"start":110,"end":132,"url":"http://t.co/l1OLxmq096","expanded_url":"http://bit.ly/Lo9Xoe","display_url":"bit.ly/Lo9Xoe"}],"annotations":{}},"referenced_tweets":{},"text":"Last chance to comment on our guideline on medicines for the treatment of amyotrophic lateral sclerosis #ALS: http://t.co/l1OLxmq096","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428860410712694784","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-30T12:01:04.000Z","id":"428860410712694784","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":99,"end":112,"tag":"hypertension"}],"urls":[{"start":114,"end":136,"url":"http://t.co/v5dygHNGA4","expanded_url":"http://bit.ly/KmWGe9","display_url":"bit.ly/KmWGe9"}],"annotations":{}},"referenced_tweets":{},"text":"Last chance to comment on our guideline on clinical investigation of medicines in the treatment of #hypertension: http://t.co/v5dygHNGA4","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"428860299412664321","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-30T12:00:37.000Z","id":"428860299412664321","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":8,"username":"uicc","id":"53023973"}],"hashtags":[{"start":45,"end":60,"tag":"WorldCancerDay"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428845556329615360"}],"text":"RT @uicc: You have something planned to mark #WorldCancerDay 2014? No matter how big or small, share it on our Map of Events: http://t.co/D…","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428859550478106624","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-30T11:57:39.000Z","id":"428859550478106624","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":89,"end":100,"tag":"withdrawal"}],"urls":[{"start":110,"end":132,"url":"http://t.co/ee3XNmieSU","expanded_url":"http://bit.ly/1dANpe9","display_url":"bit.ly/1dANpe9"}],"annotations":{}},"referenced_tweets":{},"text":"One day left to comment on revision of guidance on the approach towards harmonisation of #withdrawal periods: http://t.co/ee3XNmieSU","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428816569292963841","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-30T09:06:51.000Z","id":"428816569292963841","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":105,"end":109,"tag":"ALS"}],"urls":[{"start":111,"end":133,"url":"http://t.co/l1OLxmq096","expanded_url":"http://bit.ly/Lo9Xoe","display_url":"bit.ly/Lo9Xoe"}],"annotations":{}},"referenced_tweets":{},"text":"One day left to comment on our guideline on medicines for the treatment of amyotrophic lateral sclerosis #ALS: http://t.co/l1OLxmq096","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428816432495734785","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-30T09:06:19.000Z","id":"428816432495734785","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":100,"end":113,"tag":"hypertension"}],"urls":[{"start":115,"end":137,"url":"http://t.co/v5dygHNGA4","expanded_url":"http://bit.ly/KmWGe9","display_url":"bit.ly/KmWGe9"}],"annotations":{}},"referenced_tweets":{},"text":"One day left to comment on our guideline on clinical investigation of medicines in the treatment of #hypertension: http://t.co/v5dygHNGA4","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428816291902668800","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-30T09:05:45.000Z","id":"428816291902668800","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":81,"end":88,"username":"Forbes","id":"91478624"}],"hashtags":{},"urls":[{"start":54,"end":76,"url":"http://t.co/nI52f0WBhz","expanded_url":"http://onforb.es/1esBw6J","display_url":"onforb.es/1esBw6J"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428813671251189760"}],"text":"RT @EAHPtweet: How To Avert An Antibiotic Apocalypse  http://t.co/nI52f0WBhz via @forbes","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428814602395471872","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-30T08:59:02.000Z","id":"428814602395471872","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":12,"username":"HJF29088181","id":"1007144522"}],"hashtags":{},"urls":[{"start":115,"end":137,"url":"http://t.co/ao1GRhKAKe","expanded_url":"http://bit.ly/1iOfemS","display_url":"bit.ly/1iOfemS"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"428762748860628992"}],"text":"@HJF29088181 The link goes to a news item announcing the publication of the minutes. The minutes themselves are at http://t.co/ao1GRhKAKe.","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"428762335767826432","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-30T08:52:14.000Z","id":"428812889336848384","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"1007144522","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":68,"end":88,"tag":"radiopharmaceutical"}],"urls":[{"start":113,"end":135,"url":"http://t.co/jBIHx4V6jR","expanded_url":"http://bit.ly/1mWtOpR","display_url":"bit.ly/1mWtOpR"}],"annotations":{}},"referenced_tweets":{},"text":"We've published draft guidance on preparing product information for #radiopharmaceutical (99Mo/99mTc) generator: http://t.co/jBIHx4V6jR","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428560510796042241","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-29T16:09:22.000Z","id":"428560510796042241","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"AGE_PlatformEU","id":"537373439"}],"hashtags":[{"start":118,"end":130,"tag":"brainhealth"}],"urls":[{"start":95,"end":117,"url":"http://t.co/o1HlSJbSjH","expanded_url":"http://www.age-platform.eu","display_url":"age-platform.eu"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428539370640248832"}],"text":"RT @AGE_PlatformEU: Read on AGE website focus: HELLO BRAIN campaign is looking for volunteers! http://t.co/o1HlSJbSjH #brainhealth","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428556128348565504","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-29T15:51:57.000Z","id":"428556128348565504","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"hashtags":[{"start":48,"end":60,"tag":"RareDisease"}],"urls":[{"start":79,"end":101,"url":"http://t.co/C5bEUY2ohl","expanded_url":"http://ow.ly/t42rG","display_url":"ow.ly/t42rG"}],"annotations":[{"start":72,"end":77,"probability":0.962,"type":"Place","normalized_text":"Europe"}]},"referenced_tweets":[{"type":"retweeted","id":"428540699316080642"}],"text":"RT @eurordis: Information on National Plans for #RareDisease throughout Europe http://t.co/C5bEUY2ohl Is your country on there?","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428556059285155840","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-29T15:51:41.000Z","id":"428556059285155840","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"hashtags":[{"start":32,"end":39,"tag":"Cancer"}],"urls":{},"annotations":[{"start":123,"end":128,"probability":0.3434,"type":"Place","normalized_text":"Dublin"}]},"referenced_tweets":[{"type":"retweeted","id":"428548800169275392"}],"text":"RT @innovationunion: Nano World #Cancer Day - Shedding Light on Nanomedicine and Cancer - 31 January 2014, Trinity College Dublin: In... ht…","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428555810441297921","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-29T15:50:42.000Z","id":"428555810441297921","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"hashtags":[{"start":18,"end":23,"tag":"h7n9"}],"urls":[{"start":109,"end":131,"url":"http://t.co/KbeQ94unv6","expanded_url":"http://bit.ly/1fvDLbm","display_url":"bit.ly/1fvDLbm"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428461940134776833"}],"text":"RT @ECDC_Flu: See #h7n9 cases by age &amp; gender. No sustained H2H transmission, a few mild cases detected: http://t.co/KbeQ94unv6 http://t.co…","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428482092134322176","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-29T10:57:46.000Z","id":"428482092134322176","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":82,"end":87,"tag":"CHMP"}],"urls":[{"start":109,"end":131,"url":"http://t.co/2Dsjgi2xhH","expanded_url":"http://bit.ly/L5U0SH","display_url":"bit.ly/L5U0SH"}],"annotations":{}},"referenced_tweets":{},"text":"We've published the meeting minutes from all our scientific committees, including #CHMP, for the first time: http://t.co/2Dsjgi2xhH","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"428481304682700800","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-29T10:54:38.000Z","id":"428481304682700800","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"hashtags":[{"start":40,"end":52,"tag":"RareDisease"}],"urls":[{"start":63,"end":85,"url":"http://t.co/YYUkasuZ8W","expanded_url":"http://ow.ly/t3LgT","display_url":"ow.ly/t3LgT"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428468824560926720"}],"text":"RT @eurordis: Registration open for our #RareDisease Day event http://t.co/YYUkasuZ8W Improving Access to Rare Disease Care: the Vision of …","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428480305562144768","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-29T10:50:40.000Z","id":"428480305562144768","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"hashtags":{},"urls":[{"start":75,"end":97,"url":"http://t.co/shwHqejshL","expanded_url":"http://www.pharmafile.com/news/182010/world-s-first-alzheimer-s-vaccine-trial-begins#.Uuja1kS1my0.twitter","display_url":"pharmafile.com/news/182010/wo…"}],"annotations":[{"start":29,"end":37,"probability":0.5723,"type":"Other","normalized_text":"Alzheimer"}]},"referenced_tweets":[{"type":"retweeted","id":"428477997369143296"}],"text":"RT @EAHPtweet: World’s first Alzheimer’s vaccine trial begins | Pharmafile http://t.co/shwHqejshL","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428480043455901696","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-29T10:49:37.000Z","id":"428480043455901696","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"hashtags":{},"urls":[{"start":101,"end":123,"url":"http://t.co/uXIByTHQRf","expanded_url":"http://bit.ly/1iKrrsK","display_url":"bit.ly/1iKrrsK"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428478231893659648"}],"text":"RT @ESEndocrinology: In the news: Radiotherapy plus hormone therapy halved prostate cancer mortality http://t.co/uXIByTHQRf","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428480024178860032","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-29T10:49:33.000Z","id":"428480024178860032","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":116,"end":136,"tag":"radiopharmaceutical"}],"urls":[{"start":93,"end":115,"url":"http://t.co/dLQhVYccjm","expanded_url":"http://bit.ly/1mWtOpR","display_url":"bit.ly/1mWtOpR"}],"annotations":{}},"referenced_tweets":{},"text":"We've released draft guidance on preparing product information for a (99Mo/99mTc) generator: http://t.co/dLQhVYccjm #radiopharmaceutical","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428474698293600256","author_id":"116716199","source":"bitly bitlink","created_at":"2014-01-29T10:28:23.000Z","id":"428474698293600256","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":33,"end":39,"username":"EFPIA","id":"52084584"}],"hashtags":{},"urls":{},"annotations":[{"start":15,"end":31,"probability":0.9894,"type":"Person","normalized_text":"Richard Bergstrom"},{"start":125,"end":130,"probability":0.9392,"type":"Place","normalized_text":"Europe"}]},"referenced_tweets":[{"type":"retweeted","id":"428225966322614272"}],"text":"RT @EAHPtweet: Richard Bergstrom @EFPIA believes there needs to be less fragmentation of Health Technology Assessment within Europe #EFPIAL…","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428228230374768640","author_id":"116716199","source":"Twitter for iPhone","created_at":"2014-01-28T18:09:00.000Z","id":"428228230374768640","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"CDCgov","id":"146569971"}],"hashtags":[{"start":89,"end":104,"tag":"drugresistance"}],"urls":[{"start":114,"end":136,"url":"http://t.co/oSMeK0Qj1i","expanded_url":"http://bit.ly/19XKl88","display_url":"bit.ly/19XKl88"}],"annotations":[{"start":12,"end":14,"probability":0.7017,"type":"Organization","normalized_text":"CDC"}]},"referenced_tweets":[{"type":"retweeted","id":"428206945787342848"}],"text":"RT @CDCgov: CDC’s Pinterest board highlights antibiotic resistance and 18 of the biggest #drugresistance threats. http://t.co/oSMeK0Qj1i #C…","public_metrics":{"retweet_count":33,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428211125839495168","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-28T17:01:02.000Z","id":"428211125839495168","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"USPharmacopeia","id":"47953929"},{"start":125,"end":133,"username":"Reuters","id":"1652541"}],"hashtags":{},"urls":[{"start":98,"end":120,"url":"http://t.co/Ool6rsb0ho","expanded_url":"http://reut.rs/Mp3Osm","display_url":"reut.rs/Mp3Osm"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428203402237976576"}],"text":"RT @USPharmacopeia: In the news: Production snag forces worldwide hold on GSK chickenpox vaccines http://t.co/Ool6rsb0ho via @reuters","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428204411270471680","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-28T16:34:21.000Z","id":"428204411270471680","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"},{"start":111,"end":115,"username":"ABC","id":"28785486"}],"hashtags":[{"start":36,"end":40,"tag":"Flu"}],"urls":[{"start":83,"end":105,"url":"http://t.co/AK4m7KgMNF","expanded_url":"http://abcn.ws/1f7LkGr","display_url":"abcn.ws/1f7LkGr"}],"annotations":[{"start":74,"end":81,"probability":0.6963,"type":"Organization","normalized_text":"ABC News"}]},"referenced_tweets":[{"type":"retweeted","id":"428197840309846018"}],"text":"RT @nakosbalamotis: Want to Get the #Flu? Volunteers Sneeze for Science - ABC News http://t.co/AK4m7KgMNF (via @ABC)","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428197992253116416","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-28T16:08:51.000Z","id":"428197992253116416","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"},{"start":114,"end":127,"username":"phillydotcom","id":"1265336858193641474"}],"hashtags":[{"start":72,"end":77,"tag":"Drug"}],"urls":[{"start":87,"end":109,"url":"http://t.co/n9lIZq81EH","expanded_url":"http://po.st/rd7S6N","display_url":"po.st/rd7S6N"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428196261385093122"}],"text":"RT @nakosbalamotis: Researchers: \"Design Flaws Plague Many Animal-Based #Drug Studies\" http://t.co/n9lIZq81EH via @phillydotcom","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428197779769663488","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-28T16:08:00.000Z","id":"428197779769663488","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"},{"start":87,"end":94,"username":"Forbes","id":"91478624"}],"hashtags":[{"start":36,"end":47,"tag":"Antibiotic"}],"urls":[{"start":60,"end":82,"url":"http://t.co/iQgQ3aN9EO","expanded_url":"http://onforb.es/1esBw6J","display_url":"onforb.es/1esBw6J"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428184437755359233"}],"text":"RT @nakosbalamotis: How To Avert An #Antibiotic Apocalypse  http://t.co/iQgQ3aN9EO via @forbes","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428190525926440960","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-28T15:39:11.000Z","id":"428190525926440960","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":93,"end":106,"tag":"AnimalHealth"}],"urls":[{"start":70,"end":92,"url":"http://t.co/lyQeW4R1fN","expanded_url":"http://bit.ly/1b0BW6H","display_url":"bit.ly/1b0BW6H"},{"start":107,"end":129,"url":"http://t.co/ucBUvbajcG","expanded_url":"https://twitter.com/IFAHEurope/status/428181771029458946/photo/1","display_url":"pic.twitter.com/ucBUvbajcG"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428181771029458946"}],"text":"RT @IFAHEurope: Just published our 2013 Annual Report. Download here: http://t.co/lyQeW4R1fN #AnimalHealth http://t.co/ucBUvbajcG","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428189981409300480","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-28T15:37:01.000Z","id":"428189981409300480","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":["3_428181771042041856"]}},{"entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"},{"start":70,"end":77,"username":"cenmag","id":"106542267"}],"hashtags":[{"start":36,"end":42,"tag":"Drugs"}],"urls":[{"start":43,"end":65,"url":"http://t.co/pWbFfFlqSg","expanded_url":"http://cen.acs.org/articles/92/i4/Year-New-Drugs.html","display_url":"cen.acs.org/articles/92/i4…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428179159454466050"}],"text":"RT @nakosbalamotis: The Year In New #Drugs http://t.co/pWbFfFlqSg via @cenmag","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428179570513043458","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-28T14:55:39.000Z","id":"428179570513043458","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":64,"end":69,"tag":"CHMP"}],"urls":[{"start":91,"end":113,"url":"http://t.co/rL5LPR27cV","expanded_url":"http://bit.ly/L5U0SH","display_url":"bit.ly/L5U0SH"}],"annotations":{}},"referenced_tweets":{},"text":"We've published the minutes of all of our committees, including #CHMP, for the first time: http://t.co/rL5LPR27cV","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":5,"quote_count":0},"conversation_id":"428165878551937025","author_id":"116716199","source":"bitly bitlink","created_at":"2014-01-28T14:01:15.000Z","id":"428165878551937025","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":8,"username":"uicc","id":"53023973"}],"hashtags":[{"start":37,"end":52,"tag":"WorldCancerDay"}],"urls":[{"start":108,"end":130,"url":"http://t.co/F5kOCX6EsG","expanded_url":"http://ow.ly/spB1l","display_url":"ow.ly/spB1l"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428151437043187712"}],"text":"RT @uicc: Please use &amp; share the #WorldCancerDay badge to show your support on the Day! Available here: http://t.co/F5kOCX6EsG","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428154108143730689","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-28T13:14:28.000Z","id":"428154108143730689","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":65,"end":75,"tag":"medicines"},{"start":77,"end":88,"tag":"biomarkers"}],"urls":[{"start":89,"end":111,"url":"http://t.co/nwISvhw8L9","expanded_url":"http://bit.ly/1f74Ant","display_url":"bit.ly/1f74Ant"}],"annotations":{}},"referenced_tweets":{},"text":"RT @Aifa_ufficiale: An invaluable tool in the development of new #medicines, #biomarkers http://t.co/nwISvhw8L9","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"428154024362508288","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-28T13:14:08.000Z","id":"428154024362508288","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"hashtags":[{"start":14,"end":20,"tag":"H2020"}],"urls":[{"start":66,"end":88,"url":"http://t.co/uSi6zmMU3V","expanded_url":"http://dlvr.it/4p2Znq","display_url":"dlvr.it/4p2Znq"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428137912387911680"}],"text":"RT @EU_H2020: #H2020 call update: Health Co-ordination activities http://t.co/uSi6zmMU3V","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428138680327614464","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-28T12:13:10.000Z","id":"428138680327614464","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"hashtags":[{"start":14,"end":20,"tag":"H2020"}],"urls":[{"start":64,"end":86,"url":"http://t.co/1M0iYw3lEh","expanded_url":"http://dlvr.it/4p2ZkY","display_url":"dlvr.it/4p2ZkY"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428137904531972097"}],"text":"RT @EU_H2020: #H2020 call update: Personalising health and care http://t.co/1M0iYw3lEh","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428138621070479360","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-28T12:12:56.000Z","id":"428138621070479360","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"hashtags":[{"start":18,"end":28,"tag":"Hypomania"},{"start":35,"end":41,"tag":"mania"},{"start":52,"end":61,"tag":"dopamine"},{"start":85,"end":95,"tag":"Parkinson"}],"urls":[{"start":107,"end":129,"url":"http://t.co/pbtbQr8lxw","expanded_url":"http://bit.ly/1mO0EJm","display_url":"bit.ly/1mO0EJm"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428136824163164163"}],"text":"RT @euparkinsons: #Hypomania &amp; #mania related 2 #dopamine replacement therapy in #Parkinson's disease: http://t.co/pbtbQr8lxw","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428138519148912640","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-28T12:12:32.000Z","id":"428138519148912640","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":29,"end":37,"tag":"vacancy"},{"start":54,"end":68,"tag":"Communication"},{"start":105,"end":117,"tag":"recruitment"}],"urls":[{"start":81,"end":103,"url":"http://t.co/q7szO133Tt","expanded_url":"http://bit.ly/1dmcW8j","display_url":"bit.ly/1dmcW8j"}],"annotations":{}},"referenced_tweets":{},"text":"Last chance to apply for the #vacancy for Head of our #Communication Department: http://t.co/q7szO133Tt  #recruitment","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428136636296081408","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-28T12:05:03.000Z","id":"428136636296081408","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":8,"username":"uicc","id":"53023973"}],"hashtags":[{"start":45,"end":60,"tag":"WorldCancerDay"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428121126980419584"}],"text":"RT @uicc: You have something planned to mark #WorldCancerDay 2014? No matter how big or small, share it on our Map of Events: http://t.co/l…","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428122770917314561","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-28T11:09:57.000Z","id":"428122770917314561","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":10,"username":"louis_ide","id":"1548804618"}],"hashtags":{},"urls":{},"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"428095843179065344"}],"text":"@louis_ide The recommendation has been postponed because there are still issues that our pharmacovigilance committee needs answering.","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428095843179065344","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-28T09:29:02.000Z","id":"428097372871458816","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":68,"end":76,"tag":"BigData"},{"start":77,"end":86,"tag":"Patients"},{"start":87,"end":94,"tag":"Health"},{"start":95,"end":106,"tag":"Technology"}],"urls":[{"start":107,"end":129,"url":"http://t.co/4vKlxJU2qK","expanded_url":"http://bit.ly/1nbK21c","display_url":"bit.ly/1nbK21c"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428096557611626496"}],"text":"RT @EFPIA: How big data could be used to predict a patient's future #BigData #Patients #Health #Technology http://t.co/4vKlxJU2qK","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428096711324893184","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-28T09:26:24.000Z","id":"428096711324893184","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":10,"username":"louis_ide","id":"1548804618"}],"hashtags":{},"urls":[{"start":113,"end":135,"url":"http://t.co/fbKo4AMP7U","expanded_url":"http://bit.ly/15sIeYB","display_url":"bit.ly/15sIeYB"}],"annotations":[{"start":89,"end":92,"probability":0.2901,"type":"Person","normalized_text":"CMDh"}]},"referenced_tweets":{},"text":"@louis_ide We're awaiting responses to our outstanding issues now; recommendation to the CMDh expected in March: http://t.co/fbKo4AMP7U","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"428095843179065344","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-28T09:22:57.000Z","id":"428095843179065344","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"1548804618","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"eumsplatform","id":"600110872"}],"hashtags":[{"start":95,"end":113,"tag":"MultipleSclerosis"}],"urls":[{"start":114,"end":136,"url":"http://t.co/AXvW30wBGR","expanded_url":"http://www.emsp.org/news/whats-next-on-emsp-agenda/210-save-the-date-emsp-spring-confernece-2014","display_url":"emsp.org/news/whats-nex…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428093765241151488"}],"text":"RT @eumsplatform: Our Anniversary Conference is edging closer. Find registration and programme #MultipleSclerosis http://t.co/AXvW30wBGR","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428094044028547072","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-28T09:15:48.000Z","id":"428094044028547072","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":35,"end":43,"tag":"vacancy"},{"start":60,"end":74,"tag":"Communication"},{"start":111,"end":123,"tag":"recruitment"}],"urls":[{"start":87,"end":109,"url":"http://t.co/q7szO133Tt","expanded_url":"http://bit.ly/1dmcW8j","display_url":"bit.ly/1dmcW8j"}],"annotations":{}},"referenced_tweets":{},"text":"One more day left to apply for the #vacancy for Head of our #Communication Department: http://t.co/q7szO133Tt  #recruitment","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428089574116442112","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-28T08:58:02.000Z","id":"428089574116442112","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":33,"end":48,"tag":"contraceptives"}],"urls":[{"start":50,"end":72,"url":"http://t.co/KBscS6pxzV","expanded_url":"http://bit.ly/LPQqN8","display_url":"bit.ly/LPQqN8"}],"annotations":{}},"referenced_tweets":{},"text":"We started a review of emergency #contraceptives: http://t.co/KBscS6pxzV","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"428089156573470720","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-28T08:56:23.000Z","id":"428089156573470720","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"urls":[{"start":90,"end":112,"url":"http://t.co/ofUmlAUtSR","expanded_url":"http://cordis.europa.eu/news/rcn/36426_en.html","display_url":"cordis.europa.eu/news/rcn/36426…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428088971994750976"}],"text":"RT @GCessak: Assessing the long term impact of HPV screening on cervical cancer detection\nhttp://t.co/ofUmlAUtSR","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428089114702147584","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-28T08:56:13.000Z","id":"428089114702147584","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":54,"end":76,"url":"http://t.co/BzN9YLSAAu","expanded_url":"http://bit.ly/KPtsVt","display_url":"bit.ly/KPtsVt"}],"annotations":{}},"referenced_tweets":{},"text":"Last Friday we published the CHMP meeting highlights: http://t.co/BzN9YLSAAu","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"428088936766771200","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-28T08:55:30.000Z","id":"428088936766771200","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"CPME_EUROPA","id":"440810430"},{"start":116,"end":126,"username":"EU_Health","id":"606325697"},{"start":127,"end":139,"username":"Europarl_EN","id":"36329597"}],"hashtags":[{"start":17,"end":32,"tag":"Dataprotection"},{"start":45,"end":52,"tag":"Health"}],"urls":[{"start":93,"end":115,"url":"http://t.co/YxF2km2bgH","expanded_url":"http://bit.ly/1fgCeXv","display_url":"bit.ly/1fgCeXv"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"428088650471985152"}],"text":"RT @CPME_EUROPA: #Dataprotection regulation: #Health and medical data need special attention http://t.co/YxF2km2bgH @EU_Health @Europarl_EN…","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"428088908375941121","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-28T08:55:23.000Z","id":"428088908375941121","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"hashtags":[{"start":97,"end":103,"tag":"payer"},{"start":104,"end":115,"tag":"healthcare"}],"urls":[{"start":74,"end":96,"url":"http://t.co/v7aqLfzMcS","expanded_url":"http://www.bloomberg.com/news/2014-01-27/at-84-000-gilead-hepatitis-c-drug-sets-off-payer-revolt.html","display_url":"bloomberg.com/news/2014-01-2…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"427862688396750848"}],"text":"RT @DrugInfoAssn: Payers Push Back Against Expensive New Medicines’ Costs.http://t.co/v7aqLfzMcS #payer #healthcare","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"427891792064032768","author_id":"116716199","source":"Twitter for iPhone","created_at":"2014-01-27T19:52:07.000Z","id":"427891792064032768","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"hashtags":{},"urls":[{"start":109,"end":131,"url":"http://t.co/IPhS1YAqhm","expanded_url":"http://bit.ly/1f1QxPY","display_url":"bit.ly/1f1QxPY"}],"annotations":{}},"referenced_tweets":{},"text":"RT @agesnews: Wanted: Communication expert (public health), doctor (epidemiology of infection), SAP support: http://t.co/IPhS1YAqhm","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"427816957703127040","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-27T14:54:45.000Z","id":"427816957703127040","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"},{"start":52,"end":61,"username":"ECDC_Flu","id":"1371668696"}],"hashtags":[{"start":14,"end":24,"tag":"Influenza"}],"urls":[{"start":96,"end":118,"url":"http://t.co/xrv2poT6eR","expanded_url":"http://bit.ly/1aCqeRY","display_url":"bit.ly/1aCqeRY"},{"start":120,"end":142,"url":"http://t.co/D2uyZ4Tcdk","expanded_url":"http://bit.ly/1f1P1gE","display_url":"bit.ly/1f1P1gE"}],"annotations":{}},"referenced_tweets":{},"text":"RT @agesnews: #Influenza -current European figures  @ECDC_Flu weekly report &amp; infographics: http://t.co/xrv2poT6eR  http://t.co/D2uyZ4Tcdk","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"427815702448578560","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-27T14:49:46.000Z","id":"427815702448578560","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":50,"end":58,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":14,"end":24,"tag":"Influenza"},{"start":66,"end":70,"tag":"flu"}],"urls":[{"start":113,"end":135,"url":"http://t.co/g4UdLjf9Qf","expanded_url":"http://bit.ly/1aREy3n","display_url":"bit.ly/1aREy3n"}],"annotations":[{"start":28,"end":33,"probability":0.9939,"type":"Place","normalized_text":"Europe"}]},"referenced_tweets":[{"type":"retweeted","id":"427789828155899904"}],"text":"RT @ECDC_Flu: #Influenza in Europe at a glance in @ECDC_EU weekly #flu infographics &amp; more in weekly report: http://t.co/g4UdLjf9Qf http://…","public_metrics":{"retweet_count":35,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"427815288827314176","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-27T14:48:07.000Z","id":"427815288827314176","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":27,"end":31,"tag":"Flu"},{"start":55,"end":63,"tag":"science"},{"start":87,"end":94,"tag":"health"},{"start":95,"end":104,"tag":"research"}],"urls":[{"start":64,"end":86,"url":"http://t.co/4QefCMxTyY","expanded_url":"http://apne.ws/1clbiWX","display_url":"apne.ws/1clbiWX"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"427782648547643392"}],"text":"RT @EFPIA: Want to get the #Flu? Volunteers sneeze for #science http://t.co/4QefCMxTyY #health #research","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"427815039983423488","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-27T14:47:08.000Z","id":"427815039983423488","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"hashtags":[{"start":19,"end":31,"tag":"OncologyPRO"}],"urls":[{"start":102,"end":124,"url":"http://t.co/qiTmA4MdmQ","expanded_url":"http://ow.ly/sYU6K","display_url":"ow.ly/sYU6K"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"427777868001583104"}],"text":"RT @myESMO: New on #OncologyPRO: view all content of our scientific &amp; educational portal by topic http://t.co/qiTmA4MdmQ http://t.co/XMnVsv…","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"427814583257280512","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-27T14:45:19.000Z","id":"427814583257280512","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"hashtags":[{"start":60,"end":68,"tag":"Generic"},{"start":69,"end":74,"tag":"Drug"},{"start":75,"end":84,"tag":"Labeling"},{"start":115,"end":119,"tag":"FDA"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"427777287241478144"}],"text":"RT @nakosbalamotis: Lawmakers Express “Grave Concerns” with #Generic #Drug #Labeling Proposal; Demand Answers from #FDA http://t.co/H8sPEcW…","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"427814572628914176","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-27T14:45:17.000Z","id":"427814572628914176","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":99,"end":106,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":[{"start":107,"end":111,"tag":"IMI"}],"urls":[{"start":76,"end":98,"url":"http://t.co/IdNZKBK75w","expanded_url":"http://bit.ly/1hDNgH0","display_url":"bit.ly/1hDNgH0"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"427770822636208129"}],"text":"RT @EFPIA: MEPs vote for new public-private scheme for innovative medicines http://t.co/IdNZKBK75w @IMI_JU #IMI","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"427771919526817793","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-27T11:55:47.000Z","id":"427771919526817793","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"hashtags":{},"urls":[{"start":121,"end":143,"url":"http://t.co/Imgix9L1wG","expanded_url":"http://bit.ly/1erEIPV","display_url":"bit.ly/1erEIPV"}],"annotations":{}},"referenced_tweets":{},"text":"RT @URPLWMiPB: Information on the position of the CHMP on restricting the use of creams Linoladiol N &amp; Linoladiol HN http://t.co/Imgix9L1wG","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"427744419530702848","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-27T10:06:31.000Z","id":"427744419530702848","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"hashtags":{},"urls":[{"start":118,"end":140,"url":"http://t.co/3mp0Pl43Eb","expanded_url":"http://bit.ly/1erEmIV","display_url":"bit.ly/1erEmIV"}],"annotations":[{"start":82,"end":95,"probability":0.3903,"type":"Organization","normalized_text":"Kogenate Bayer"},{"start":101,"end":115,"probability":0.5358,"type":"Organization","normalized_text":"Helixate NexGen"}]},"referenced_tweets":{},"text":"RT @URPLWMiPB: Information on the position of the CHMP on the use of the products Kogenate Bayer and Helixate NexGen.\nhttp://t.co/3mp0Pl43Eb","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"427743603071680512","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-27T10:03:16.000Z","id":"427743603071680512","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":19,"end":26,"tag":"animal"},{"start":27,"end":35,"tag":"welfare"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"427742806065438720"}],"text":"RT @EFPIA: Putting #animal #welfare principles and 3Rs into action: European Pharmaceutical Industry 2012 Report Update http://t.co/TEbCmoq…","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"427742924051611648","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-27T10:00:34.000Z","id":"427742924051611648","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":74,"end":85,"tag":"veterinary"},{"start":86,"end":93,"tag":"NSAIDs"}],"urls":[{"start":95,"end":117,"url":"http://t.co/42m5jnCWwB","expanded_url":"http://bit.ly/1jso4qB","display_url":"bit.ly/1jso4qB"}],"annotations":{}},"referenced_tweets":{},"text":"Last week we published a guideline on the conduct of efficacy studies for #veterinary #NSAIDs: http://t.co/42m5jnCWwB","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"427742292162523136","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-27T09:58:04.000Z","id":"427742292162523136","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"urls":[{"start":79,"end":101,"url":"http://t.co/ar95huOQfv","expanded_url":"http://bit.ly/1erDaW1","display_url":"bit.ly/1erDaW1"}],"annotations":{}},"referenced_tweets":{},"text":"RT @GCessak: Information on second-generation products containing factor VIII: http://t.co/ar95huOQfv","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"427740856729477120","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-27T09:52:21.000Z","id":"427740856729477120","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"urls":[{"start":97,"end":119,"url":"http://t.co/KEJiIH0zAW","expanded_url":"http://bit.ly/1erD40G","display_url":"bit.ly/1erD40G"}],"annotations":{}},"referenced_tweets":{},"text":"RT @GCessak: Information on the restriction of the use of creams Linoladiol N and Linoladiol HN: http://t.co/KEJiIH0zAW","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"427740576998772737","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-27T09:51:15.000Z","id":"427740576998772737","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"eular_org","id":"273422795"},{"start":36,"end":44,"username":"ARD_BMJ","id":"138744646"}],"hashtags":[{"start":86,"end":92,"tag":"EULAR"},{"start":125,"end":128,"tag":"RA"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"427738186597400577"}],"text":"RT @eular_org: One of the most read @ARD_BMJ articles at the moment is an update on a #EULAR recommendation for the mgmt. of #RA : http://t…","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"427740399663579137","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-27T09:50:32.000Z","id":"427740399663579137","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":8,"username":"Bontrop","id":"3148384150"}],"hashtags":{},"urls":[{"start":47,"end":69,"url":"http://t.co/rtRAGqmWa5","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"426997100833153024"}],"text":"@Bontrop Please forward your question to us at http://t.co/rtRAGqmWa5 so that we can respond to you directly and in full.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426681749369024512","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-27T09:49:00.000Z","id":"427740009903718400","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"60281159","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":105,"end":119,"username":"FightTheFakes","id":"1860605736"}],"hashtags":[{"start":59,"end":71,"tag":"counterfeit"}],"urls":[{"start":82,"end":104,"url":"http://t.co/hZMV0K1GWk","expanded_url":"http://bit.ly/1lfOgXa","display_url":"bit.ly/1lfOgXa"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"427730808514695168"}],"text":"RT @EFPIA: EFPIA DG Richard Bergström on the fight against #counterfeit medicines http://t.co/hZMV0K1GWk @FightTheFakes","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"427738875512246272","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-27T09:44:29.000Z","id":"427738875512246272","possibly_sensitive":false,"lang":"da","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"hashtags":{},"urls":[{"start":60,"end":82,"url":"http://t.co/TauCenQmbK","expanded_url":"http://bit.ly/1erBFqO","display_url":"bit.ly/1erBFqO"}],"annotations":{}},"referenced_tweets":{},"text":"RT @INFARMED_IP: Emergency contraceptives - start of review http://t.co/TauCenQmbK","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"427737505988108288","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-27T09:39:03.000Z","id":"427737505988108288","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"hashtags":{},"urls":[{"start":100,"end":122,"url":"http://t.co/s93b9FopMt","expanded_url":"http://1.usa.gov/1aKEaGd","display_url":"1.usa.gov/1aKEaGd"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426770916874256385"}],"text":"RT @FDAanimalhealth: It's Animal Feed Friday. Watch this video on  Understand Medicated Feed Labels http://t.co/s93b9FopMt","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426772096929517568","author_id":"116716199","source":"Twitter for iPhone","created_at":"2014-01-24T17:42:51.000Z","id":"426772096929517568","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"},{"start":116,"end":127,"username":"bmj_latest","id":"16949344"}],"hashtags":[{"start":48,"end":52,"tag":"HPV"},{"start":75,"end":82,"tag":"cancer"}],"urls":[{"start":93,"end":115,"url":"http://t.co/Vxq4SRtpW3","expanded_url":"http://cordis.europa.eu/news/rcn/36426_en.html","display_url":"cordis.europa.eu/news/rcn/36426…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426766689204596736"}],"text":"RT @myCORDIS: Assessing the long term impact of #HPV screening on cervical #cancer detection http://t.co/Vxq4SRtpW3 @bmj_latest","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426771865940819968","author_id":"116716199","source":"Twitter for iPhone","created_at":"2014-01-24T17:41:56.000Z","id":"426771865940819968","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":52,"end":56,"tag":"flu"},{"start":58,"end":66,"tag":"measles"},{"start":68,"end":76,"tag":"rubella"},{"start":78,"end":83,"tag":"H7N9"},{"start":85,"end":90,"tag":"MERS"},{"start":96,"end":108,"tag":"chikungunya"},{"start":110,"end":115,"tag":"zika"},{"start":117,"end":123,"tag":"polio"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426732109651521536"}],"text":"RT @ECDC_EU: Our weekly threat report has latest on #flu, #measles, #rubella, #H7N9, #MERS-CoV, #chikungunya, #zika, #polio &amp;more: http://t…","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426732401205993472","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T15:05:07.000Z","id":"426732401205993472","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":8,"username":"uicc","id":"53023973"}],"hashtags":[{"start":10,"end":14,"tag":"TIL"},{"start":73,"end":81,"tag":"cancers"},{"start":92,"end":107,"tag":"WorldCancerDay"},{"start":108,"end":126,"tag":"DebunkCancerMyths"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426732070757761024"}],"text":"RT @uicc: #TIL that chronic infections are estimated to cause 16% of all #cancers globally. #WorldCancerDay #DebunkCancerMyths","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426732363213979648","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T15:04:58.000Z","id":"426732363213979648","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":18,"end":29,"tag":"Regulatory"},{"start":42,"end":53,"tag":"biosimilar"},{"start":66,"end":74,"tag":"Nigeria"}],"urls":[{"start":75,"end":97,"url":"http://t.co/xBqPA0wlFF","expanded_url":"http://www.pharmaafrica.com/regulatory-pathway-for-biosimilar-products-in-nigeria/","display_url":"pharmaafrica.com/regulatory-pat…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426728793105911808"}],"text":"RT @sailinsomnia: #Regulatory pathway for #biosimilar products in #Nigeria http://t.co/xBqPA0wlFF","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426729610412584960","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T14:54:02.000Z","id":"426729610412584960","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":18,"end":23,"tag":"CHMP"},{"start":39,"end":49,"tag":"Medicines"},{"start":100,"end":104,"tag":"EMA"}],"urls":[{"start":77,"end":99,"url":"http://t.co/2D6gvlFXYp","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/01/news_detail_002009.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426726261868605440"}],"text":"RT @sailinsomnia: #CHMP Recommends Six #Medicines for Approval, Rejects Four http://t.co/2D6gvlFXYp #EMA","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426726645878489088","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T14:42:15.000Z","id":"426726645878489088","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":108,"end":116,"username":"Reuters","id":"1652541"}],"hashtags":[{"start":18,"end":24,"tag":"India"},{"start":27,"end":35,"tag":"Ranbaxy"},{"start":43,"end":47,"tag":"FDA"},{"start":74,"end":80,"tag":"plant"}],"urls":[{"start":81,"end":103,"url":"http://t.co/ogJk8PE2QM","expanded_url":"http://reut.rs/1jGWiEf","display_url":"reut.rs/1jGWiEf"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426725156191358976"}],"text":"RT @sailinsomnia: #India's #Ranbaxy hit by #FDA product ban at 4th Indian #plant http://t.co/ogJk8PE2QM via @reuters","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426726571693862912","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T14:41:57.000Z","id":"426726571693862912","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"hashtags":[{"start":63,"end":73,"tag":"influenza"}],"urls":[{"start":110,"end":132,"url":"http://t.co/g4UdLjf9Qf","expanded_url":"http://bit.ly/1aREy3n","display_url":"bit.ly/1aREy3n"}],"annotations":[{"start":87,"end":92,"probability":0.9831,"type":"Place","normalized_text":"Europe"}]},"referenced_tweets":[{"type":"retweeted","id":"426717934145110016"}],"text":"RT @ECDC_Flu: Growing proportion of lab tests are positive for #influenza virus across Europe; 32% in week 3: http://t.co/g4UdLjf9Qf","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426718189108854784","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T14:08:38.000Z","id":"426718189108854784","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"hashtags":{},"urls":{},"annotations":[{"start":75,"end":87,"probability":0.5125,"type":"Organization","normalized_text":"EAHP Congress"}]},"referenced_tweets":[{"type":"retweeted","id":"426713612091023360"}],"text":"RT @EAHPtweet: Dont miss a January bargain - just one week left to get the EAHP Congress discount fee. Programme &amp; info here http://t.co/Uv…","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426713660829220864","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T13:50:39.000Z","id":"426713660829220864","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":85,"end":95,"username":"PMLiVEcom","id":"45543166"}],"hashtags":[{"start":11,"end":24,"tag":"INFOGRAPHICS"},{"start":46,"end":53,"tag":"pharma"},{"start":54,"end":61,"tag":"health"}],"urls":[{"start":62,"end":84,"url":"http://t.co/jByMbnzwfu","expanded_url":"http://bit.ly/1aP1GTl","display_url":"bit.ly/1aP1GTl"},{"start":96,"end":118,"url":"http://t.co/EQttWEWHzG","expanded_url":"https://twitter.com/EFPIA/status/426713050897342464/photo/1","display_url":"pic.twitter.com/EQttWEWHzG"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426713050897342464"}],"text":"RT @EFPIA: #INFOGRAPHICS : Orphan drug market #pharma #health http://t.co/jByMbnzwfu @PMLiVEcom http://t.co/EQttWEWHzG","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426713565727186944","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T13:50:16.000Z","id":"426713565727186944","possibly_sensitive":false,"lang":"da","attachments":{"media_keys":["3_426713050905731072"]}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":55,"end":60,"tag":"IMI2"},{"start":61,"end":69,"tag":"BigData"},{"start":70,"end":78,"tag":"Science"},{"start":79,"end":86,"tag":"Health"}],"urls":[{"start":88,"end":110,"url":"http://t.co/NCW36eMgON","expanded_url":"http://bit.ly/1aOBDvs","display_url":"bit.ly/1aOBDvs"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426710429432172545"}],"text":"RT @EFPIA: It's FRIDAY! Our weekly Newsletter is OUT - #IMI2 #BigData #Science #Health  http://t.co/NCW36eMgON","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426713384906936320","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T13:49:33.000Z","id":"426713384906936320","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":72,"end":83,"tag":"veterinary"},{"start":84,"end":91,"tag":"NSAIDs"}],"urls":[{"start":93,"end":115,"url":"http://t.co/5mpCX68ZKW","expanded_url":"http://bit.ly/1jso4qB","display_url":"bit.ly/1jso4qB"}],"annotations":{}},"referenced_tweets":{},"text":"We've just published a guideline on the conduct of efficacy studies for #veterinary #NSAIDs: http://t.co/5mpCX68ZKW","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"426710469299417088","author_id":"116716199","source":"bitly bitlink","created_at":"2014-01-24T13:37:58.000Z","id":"426710469299417088","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":8,"username":"uicc","id":"53023973"}],"hashtags":[{"start":37,"end":52,"tag":"WorldCancerDay"}],"urls":[{"start":108,"end":130,"url":"http://t.co/euPBiycxy0","expanded_url":"http://ow.ly/spAxW","display_url":"ow.ly/spAxW"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426701506185007104"}],"text":"RT @uicc: Please use &amp; share the #WorldCancerDay badge to show your support on the Day! Available here: http://t.co/euPBiycxy0","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426707338742222848","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T13:25:32.000Z","id":"426707338742222848","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EUTenders","id":"294046348"}],"hashtags":[{"start":15,"end":27,"tag":"Horizon2020"},{"start":76,"end":98,"tag":"businessopportunities"},{"start":102,"end":111,"tag":"research"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426694715116118016"}],"text":"RT @EUTenders: #Horizon2020 \"research and innovation mean growth and jobs\". #businessopportunities on #research in all EU are on TED http:/…","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426695066753990656","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T12:36:46.000Z","id":"426695066753990656","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":106,"end":110,"tag":"ALS"}],"urls":[{"start":112,"end":134,"url":"http://t.co/l1OLxmq096","expanded_url":"http://bit.ly/Lo9Xoe","display_url":"bit.ly/Lo9Xoe"}],"annotations":{}},"referenced_tweets":{},"text":"One more week to comment on our guideline on medicines for the treatment of amyotrophic lateral sclerosis #ALS: http://t.co/l1OLxmq096","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426694694270017537","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-24T12:35:17.000Z","id":"426694694270017537","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":101,"end":114,"tag":"hypertension"}],"urls":[{"start":116,"end":138,"url":"http://t.co/v5dygHNGA4","expanded_url":"http://bit.ly/KmWGe9","display_url":"bit.ly/KmWGe9"}],"annotations":{}},"referenced_tweets":{},"text":"One more week to comment on our guideline on clinical investigation of medicines in the treatment of #hypertension: http://t.co/v5dygHNGA4","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"426694494784716800","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-24T12:34:29.000Z","id":"426694494784716800","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":90,"end":101,"tag":"withdrawal"}],"urls":[{"start":111,"end":133,"url":"http://t.co/ee3XNmieSU","expanded_url":"http://bit.ly/1dANpe9","display_url":"bit.ly/1dANpe9"}],"annotations":{}},"referenced_tweets":{},"text":"One more week to comment on revision of guidance on the approach towards harmonisation of #withdrawal periods: http://t.co/ee3XNmieSU","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426694292887703552","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-24T12:33:41.000Z","id":"426694292887703552","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":18,"end":23,"tag":"Drug"},{"start":24,"end":31,"tag":"patent"},{"start":47,"end":54,"tag":"pharma"},{"start":66,"end":77,"tag":"innovation"},{"start":79,"end":88,"tag":"research"}],"urls":[{"start":89,"end":111,"url":"http://t.co/PdMFOrk4Xx","expanded_url":"http://businessdayonline.com/2014/01/drug-patent-cliff-to-drive-pharma-firms-into-innovation-research/","display_url":"businessdayonline.com/2014/01/drug-p…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426692579543879680"}],"text":"RT @sailinsomnia: #Drug #patent cliff to drive #pharma firms into #innovation, #research http://t.co/PdMFOrk4Xx","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426693982010490880","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T12:32:27.000Z","id":"426693982010490880","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":{},"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"426692465543114752"}],"text":"@PinkyG123 Applicants receive an official notification of the opinions on their applications in the week after each meeting.","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"426690896747589632","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T12:30:16.000Z","id":"426693433563291648","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"1506550260","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":118,"end":140,"url":"http://t.co/rtRAGqmWa5","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"426691417575276544"}],"text":"@PinkyG123 Information on line extensions will be in the minutes, published next month. You can send us a question at http://t.co/rtRAGqmWa5","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"conversation_id":"426690896747589632","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T12:25:04.000Z","id":"426692122541293568","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"1506550260","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":36,"end":51,"tag":"contraceptives"}],"urls":[{"start":53,"end":75,"url":"http://t.co/6FJ0akVFp1","expanded_url":"http://bit.ly/LPQqN8","display_url":"bit.ly/LPQqN8"}],"annotations":{}},"referenced_tweets":{},"text":"We've started a review of emergency #contraceptives: http://t.co/6FJ0akVFp1","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":3,"quote_count":0},"conversation_id":"426691399715946497","author_id":"116716199","source":"bitly bitlink","created_at":"2014-01-24T12:22:11.000Z","id":"426691399715946497","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":50,"end":72,"url":"http://t.co/RGxpoOfGNh","expanded_url":"http://bit.ly/KPtsVt","display_url":"bit.ly/KPtsVt"}],"annotations":{}},"referenced_tweets":{},"text":"We've just published the CHMP meeting highlights: http://t.co/RGxpoOfGNh","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"426690896747589632","author_id":"116716199","source":"bitly bitlink","created_at":"2014-01-24T12:20:11.000Z","id":"426690896747589632","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":13,"username":"FinansciCenk","id":"362772214"}],"hashtags":{},"urls":[{"start":110,"end":132,"url":"http://t.co/rtRAGqmWa5","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"426682285224521728"}],"text":"@FinansciCenk This will be in the minutes of the meeting, published next month. You can send us a question at http://t.co/rtRAGqmWa5","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426682285224521728","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T11:56:10.000Z","id":"426684849018404864","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"362772214","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"Igznl","id":"1601603352"}],"hashtags":[{"start":80,"end":84,"tag":"IGZ"}],"urls":[{"start":85,"end":107,"url":"http://t.co/2JCCWkzxRy","expanded_url":"http://bit.ly/1itiRP8","display_url":"bit.ly/1itiRP8"}],"annotations":[{"start":15,"end":25,"probability":0.8397,"type":"Place","normalized_text":"Netherlands"}]},"referenced_tweets":{},"text":"RT @igznl: The Netherlands refuses Ranbaxy raw materials for medicinal products #IGZ\nhttp://t.co/2JCCWkzxRy","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"426681749369024512","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T11:43:51.000Z","id":"426681749369024512","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":8,"username":"uicc","id":"53023973"}],"hashtags":[{"start":45,"end":60,"tag":"WorldCancerDay"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426671284362440704"}],"text":"RT @uicc: You have something planned to mark #WorldCancerDay 2014? No matter how big or small, share it on our Map of Events: http://t.co/a…","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426673524879925248","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T11:11:10.000Z","id":"426673524879925248","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":111,"end":118,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":[{"start":55,"end":60,"tag":"IMI2"},{"start":61,"end":69,"tag":"BigData"},{"start":70,"end":78,"tag":"Science"},{"start":79,"end":86,"tag":"Health"}],"urls":[{"start":88,"end":110,"url":"http://t.co/NCW36eMgON","expanded_url":"http://bit.ly/1aOBDvs","display_url":"bit.ly/1aOBDvs"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426664422757527553"}],"text":"RT @EFPIA: It's FRIDAY! Our weekly Newsletter is OUT - #IMI2 #BigData #Science #Health  http://t.co/NCW36eMgON @IMI_JU","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426665684261949440","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T10:40:00.000Z","id":"426665684261949440","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"hashtags":[{"start":100,"end":115,"tag":"WorldCancerDay"}],"urls":[{"start":66,"end":88,"url":"http://t.co/eARx1JxB7d","expanded_url":"http://www.cancerresearchuk.org/cancer-info/cancerstats/causes/infectiousagents/hepatitisviruses/hepatitis-viruses-and-cancer","display_url":"cancerresearchuk.org/cancer-info/ca…"}],"annotations":[{"start":18,"end":26,"probability":0.2712,"type":"Other","normalized_text":"Hep C & B"}]},"referenced_tweets":[{"type":"retweeted","id":"426662755181940736"}],"text":"RT @Hep_Alliance: Hep C &amp; B is the main cause of liver cancer http://t.co/eARx1JxB7d feb 4th is #WorldCancerDay pls show your support","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426665571791667200","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T10:39:34.000Z","id":"426665571791667200","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"hashtags":{},"urls":[{"start":46,"end":68,"url":"http://t.co/LFVgX0Y1Ir","expanded_url":"http://www.worldcancerday.org/","display_url":"worldcancerday.org"}],"annotations":[{"start":29,"end":44,"probability":0.4599,"type":"Other","normalized_text":"World Cancer Day"}]},"referenced_tweets":[{"type":"retweeted","id":"426662500478623744"}],"text":"RT @Hep_Alliance: Feb 4th is World Cancer Day http://t.co/LFVgX0Y1Ir did you know chronic hepatitis B &amp; C causes 75-80% of liver cancers di…","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426665522345050112","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T10:39:22.000Z","id":"426665522345050112","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":90,"end":101,"tag":"withdrawal"}],"urls":[{"start":111,"end":133,"url":"http://t.co/sfstXoyBqs","expanded_url":"http://bit.ly/1dANpe9","display_url":"bit.ly/1dANpe9"}],"annotations":{}},"referenced_tweets":{},"text":"One week left to comment on revision of guidance on the approach towards harmonisation of #withdrawal periods: http://t.co/sfstXoyBqs","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426648320397029376","author_id":"116716199","source":"bitly bitlink","created_at":"2014-01-24T09:31:00.000Z","id":"426648320397029376","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":101,"end":114,"tag":"hypertension"}],"urls":[{"start":116,"end":138,"url":"http://t.co/GUXusFvTI9","expanded_url":"http://bit.ly/KmWGe9","display_url":"bit.ly/KmWGe9"}],"annotations":{}},"referenced_tweets":{},"text":"One week left to comment on our guideline on clinical investigation of medicines in the treatment of #hypertension: http://t.co/GUXusFvTI9","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426647849464786944","author_id":"116716199","source":"bitly bitlink","created_at":"2014-01-24T09:29:08.000Z","id":"426647849464786944","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":106,"end":110,"tag":"ALS"}],"urls":[{"start":112,"end":134,"url":"http://t.co/eVLX7dS45P","expanded_url":"http://bit.ly/Lo9Xoe","display_url":"bit.ly/Lo9Xoe"}],"annotations":{}},"referenced_tweets":{},"text":"One week left to comment on our guideline on medicines for the treatment of amyotrophic lateral sclerosis #ALS: http://t.co/eVLX7dS45P","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426647448212492288","author_id":"116716199","source":"bitly bitlink","created_at":"2014-01-24T09:27:33.000Z","id":"426647448212492288","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"},{"start":72,"end":81,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":95,"end":107,"tag":"PrimaryCare"}],"urls":{},"annotations":[{"start":46,"end":70,"probability":0.4131,"type":"Organization","normalized_text":"European Medicines Agency"}]},"referenced_tweets":[{"type":"retweeted","id":"426641426365952000"}],"text":"RT @PrimaryCare4um: EFPC has been accepted by European Medicines Agency @EMA_News to represent #PrimaryCare professionals in EMA actions ht…","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426646462777524224","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T09:23:38.000Z","id":"426646462777524224","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"hashtags":[{"start":68,"end":80,"tag":"RareDisease"}],"urls":[{"start":101,"end":123,"url":"http://t.co/1k0Ljg4hGq","expanded_url":"http://ow.ly/sMXPC","display_url":"ow.ly/sMXPC"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426635559969513472"}],"text":"RT @rarediseaseday: 21 ways anyone can participate in International #RareDisease Day 2014 on Feb. 28 http://t.co/1k0Ljg4hGq\nJoin Together f…","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426644880807702528","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-24T09:17:20.000Z","id":"426644880807702528","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":18,"end":23,"tag":"EDQM"},{"start":55,"end":59,"tag":"ISO"},{"start":102,"end":113,"tag":"laboratory"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426396331687419905"}],"text":"RT @sailinsomnia: #EDQM announces the extension of its #ISO 9001:2008 Certification to the conduct of #laboratory studies  -  http://t.co/o…","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426409866450968576","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-23T17:43:29.000Z","id":"426409866450968576","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"hashtags":[{"start":21,"end":39,"tag":"ResearchHeadlines"},{"start":58,"end":65,"tag":"Cancer"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426343123401183232"}],"text":"RT @innovationunion: #ResearchHeadlines - Ground-breaking #Cancer research: Cancer treatment is one of the most important areas of... http:…","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426355183720075264","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-23T14:06:11.000Z","id":"426355183720075264","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"JNNP_BMJ","id":"136288884"}],"hashtags":[{"start":53,"end":63,"tag":"Parkinson"},{"start":75,"end":79,"tag":"DBS"},{"start":80,"end":83,"tag":"PD"},{"start":84,"end":93,"tag":"movement"},{"start":94,"end":97,"tag":"MD"}],"urls":[{"start":98,"end":120,"url":"http://t.co/CvDGrT1m0m","expanded_url":"http://m.jnnp.bmj.com/content/early/2014/01/20/jnnp-2013-306090","display_url":"m.jnnp.bmj.com/content/early/…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426096218138091520"}],"text":"RT @JNNP_BMJ: Which target is best for patients with #Parkinson's disease? #DBS #PD #movement #MD http://t.co/CvDGrT1m0m","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426354565861359616","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-23T14:03:44.000Z","id":"426354565861359616","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":102,"end":111,"username":"guardian","id":"87818409"}],"hashtags":[{"start":21,"end":29,"tag":"bigdata"},{"start":112,"end":119,"tag":"health"}],"urls":[{"start":75,"end":97,"url":"http://t.co/vRCNd736P3","expanded_url":"http://gu.com/p/3mv2k/tw","display_url":"gu.com/p/3mv2k/tw"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426275603055009792"}],"text":"RT @EU_eHealth: \"How #bigdata could be used to predict a patient's future\" http://t.co/vRCNd736P3 via @guardian #health","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426287579802370048","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-23T09:37:33.000Z","id":"426287579802370048","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":12,"username":"thedanalyst","id":"614450788"}],"hashtags":{},"urls":{},"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"426049086538534912"}],"text":"@thedanalyst Yes that's correct. We will publish the January minutes after the February meeting.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425673392335773697","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T17:50:45.000Z","id":"426049306790219776","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"614450788","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":12,"username":"thedanalyst","id":"614450788"}],"hashtags":{},"urls":{},"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"426046517380513794"}],"text":"@thedanalyst We were referring to the December minutes. Minutes are adopted during the following month's meeting and published afterwards.","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"425673392335773697","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T17:46:55.000Z","id":"426048345074049024","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"614450788","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":12,"username":"thedanalyst","id":"614450788"}],"hashtags":{},"urls":[{"start":117,"end":139,"url":"http://t.co/tgGL9p4r9N","expanded_url":"http://bit.ly/1eSRmZC","display_url":"bit.ly/1eSRmZC"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"426044437924298752"}],"text":"@thedanalyst We will be publishing the minutes after this week's meeting where they are being adopted, on this page: http://t.co/tgGL9p4r9N","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"425673392335773697","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T17:37:01.000Z","id":"426045852231426048","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"614450788","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":98,"end":102,"tag":"FDA"}],"urls":[{"start":104,"end":126,"url":"http://t.co/TH29QmRc46","expanded_url":"http://patientnetwork.fda.gov/get-involved/e-newsletter/some-wart-removers-are-flammable","display_url":"patientnetwork.fda.gov/get-involved/e…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426043239791992832"}],"text":"RT @US_FDA: Here is the most recent bi-weekly Patient Network Newsletter with all the latest from #FDA. http://t.co/TH29QmRc46","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426044865408139264","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T17:33:06.000Z","id":"426044865408139264","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"EP_Environment","id":"951333319"}],"hashtags":[{"start":20,"end":35,"tag":"Clinicaltrials"}],"urls":[{"start":83,"end":105,"url":"http://t.co/h0d8oCdPSa","expanded_url":"http://bit.ly/1f6DSM7","display_url":"bit.ly/1f6DSM7"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426026844521889792"}],"text":"RT @EP_Environment: #Clinicaltrials: clearer rules, better protection for patients http://t.co/h0d8oCdPSa","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426028823147462656","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T16:29:21.000Z","id":"426028823147462656","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"hashtags":[{"start":47,"end":52,"tag":"EJHP"},{"start":100,"end":104,"tag":"HIV"},{"start":105,"end":118,"tag":"polypharmacy"},{"start":125,"end":135,"tag":"labelling"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"426018037368504320"}],"text":"RT @EAHPtweet: Dont miss the latest edition of #EJHP published online this wk. Includes articles on #HIV #polypharmacy &amp; #labelling http://…","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426024926773276672","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T16:13:52.000Z","id":"426024926773276672","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":8,"username":"uicc","id":"53023973"}],"hashtags":[{"start":63,"end":78,"tag":"WorldCancerDay"},{"start":79,"end":87,"tag":"toolkit"},{"start":92,"end":100,"tag":"members"}],"urls":[{"start":109,"end":131,"url":"http://t.co/6llBo6gZg3","expanded_url":"http://instagram.com/p/jecHJzChTb/","display_url":"instagram.com/p/jecHJzChTb/"}],"annotations":[{"start":41,"end":56,"probability":0.6732,"type":"Other","normalized_text":"World Cancer Day"}]},"referenced_tweets":[{"type":"retweeted","id":"426009027857108992"}],"text":"RT @uicc: Want some ideas on how to mark World Cancer Day? The #WorldCancerDay #toolkit for #members is now… http://t.co/6llBo6gZg3","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426011129652199424","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T15:19:02.000Z","id":"426011129652199424","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":{},"annotations":[{"start":89,"end":102,"probability":0.5358,"type":"Place","normalized_text":"United Kingdom"}]},"referenced_tweets":[{"type":"replied_to","id":"426005088952659968"}],"text":"@coraya82 We will publish the highlights of this week's meeting this Friday around noon (United Kingdom time).","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426005088952659968","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T15:00:23.000Z","id":"426006433021587456","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"21536238","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"urls":[{"start":39,"end":61,"url":"http://t.co/uPCoBavMqn","expanded_url":"http://bit.ly/1msrpTA","display_url":"bit.ly/1msrpTA"},{"start":62,"end":84,"url":"http://t.co/4trzO0AW8p","expanded_url":"http://bit.ly/1f6lxiv","display_url":"bit.ly/1f6lxiv"}],"annotations":{}},"referenced_tweets":{},"text":"RT @GCessak: Read the package leaflet: http://t.co/uPCoBavMqn http://t.co/4trzO0AW8p","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"426000589479477248","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T14:37:09.000Z","id":"426000589479477248","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"hashtags":{},"urls":[{"start":40,"end":62,"url":"http://t.co/Da9xBbNZ04","expanded_url":"http://bit.ly/1msr1Vj","display_url":"bit.ly/1msr1Vj"}],"annotations":{}},"referenced_tweets":{},"text":"RT @URPLWMiPB: Read the package leaflet http://t.co/Da9xBbNZ04","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"426000111534346240","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T14:35:15.000Z","id":"426000111534346240","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":8,"username":"uicc","id":"53023973"}],"hashtags":[{"start":18,"end":33,"tag":"WorldCancerDay"}],"urls":[{"start":90,"end":112,"url":"http://t.co/vOP79Fyryi","expanded_url":"http://ow.ly/spA9K","display_url":"ow.ly/spA9K"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"425976749504339968"}],"text":"RT @uicc: Use the #WorldCancerDay Poster &amp; Postcards to mark the Day! Available here: http://t.co/vOP79Fyryi","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425999801504006144","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T14:34:02.000Z","id":"425999801504006144","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"}],"hashtags":[{"start":48,"end":52,"tag":"flu"},{"start":96,"end":106,"tag":"influenza"},{"start":107,"end":118,"tag":"prevention"},{"start":119,"end":130,"tag":"healthcare"}],"urls":[{"start":73,"end":95,"url":"http://t.co/njwmbamWmK","expanded_url":"http://bit.ly/1jyJEr3","display_url":"bit.ly/1jyJEr3"}],"annotations":[{"start":13,"end":25,"probability":0.6175,"type":"Organization","normalized_text":"EU Commission"}]},"referenced_tweets":[{"type":"retweeted","id":"425971417612423168"}],"text":"RT @EPHA_EU: EU Commission report reveals unmet #flu vaccination targets:http://t.co/njwmbamWmK #influenza #prevention #healthcare #vaccina…","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425999370430189568","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T14:32:19.000Z","id":"425999370430189568","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":45,"end":50,"tag":"H7N9"}],"urls":[{"start":51,"end":73,"url":"http://t.co/FzuN0s6xDC","expanded_url":"http://goo.gl/9TMAOT","display_url":"goo.gl/9TMAOT"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"425961475790733312"}],"text":"RT @WHO: Latest WHO Disease Outbreak News on #H7N9 http://t.co/FzuN0s6xDC (22 January 2014)","public_metrics":{"retweet_count":73,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425998971551879168","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T14:30:44.000Z","id":"425998971551879168","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":30,"end":38,"tag":"vacancy"},{"start":55,"end":69,"tag":"Communication"},{"start":120,"end":132,"tag":"recruitment"}],"urls":[{"start":97,"end":119,"url":"http://t.co/q7szO133Tt","expanded_url":"http://bit.ly/1dmcW8j","display_url":"bit.ly/1dmcW8j"}],"annotations":{}},"referenced_tweets":{},"text":"The deadline to apply for the #vacancy for Head of our #Communication Department is in one week: http://t.co/q7szO133Tt #recruitment","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425992483428790272","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-22T14:04:57.000Z","id":"425992483428790272","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":{},"annotations":[{"start":88,"end":101,"probability":0.5358,"type":"Place","normalized_text":"United Kingdom"}]},"referenced_tweets":[{"type":"replied_to","id":"425958288560521216"}],"text":"@Masrybs We will publish the highlights of this week's meeting this Friday around noon (United Kingdom time).","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425958288560521216","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T11:50:32.000Z","id":"425958657529221120","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"738341252","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"hashtags":[{"start":49,"end":59,"tag":"Parkinson"},{"start":62,"end":70,"tag":"Disease"}],"urls":[{"start":90,"end":112,"url":"http://t.co/Q352Vog3Z9","expanded_url":"http://bit.ly/O15CaG","display_url":"bit.ly/O15CaG"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"425952392794742784"}],"text":"RT @euparkinsons: Stay up-2-date with the latest #Parkinson's #Disease research articles: http://t.co/Q352Vog3Z9","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425952689277911040","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T11:26:49.000Z","id":"425952689277911040","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"hashtags":[{"start":102,"end":108,"tag":"H2020"}],"urls":[{"start":109,"end":131,"url":"http://t.co/VIEJYDEe3t","expanded_url":"http://dlvr.it/4lTfrk","display_url":"dlvr.it/4lTfrk"}],"annotations":[{"start":16,"end":37,"probability":0.4989,"type":"Person","normalized_text":"Commissioner GEOGHEGAN"}]},"referenced_tweets":[{"type":"retweeted","id":"425951208248197120"}],"text":"RT @EU_eHealth: Commissioner GEOGHEGAN-QUINN speech: We need to do better on research and innovation! #H2020 http://t.co/VIEJYDEe3t @EU_H20…","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425952511552274432","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T11:26:07.000Z","id":"425952511552274432","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":8,"username":"uicc","id":"53023973"}],"hashtags":[{"start":45,"end":60,"tag":"WorldCancerDay"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"425946317358374913"}],"text":"RT @uicc: You have something planned to mark #WorldCancerDay 2014? No matter how big or small, share it on our Map of Events: http://t.co/A…","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425949656183750656","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T11:14:46.000Z","id":"425949656183750656","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":56,"end":70,"tag":"Communication"},{"start":107,"end":119,"tag":"recruitment"}],"urls":[{"start":83,"end":105,"url":"http://t.co/q7szO133Tt","expanded_url":"http://bit.ly/1dmcW8j","display_url":"bit.ly/1dmcW8j"}],"annotations":{}},"referenced_tweets":{},"text":"One week left to apply for the #vacancy for Head of our #Communication Department: http://t.co/q7szO133Tt  #recruitment","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"425943492494233600","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-22T10:50:16.000Z","id":"425943492494233600","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"urls":[{"start":118,"end":140,"url":"http://t.co/jfJGXOltgy","expanded_url":"http://bit.ly/1f5FYMs","display_url":"bit.ly/1f5FYMs"}],"annotations":[{"start":100,"end":115,"probability":0.5131,"type":"Organization","normalized_text":"Safety Committee"}]},"referenced_tweets":{},"text":"RT @GCessak: Presentation from press conference - Safe Drugs \"Dissemination of information from the Safety Committee\" http://t.co/jfJGXOltgy","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":3,"quote_count":0},"conversation_id":"425932234604814337","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T10:05:32.000Z","id":"425932234604814337","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":38,"end":48,"username":"EAHPtweet","id":"203357203"},{"start":81,"end":90,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":49,"end":52,"tag":"EU"},{"start":123,"end":135,"tag":"horizon2020"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"425916813709283329"}],"text":"RT @EAHPtweet: Hotoffthepress! Latest @EAHPtweet #EU Monitor includes news on an @EMA_News medicines shortage portal &amp; #horizon2020 http://…","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425930618594418688","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T09:59:07.000Z","id":"425930618594418688","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":109,"end":118,"username":"eurordis","id":"26993786"}],"hashtags":{},"urls":[{"start":86,"end":108,"url":"http://t.co/lhY4tmRAVv","expanded_url":"http://www.rare-diseases.eu/","display_url":"rare-diseases.eu"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"425915365265125376"}],"text":"RT @EFPIA: ECRD 2014 : The European Conference on Rare Diseases &amp; Orphan Products http://t.co/lhY4tmRAVv @eurordis","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425930488365084672","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T09:58:36.000Z","id":"425930488365084672","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":111,"end":119,"tag":"BigData"},{"start":120,"end":127,"tag":"Pharma"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"425911381938798592"}],"text":"RT @EFPIA: BLOG - Making the Case for Big Data: Swedish Study Offers Real Evidence of Real World Data’s Impact #BigData #Pharma http://t.co…","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425929861580877825","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T09:56:07.000Z","id":"425929861580877825","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":11,"username":"Arrrrmatey","id":"344763008"}],"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/vxL1N38CvL","expanded_url":"http://bit.ly/1dTDssj","display_url":"bit.ly/1dTDssj"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"425704264661360640"}],"text":"@Arrrrmatey Scenesse is not authorised yet. This month, our committee is discussing a list of outstanding issues: http://t.co/vxL1N38CvL","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425704264661360640","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T09:49:59.000Z","id":"425928319054258176","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"344763008","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":12,"username":"thedanalyst","id":"614450788"}],"hashtags":{},"urls":{},"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"425691010442596352"}],"text":"@thedanalyst It will be included in the minutes from the meeting.","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"425673392335773697","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-22T09:43:49.000Z","id":"425926768411697152","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"614450788","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":12,"username":"thedanalyst","id":"614450788"}],"hashtags":{},"urls":{},"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"425673392335773697"}],"text":"@thedanalyst Not necessarily, it depends on whether CHMP has more questions that the company needs to answer.","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"425673392335773697","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-21T17:43:59.000Z","id":"425685220067921920","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"614450788","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":13,"username":"KaiGriebenow","id":"423776545"},{"start":14,"end":21,"username":"dsobek","id":"243801041"},{"start":22,"end":33,"username":"Masdeutaff","id":"597154294"}],"hashtags":{},"urls":[{"start":94,"end":116,"url":"http://t.co/11nNPPeBxP","expanded_url":"http://bit.ly/LO8I1U","display_url":"bit.ly/LO8I1U"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"425668560501751808"}],"text":"@KaiGriebenow @dsobek @Masdeutaff 17-20 Feb 2014. See our calendar for all forthcoming dates: http://t.co/11nNPPeBxP","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"425666668686090240","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-21T16:41:09.000Z","id":"425669403863433216","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"423776545","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":11,"username":"Masdeutaff","id":"597154294"}],"hashtags":{},"urls":{},"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"425655211177574400"}],"text":"@Masdeutaff It will be discussed, with an oral explanation by the applicant, but it is not expected to go for opinion this week.","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"425655211177574400","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-21T15:58:07.000Z","id":"425658574606729216","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"597154294","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"},{"start":25,"end":41,"username":"DigitalAgendaEU","id":"2894539229"}],"hashtags":[{"start":82,"end":89,"tag":"Cancer"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"425620565030735872"}],"text":"RT @innovationunion: via @DigitalAgendaEU Video: How to optimise radiotherapy for #Cancer treatment?: This video explains how the... http:/…","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425626904998469632","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-21T13:52:16.000Z","id":"425626904998469632","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"hashtags":[{"start":71,"end":84,"tag":"RareDiseases"}],"urls":[{"start":110,"end":132,"url":"http://t.co/unYgZPKMKh","expanded_url":"http://ow.ly/sMMKq","display_url":"ow.ly/sMMKq"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"425572587474014208"}],"text":"RT @eurordis: Advanced online programme for the European Conference on #RareDiseases is NOW available online. http://t.co/unYgZPKMKh May 8-…","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425577133558087680","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-21T10:34:30.000Z","id":"425577133558087680","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"hashtags":{},"urls":[{"start":115,"end":138,"url":"https://t.co/AYdIZV5CDR","expanded_url":"https://www.topra.org/hta14","display_url":"topra.org/hta14"}],"annotations":[{"start":106,"end":111,"probability":0.9923,"type":"Place","normalized_text":"London"}]},"referenced_tweets":[{"type":"retweeted","id":"425574567667449856"}],"text":"RT @NICEcomms: Sign up for the NICE-TOPRA pharma workshop on health technology assessment. March 19-20 in London : https://t.co/AYdIZV5CDR","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425577059121778688","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-21T10:34:12.000Z","id":"425577059121778688","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":29,"end":43,"tag":"Levetiracetam"},{"start":55,"end":63,"tag":"generic"},{"start":67,"end":74,"tag":"Keppra"},{"start":84,"end":93,"tag":"epilepsy"}],"urls":[{"start":95,"end":117,"url":"http://t.co/q0a2bRVd5c","expanded_url":"http://bit.ly/1e4EosY","display_url":"bit.ly/1e4EosY"}],"annotations":{}},"referenced_tweets":{},"text":"We've published the EPAR for #Levetiracetam Hospira, a #generic of #Keppra to treat #epilepsy: http://t.co/q0a2bRVd5c","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425569931795521536","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-21T10:05:53.000Z","id":"425569931795521536","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":[{"start":65,"end":87,"url":"http://t.co/t5vBbsrYl9","expanded_url":"http://bit.ly/1dAXr0q","display_url":"bit.ly/1dAXr0q"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"425336398234001409"}],"text":"@PinkyG123 The agenda is now published, apologies for the delay: http://t.co/t5vBbsrYl9","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425336398234001409","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-21T10:03:54.000Z","id":"425569434699169792","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"1506550260","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":12,"end":21,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":93,"end":115,"url":"http://t.co/PCGafNo5sr","expanded_url":"http://bit.ly/1mkyhm1","display_url":"bit.ly/1mkyhm1"}],"annotations":[{"start":71,"end":76,"probability":0.9945,"type":"Place","normalized_text":"London"}]},"referenced_tweets":{},"text":"This year's @EMA_News / @IFAHEurope info day is on 13-14 March 2014 in London. Register now: http://t.co/PCGafNo5sr","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"425566738093076480","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-21T09:53:11.000Z","id":"425566738093076480","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":45,"end":50,"tag":"H7N9"}],"urls":[{"start":51,"end":73,"url":"http://t.co/VzwjDhOhLf","expanded_url":"http://goo.gl/W06UiN","display_url":"goo.gl/W06UiN"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"425319879865278464"}],"text":"RT @WHO: Latest WHO Disease Outbreak News on #H7N9 http://t.co/VzwjDhOhLf (20 January 2014 - with 16 additional lab-confirmed cases)","public_metrics":{"retweet_count":55,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425320186330095616","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T17:33:29.000Z","id":"425320186330095616","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":9,"end":15,"tag":"China"},{"start":80,"end":85,"tag":"H7N9"}],"urls":[{"start":86,"end":108,"url":"http://t.co/VzwjDhOhLf","expanded_url":"http://goo.gl/W06UiN","display_url":"goo.gl/W06UiN"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"425317252666519553"}],"text":"RT @WHO: #China has notified WHO of 16 additional laboratory-confirmed cases of #H7N9 http://t.co/VzwjDhOhLf","public_metrics":{"retweet_count":52,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425320155795554304","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T17:33:21.000Z","id":"425320155795554304","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"hashtags":{},"urls":[{"start":100,"end":122,"url":"http://t.co/NTV41xvMvz","expanded_url":"http://bit.ly/1dJAW9v","display_url":"bit.ly/1dJAW9v"}],"annotations":{}},"referenced_tweets":{},"text":"RT @INFARMED_IP: Counterfeiting of products Restylane and Restylane Perlane - Manufacturer Q-MED AB http://t.co/NTV41xvMvz","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425310435827412992","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T16:54:44.000Z","id":"425310435827412992","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":18,"end":29,"tag":"Scientists"},{"start":92,"end":101,"tag":"bacteria"},{"start":115,"end":127,"tag":"antibiotics"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"425306856831991808"}],"text":"RT @sailinsomnia: #Scientists develop new class of molecules that provide new way to attack #bacteria resistant to #antibiotics http://t.co…","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425306957151354882","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T16:40:55.000Z","id":"425306957151354882","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":13,"end":25,"tag":"Chikungunya"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"425304828777349120"}],"text":"RT @ECDC_EU: #Chikungunya fever in the Caribbean region: 485 cases reported on several islands,see latest update &amp; risk assessment http://t…","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425306453717422080","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T16:38:55.000Z","id":"425306453717422080","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":12,"username":"Wolf_S_Punk","id":"1171771501"}],"hashtags":{},"urls":[{"start":88,"end":110,"url":"http://t.co/tSRpVODW4a","expanded_url":"http://bit.ly/1e5UEKk","display_url":"bit.ly/1e5UEKk"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"425302255202340865"}],"text":"@Wolf_S_Punk All documents mentioning mefloquine are listed in the search results here: http://t.co/tSRpVODW4a","public_metrics":{"retweet_count":0,"reply_count":4,"like_count":0,"quote_count":0},"conversation_id":"425288995694592001","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T16:26:45.000Z","id":"425303392982798336","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"1171771501","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":12,"username":"Wolf_S_Punk","id":"1171771501"}],"hashtags":{},"urls":[{"start":58,"end":80,"url":"http://t.co/rMxJXKOpHn","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"425298339249135616"}],"text":"@Wolf_S_Punk Please forward your precise request to us at http://t.co/rMxJXKOpHn so that we can investigate and reply to you in full.","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"425288995694592001","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T16:09:05.000Z","id":"425298945850347520","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"1171771501","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":12,"username":"Wolf_S_Punk","id":"1171771501"}],"hashtags":{},"urls":[{"start":107,"end":129,"url":"http://t.co/rMxJXKOpHn","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"425293604198686720"}],"text":"@Wolf_S_Punk To get a more detailed answer, please send your questions and requests for documents to us at http://t.co/rMxJXKOpHn.","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"conversation_id":"425288995694592001","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T15:49:31.000Z","id":"425294022588895232","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"1171771501","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":12,"username":"Wolf_S_Punk","id":"1171771501"}],"hashtags":{},"urls":{},"annotations":[{"start":46,"end":51,"probability":0.3707,"type":"Organization","normalized_text":"Lariam"}]},"referenced_tweets":[{"type":"replied_to","id":"425287357923721216"}],"text":"@Wolf_S_Punk We have not published an EPAR on Lariam because it is authorised at national level, and not centrally at European Union level.","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"425287357923721216","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T15:40:00.000Z","id":"425291626890539008","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"1171771501","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":12,"username":"Wolf_S_Punk","id":"1171771501"}],"hashtags":[{"start":61,"end":79,"tag":"pharmacovigilance"}],"urls":[{"start":116,"end":138,"url":"http://t.co/vwyRLJn4cW","expanded_url":"http://bit.ly/1aE7m2w","display_url":"bit.ly/1aE7m2w"}],"annotations":[{"start":13,"end":22,"probability":0.5122,"type":"Person","normalized_text":"Mefloquine"}]},"referenced_tweets":[{"type":"replied_to","id":"425288995694592001"}],"text":"@Wolf_S_Punk Mefloquine has not been referred to us, but our #pharmacovigilance committee is looking into a signal: http://t.co/vwyRLJn4cW","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"425288995694592001","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T15:38:41.000Z","id":"425291295620206592","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"1171771501","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"},{"start":84,"end":95,"username":"luca__pani","id":"2176193576"}],"hashtags":[{"start":20,"end":28,"tag":"Bigdata"},{"start":61,"end":70,"tag":"medicine"}],"urls":[{"start":110,"end":132,"url":"http://t.co/iECvEx2gqS","expanded_url":"http://bit.ly/1h9f3i5","display_url":"bit.ly/1h9f3i5"}],"annotations":{}},"referenced_tweets":{},"text":"RT @Aifa_ufficiale: #Bigdata is revolutionising the world of #medicine according to @luca__pani (Special Tg1) http://t.co/iECvEx2gqS","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"425286926082396161","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T15:21:19.000Z","id":"425286926082396161","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":{},"urls":[{"start":76,"end":98,"url":"http://t.co/b6Qggmm5Wo","expanded_url":"http://bloom.bg/1docPHj","display_url":"bloom.bg/1docPHj"}],"annotations":[{"start":11,"end":17,"probability":0.9905,"type":"Place","normalized_text":"Germany"}]},"referenced_tweets":[{"type":"retweeted","id":"425281768954929152"}],"text":"RT @EFPIA: Germany Finds Mad Cow Disease in Bovine in First Case Since 2009 http://t.co/b6Qggmm5Wo","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425281988304461824","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T15:01:42.000Z","id":"425281988304461824","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"hashtags":[{"start":18,"end":28,"tag":"Parkinson"},{"start":42,"end":47,"tag":"gene"}],"urls":[{"start":82,"end":104,"url":"http://t.co/UUYwRhlvM4","expanded_url":"http://bit.ly/1h8xQu3","display_url":"bit.ly/1h8xQu3"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"425281715464962051"}],"text":"RT @euparkinsons: #Parkinson's: update on #gene therapy, fetal cell transplants - http://t.co/UUYwRhlvM4","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425281875171487744","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T15:01:15.000Z","id":"425281875171487744","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":21,"end":30,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":89,"end":111,"url":"http://t.co/9VM39ogNAc","expanded_url":"http://bit.ly/1mkyhm1","display_url":"bit.ly/1mkyhm1"}],"annotations":[{"start":81,"end":86,"probability":0.9935,"type":"Place","normalized_text":"London"}]},"referenced_tweets":{},"text":"Register now for the @EMA_News / @IFAHEurope info day 2014 - 13-14 March 2014 in London: http://t.co/9VM39ogNAc","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425276914325278720","author_id":"116716199","source":"bitly bitlink","created_at":"2014-01-20T14:41:32.000Z","id":"425276914325278720","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":42,"end":56,"tag":"Levetiracetam"},{"start":68,"end":76,"tag":"generic"},{"start":80,"end":87,"tag":"Keppra"},{"start":97,"end":106,"tag":"epilepsy"}],"urls":[{"start":108,"end":130,"url":"http://t.co/SI2Os2FXlp","expanded_url":"http://bit.ly/1e4EosY","display_url":"bit.ly/1e4EosY"}],"annotations":{}},"referenced_tweets":{},"text":"We've published the assessment report for #Levetiracetam Hospira, a #generic of #Keppra to treat #epilepsy: http://t.co/SI2Os2FXlp","public_metrics":{"retweet_count":4,"reply_count":3,"like_count":1,"quote_count":0},"conversation_id":"425275897512755200","author_id":"116716199","source":"bitly bitlink","created_at":"2014-01-20T14:37:29.000Z","id":"425275897512755200","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":9,"end":19,"tag":"medicines"}],"urls":[{"start":110,"end":132,"url":"http://t.co/FVBAbq3W7N","expanded_url":"http://bit.ly/1jhnSKI","display_url":"bit.ly/1jhnSKI"}],"annotations":{}},"referenced_tweets":{},"text":"81 human #medicines recommended for marketing authorisation in 2013, including 38 with new active substances: http://t.co/FVBAbq3W7N","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"425274507679383552","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-20T14:31:58.000Z","id":"425274507679383552","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":[{"start":83,"end":94,"tag":"veterinary"}],"urls":[{"start":106,"end":128,"url":"http://t.co/3bnBaNeKJ7","expanded_url":"http://bit.ly/1bd7LWw","display_url":"bit.ly/1bd7LWw"}],"annotations":{}},"referenced_tweets":{},"text":"In 2013, we saw a record number of 23 applications for marketing authorisation for #veterinary medicines: http://t.co/3bnBaNeKJ7","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425274392394727424","author_id":"116716199","source":"Twitter Web Client","created_at":"2014-01-20T14:31:31.000Z","id":"425274392394727424","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"hashtags":{},"urls":[{"start":115,"end":137,"url":"http://t.co/QnMSoAREDf","expanded_url":"http://bit.ly/1jnliQS","display_url":"bit.ly/1jnliQS"}],"annotations":[{"start":57,"end":75,"probability":0.8174,"type":"Organization","normalized_text":"EU Medicines Agency"}]},"referenced_tweets":{},"text":"RT @agesnews: 2013 trend in vet medicines - according to EU Medicines Agency increased requests for immunologicals http://t.co/QnMSoAREDf","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425273585259671552","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T14:28:18.000Z","id":"425273585259671552","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"},{"start":44,"end":53,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":105,"end":127,"url":"http://t.co/TYEpToKiQV","expanded_url":"http://bit.ly/KwWVDD","display_url":"bit.ly/KwWVDD"}],"annotations":{}},"referenced_tweets":{},"text":"RT @agesnews: The European Medicines Agency @EMA_News recommended approval of 81 human medicines in 2013 http://t.co/TYEpToKiQV - 57 in 2012","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"425273155691618304","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T14:26:36.000Z","id":"425273155691618304","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":8,"username":"uicc","id":"53023973"}],"hashtags":[{"start":23,"end":38,"tag":"WorldCancerDay"},{"start":120,"end":138,"tag":"debunkcancermyths"}],"urls":[{"start":68,"end":90,"url":"http://t.co/zQu3AVt13H","expanded_url":"http://ow.ly/spzUr","display_url":"ow.ly/spzUr"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"425252280649408512"}],"text":"RT @uicc: Download the #WorldCancerDay 2014 campaign materials here http://t.co/zQu3AVt13H and disseminate them to help #debunkcancermyths","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425271830715187201","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T14:21:20.000Z","id":"425271830715187201","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"hashtags":[{"start":77,"end":87,"tag":"Parkinson"}],"urls":[{"start":99,"end":121,"url":"http://t.co/eNbzgnMY0J","expanded_url":"http://bit.ly/1aDk6q0","display_url":"bit.ly/1aDk6q0"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"425251515301761025"}],"text":"RT @euparkinsons: Cerebrospinal fluid lysosomal enzymes &amp; α-synuclein in #Parkinson's disease: http://t.co/eNbzgnMY0J","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425271801736728576","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T14:21:13.000Z","id":"425271801736728576","possibly_sensitive":false,"lang":"und","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"hashtags":{},"urls":{},"annotations":{}},"referenced_tweets":[{"type":"replied_to","id":"425267917044064256"}],"text":"@PinkyG123 We're aiming to publish the agenda later today.","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425267917044064256","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T14:18:48.000Z","id":"425271192707014656","possibly_sensitive":false,"lang":"en","in_reply_to_user_id":"1506550260","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":82,"end":91,"tag":"Research"},{"start":92,"end":99,"tag":"Health"}],"urls":[{"start":59,"end":81,"url":"http://t.co/oLpjC61r2p","expanded_url":"http://bit.ly/1aDBWZW","display_url":"bit.ly/1aDBWZW"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"425236984458526720"}],"text":"RT @EFPIA: Clever chemistry and a new class of antibiotics http://t.co/oLpjC61r2p #Research #Health","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425267521055236096","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T14:04:12.000Z","id":"425267521055236096","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"hashtags":[{"start":18,"end":26,"tag":"Impulse"},{"start":59,"end":69,"tag":"Parkinson"},{"start":86,"end":95,"tag":"dopamine"}],"urls":{},"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"425236412112199682"}],"text":"RT @euparkinsons: #Impulse control disorder in patients w/ #Parkinson's disease under #dopamine agonist therapy: A multicentre study - http…","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425267444475633664","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T14:03:54.000Z","id":"425267444475633664","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"urls":[{"start":77,"end":99,"url":"http://t.co/fWnbhmj6DA","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/01/news_detail_002006.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":[{"start":13,"end":15,"probability":0.6119,"type":"Organization","normalized_text":"EMA"}]},"referenced_tweets":[{"type":"retweeted","id":"425231379995951105"}],"text":"RT @GCessak: EMA recommends 81 medicines for marketing authorisation in 2013\nhttp://t.co/fWnbhmj6DA","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425231426645016576","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T11:40:47.000Z","id":"425231426645016576","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"urls":[{"start":81,"end":103,"url":"http://t.co/mz74vU4tJv","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/01/news_detail_002008.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{}},"referenced_tweets":[{"type":"retweeted","id":"425231249087528960"}],"text":"RT @GCessak: Trends in initial evaluation of veterinary medicines by EMA in 2013 http://t.co/mz74vU4tJv","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"425231412606685185","author_id":"116716199","source":"TweetDeck","created_at":"2014-01-20T11:40:43.000Z","id":"425231412606685185","possibly_sensitive":false,"lang":"en","attachments":{"media_keys":{}}}]
